9312027	Zinc (II) ion	Durocher D	The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors.	The EMBO journal	1997	132
10924499	Zinc (II) ion	Tipnis SR	A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase.	The Journal of biological chemistry	2000	207
11223883	Zinc (II) ion	Turner AJ	The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function.	BioEssays 	2001	96
12960961	Zinc (II) ion	Wang X	Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.	Nature medicine	2003	129
15249177	Zinc (II) ion	Pikkarainen S	GATA transcription factors in the developing and adult heart.	Cardiovascular research	2004	93
15802564	Zinc (II) ion	Lange S	The kinase domain of titin controls muscle gene expression and protein turnover.	Science	2005	151
16456111	Zinc (II) ion	Khachigian LM	Early growth response-1 in cardiovascular pathobiology.	Circulation research	2006	67
16652230	Zinc (II) ion	Ram M	Matrix metalloproteinase-9 and autoimmune diseases.	Journal of clinical immunology	2006	60
17082479	Zinc (II) ion	Schefe JH	A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein.	Circulation research	2006	63
18480265	Zinc (II) ion	Juarez JC	Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
19208838	Zinc (II) ion	Devy L	Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.	Cancer research	2009	92
19566488	Zinc (II) ion	Niu J	Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.	Clinical science	2009	46
19656780	Zinc (II) ion	Kandasamy AD	Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix.	Cardiovascular research	2010	46
21183627	Zinc (II) ion	Bouchard C	Genomic predictors of the maximal O₂ uptake response to standardized exercise training programs.	Journal of applied physiology	2011	65
22223213	Zinc (II) ion	Kolattukudy PE	Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway.	Circulation research	2012	54
22449843	Zinc (II) ion	Zhou P	Regulation of GATA4 transcriptional activity in cardiovascular development and disease.	Current topics in developmental biology	2012	33
22840421	Zinc (II) ion	AREDS2 Research Group.	The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).	Ophthalmology	2012	42
23840100	Zinc (II) ion	Chen Q	Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.	Mediators of inflammation	2013	53
24584071	Zinc (II) ion	Flannick J	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.	Nature genetics	2014	118
24626089	Zinc (II) ion	Nakaya T	KLF5 regulates the integrity and oncogenicity of intestinal stem cells.	Cancer research	2014	24
25082577	Zinc (II) ion	Wang Y	Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.	Journal of the American College of Cardiology	2014	33
26025392	Zinc (II) ion	Kelwick R	The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family.	Genome biology	2015	49
26343967	Zinc (II) ion	Valko M	Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.	Archives of toxicology	2016	38
26875865	Zinc (II) ion	Luna-Zurita L	Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis.	Cell	2016	22
27288011	Zinc (II) ion	Mallipattu SK	Krüppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers.	Journal of the American Society of Nephrology 	2017	8
27597529	Zinc (II) ion	Wolk A	Potential health hazards of eating red meat.	Journal of internal medicine	2017	7
10696506	ADP	Abbott NJ	Inflammatory mediators and modulation of blood-brain barrier permeability.	Cellular and molecular neurobiology	2000	149
11196645	ADP	Hollopeter G	Identification of the platelet ADP receptor targeted by antithrombotic drugs.	Nature	2001	211
11413167	ADP	Foster CJ	Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.	The Journal of clinical investigation	2001	88
11854119	ADP	Ziccardi P	Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.	Circulation	2002	139
12223530	ADP	Virág L	The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.	Pharmacological reviews	2002	280
12716823	ADP	Ceriello A	New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.	Diabetes care	2003	121
15319286	ADP	Eltzschig HK	Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism.	Blood	2004	129
15716268	ADP	Nemoto S	SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}.	The Journal of biological chemistry	2005	306
18317590	ADP	Carneiro AM	Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.	The Journal of clinical investigation	2008	57
18480426	ADP	Dona M	Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.	Blood	2008	72
19118249	ADP	Marcucci R	Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.	Circulation	2009	54
19220204	ADP	Vanhoutte PM	Endothelial dysfunction and vascular disease.	Acta physiologica	2009	134
19706858	ADP	Shuldiner AR	Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.	JAMA	2009	261
19717846	ADP	Wallentin L	Ticagrelor versus clopidogrel in patients with acute coronary syndromes.	The New England journal of medicine	2009	497
20082095	ADP	Michel T	Cellular signaling and NO production.	Pflugers Archiv 	2010	53
21498777	ADP	Leffler CW	Carbon monoxide as an endogenous vascular modulator.	American journal of physiology. Heart and circulatory physiology	2011	39
21974986	ADP	Otvos L Jr	Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.	BMC biotechnology	2011	37
22319497	ADP	Carafa V	Sirtuins and disease: the road ahead.	Frontiers in pharmacology	2012	34
22702974	ADP	Carling D	AMP-activated protein kinase: new regulation, new roles?	The Biochemical journal	2012	94
23111421	ADP	Lewis JP	The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.	Pharmacogenetics and genomics	2013	33
23201774	ADP	Cardus A	SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence.	Cardiovascular research	2013	36
24076493	ADP	Tantry US	Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.	Journal of the American College of Cardiology	2013	68
24958846	ADP	Canault M	Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.	The Journal of experimental medicine	2014	22
26112889	ADP	Winnik S	Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.	European heart journal	2015	42
26706498	ADP	Vanhoutte PM	Endothelial dysfunction and vascular disease - a 30th anniversary update.	Acta physiologica	2017	27
26948035	ADP	Kida Y	Sirtuins, Cell Senescence, and Vascular Aging.	The Canadian journal of cardiology	2016	14
27780585	ADP	Menzies RI	Purinergic signaling in kidney disease.	Kidney international	2017	11
27881304	ADP	Yang W	Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization.	Cell	2016	15
7733230	Adenosine triphosphate	Nelson MT	Physiological roles and properties of potassium channels in arterial smooth muscle.	The American journal of physiology	1995	384
8618962	Adenosine triphosphate	Navar LG	Paracrine regulation of the renal microcirculation.	Physiological reviews	1996	116
10431237	Adenosine triphosphate	Bodzioch M	The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.	Nature genetics	1999	258
11264476	Adenosine triphosphate	Linden J	Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.	Annual review of pharmacology and toxicology	2001	171
11274139	Adenosine triphosphate	Kamradt MC	The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation.	The Journal of biological chemistry	2001	89
11309497	Adenosine triphosphate	Oliver WR Jr	A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.	Proceedings of the National Academy of Sciences of the United States of America	2001	178
11371514	Adenosine triphosphate	Blair E	Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.	Human molecular genetics	2001	96
11756336	Adenosine triphosphate	Ido Y	Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.	Diabetes	2002	87
12202460	Adenosine triphosphate	Chiang JY	Bile acid regulation of gene expression: roles of nuclear hormone receptors.	Endocrine reviews	2002	93
12788940	Adenosine triphosphate	Nagata D	AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress.	The Journal of biological chemistry	2003	103
14962470	Adenosine triphosphate	Halestrap AP	Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.	Cardiovascular research	2004	217
15001541	Adenosine triphosphate	O'Rourke B	Evidence for mitochondrial K+ channels and their role in cardioprotection.	Circulation research	2004	89
15023549	Adenosine triphosphate	Tamargo J	Pharmacology of cardiac potassium channels.	Cardiovascular research	2004	75
15034580	Adenosine triphosphate	Bienengraeber M	ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.	Nature genetics	2004	108
15041652	Adenosine triphosphate	Györke I	The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.	Biophysical journal	2004	151
15210959	Adenosine triphosphate	Wang N	ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.	Proceedings of the National Academy of Sciences of the United States of America	2004	194
15326314	Adenosine triphosphate	Bergt C	The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.	Proceedings of the National Academy of Sciences of the United States of America	2004	112
15375023	Adenosine triphosphate	Huss JM	Nuclear receptor signaling and cardiac energetics.	Circulation research	2004	111
15504342	Adenosine triphosphate	Cacicedo JM	AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.	Biochemical and biophysical research communications	2004	83
15717060	Adenosine triphosphate	Löscher W	Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.	NeuroRx 	2005	111
15804979	Adenosine triphosphate	Jackson WF	Potassium channels in the peripheral microcirculation.	Microcirculation	2005	94
15883415	Adenosine triphosphate	Nair KS	Aging muscle.	The American journal of clinical nutrition	2005	89
15910878	Adenosine triphosphate	Kane GC	Cardiac KATP channels in health and disease.	Journal of molecular and cellular cardiology	2005	70
16098463	Adenosine triphosphate	Moeller BJ	Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.	Cancer cell	2005	111
16183915	Adenosine triphosphate	Oram JF	ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.	Physiological reviews	2005	128
16357084	Adenosine triphosphate	Koehler RC	Role of astrocytes in cerebrovascular regulation.	Journal of applied physiology	2006	69
16394089	Adenosine triphosphate	Kupelian V	Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.	The Journal of clinical endocrinology and metabolism	2006	79
16452478	Adenosine triphosphate	Ullah MS	The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.	The Journal of biological chemistry	2006	171
16644800	Adenosine triphosphate	Hardie DG	AMP-activated protein kinase--development of the energy sensor concept.	The Journal of physiology	2006	210
16685256	Adenosine triphosphate	Kanmogne GD	HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.	Journal of cerebral blood flow and metabolism 	2007	81
16862155	Adenosine triphosphate	Wong CW	Connexin37 protects against atherosclerosis by regulating monocyte adhesion.	Nature medicine	2006	77
17095732	Adenosine triphosphate	Oram JF	ATP-Binding cassette cholesterol transporters and cardiovascular disease.	Circulation research	2006	115
17237240	Adenosine triphosphate	Zhang DX	Mitochondrial reactive oxygen species-mediated signaling in endothelial cells.	American journal of physiology. Heart and circulatory physiology	2007	107
17332438	Adenosine triphosphate	Arad M	AMP-activated protein kinase in the heart: role during health and disease.	Circulation research	2007	92
17377202	Adenosine triphosphate	Łowicka E	Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists.	Pharmacological reports 	2007	107
17418790	Adenosine triphosphate	Fukuda R	HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells.	Cell	2007	290
17488637	Adenosine triphosphate	Dufour CR	Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma.	Cell metabolism	2007	139
17872460	Adenosine triphosphate	Miragoli M	Myofibroblasts induce ectopic activity in cardiac tissue.	Circulation research	2007	78
18006487	Adenosine triphosphate	Gustafsson AB	Heart mitochondria: gates of life and death.	Cardiovascular research	2008	95
18048761	Adenosine triphosphate	Ferdinandy P	Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.	Pharmacological reviews	2007	157
18271871	Adenosine triphosphate	Tall AR	Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.	Journal of internal medicine	2008	125
18309108	Adenosine triphosphate	Kim JA	Role of mitochondrial dysfunction in insulin resistance.	Circulation research	2008	193
18353444	Adenosine triphosphate	Russel FG	Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules.	Trends in pharmacological sciences	2008	81
18375237	Adenosine triphosphate	Kamanna VS	Mechanism of action of niacin.	The American journal of cardiology	2008	65
18506004	Adenosine triphosphate	Klaassen S	Mutations in sarcomere protein genes in left ventricular noncompaction.	Circulation	2008	60
18535182	Adenosine triphosphate	Pacher P	Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.	The American journal of pathology	2008	107
18552454	Adenosine triphosphate	Ko EA	Physiological roles of K+ channels in vascular smooth muscle cells.	Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi	2008	77
18560012	Adenosine triphosphate	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	79
18924609	Adenosine triphosphate	Terasaka N	ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet.	The Journal of clinical investigation	2008	55
19008857	Adenosine triphosphate	Nishida M	P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.	The EMBO journal	2008	54
19056914	Adenosine triphosphate	Polli JW	An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-(3-fluorobenzyl)oxyphenyl}-6-5-({2-(methylsulfonyl)ethylamino}methyl)-2-furyl-4-quinazolinamine; GW572016).	Drug metabolism and disposition	2009	66
19094056	Adenosine triphosphate	Dauchy S	ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.	Journal of neurochemistry	2008	53
19158351	Adenosine triphosphate	Cirillo P	Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells.	Journal of the American Society of Nephrology 	2009	59
19168026	Adenosine triphosphate	Halestrap AP	The role of the mitochondrial permeability transition pore in heart disease.	Biochimica et biophysica acta	2009	85
19249331	Adenosine triphosphate	Fang J	Therapeutic strategies by modulating oxygen stress in cancer and inflammation.	Advanced drug delivery reviews	2009	71
19275766	Adenosine triphosphate	Wong AK	AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.	Clinical science	2009	46
19332488	Adenosine triphosphate	Hwang TC	Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation.	The Journal of physiology	2009	63
19509316	Adenosine triphosphate	Javadov S	Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases.	The Journal of pharmacology and experimental therapeutics	2009	51
19608989	Adenosine triphosphate	Fisslthaler B	Activation and signaling by the AMP-activated protein kinase in endothelial cells.	Circulation research	2009	86
19783654	Adenosine triphosphate	Tang C	The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor.	The Journal of biological chemistry	2009	85
20101004	Adenosine triphosphate	Hartz AM	Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.	Molecular pharmacology	2010	66
20103737	Adenosine triphosphate	Ruderman NB	AMPK and SIRT1: a long-standing partnership?	American journal of physiology. Endocrinology and metabolism	2010	145
20148667	Adenosine triphosphate	Baines CP	The cardiac mitochondrion: nexus of stress.	Annual review of physiology	2010	51
20466975	Adenosine triphosphate	Fryirs MA	Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.	Arteriosclerosis, thrombosis, and vascular biology	2010	45
20558321	Adenosine triphosphate	Medeiros-Domingo A	Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.	Heart rhythm	2010	72
20585624	Adenosine triphosphate	Ashrafian H	A mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathy.	PLoS genetics	2010	46
20636621	Adenosine triphosphate	Tang G	Interaction of hydrogen sulfide with ion channels.	Clinical and experimental pharmacology & physiology	2010	48
20658967	Adenosine triphosphate	Halestrap AP	A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.	Biochemical Society transactions	2010	79
20664073	Adenosine triphosphate	Flagg TP	Muscle KATP channels: recent insights to energy sensing and myoprotection.	Physiological reviews	2010	87
20724705	Adenosine triphosphate	Liu M	Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.	Circulation research	2010	57
20826314	Adenosine triphosphate	Nishijima T	Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS.	Neuron	2010	57
20884884	Adenosine triphosphate	Rowe GC	PGC-1 coactivators in cardiac development and disease.	Circulation research	2010	77
21081504	Adenosine triphosphate	Darshi M	ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function.	The Journal of biological chemistry	2011	76
21216854	Adenosine triphosphate	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	39
21240260	Adenosine triphosphate	Itzhaki I	Modelling the long QT syndrome with induced pluripotent stem cells.	Nature	2011	294
21304474	Adenosine triphosphate	Navab M	HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.	Nature reviews. Cardiology	2011	129
21351087	Adenosine triphosphate	Tang SC	Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.	International journal of cancer	2012	37
21363918	Adenosine triphosphate	Falcon BL	Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.	Cancer research	2011	38
21508263	Adenosine triphosphate	Niemi K	Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.	Journal of immunology	2011	68
21586291	Adenosine triphosphate	Fedorov VV	Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts.	Journal of molecular and cellular cardiology	2011	35
21620960	Adenosine triphosphate	Hers I	Akt signalling in health and disease.	Cellular signalling	2011	223
21707071	Adenosine triphosphate	Shawahna R	Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.	Molecular pharmaceutics	2011	55
21715610	Adenosine triphosphate	Eugenin EA	Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism.	The Journal of neuroscience 	2011	74
21967057	Adenosine triphosphate	Sharom FJ	The P-glycoprotein multidrug transporter.	Essays in biochemistry	2011	73
21979151	Adenosine triphosphate	Cole LK	Phosphatidylcholine biosynthesis and lipoprotein metabolism.	Biochimica et biophysica acta	2012	50
21983013	Adenosine triphosphate	Fusco A	Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis.	Cellular signalling	2012	33
22156303	Adenosine triphosphate	Rottiers V	MicroRNAs in metabolism and metabolic diseases.	Cold Spring Harbor symposia on quantitative biology	2011	36
22159088	Adenosine triphosphate	Gödecke S	Thrombin-induced ATP release from human umbilical vein endothelial cells.	American journal of physiology. Cell physiology	2012	35
22248732	Adenosine triphosphate	Natarajan K	Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.	Biochemical pharmacology	2012	80
22390198	Adenosine triphosphate	Wang S	AMP-activated protein kinase, stress responses and cardiovascular diseases.	Clinical science	2012	42
22586279	Adenosine triphosphate	Chokshi A	Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.	Circulation	2012	56
22678409	Adenosine triphosphate	Lohman AW	Mechanisms of ATP release and signalling in the blood vessel wall.	Cardiovascular research	2012	55
22714048	Adenosine triphosphate	Simard JM	Sulfonylurea receptor 1 in central nervous system injury: a focused review.	Journal of cerebral blood flow and metabolism 	2012	42
22798688	Adenosine triphosphate	Srivastava RA	AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.	Journal of lipid research	2012	33
22902320	Adenosine triphosphate	Dorn GW 2nd	SR and mitochondria: calcium cross-talk between kissing cousins.	Journal of molecular and cellular cardiology	2013	27
23235493	Adenosine triphosphate	Sánchez-Lozada LG	Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations.	Nephron. Experimental nephrology	2012	37
23298225	Adenosine triphosphate	Bijland S	Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation.	Clinical science	2013	39
23298398	Adenosine triphosphate	Strazielle N	Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.	Molecular pharmaceutics	2013	34
23371930	Adenosine triphosphate	Xiong Q	Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.	Circulation	2013	32
23440202	Adenosine triphosphate	Jih KY	Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
23520163	Adenosine triphosphate	Li XM	Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.	Arteriosclerosis, thrombosis, and vascular biology	2013	67
23538276	Adenosine triphosphate	Nichols CG	KATP channels and cardiovascular disease: suddenly a syndrome.	Circulation research	2013	41
23562078	Adenosine triphosphate	Sene A	Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration.	Cell metabolism	2013	56
23665396	Adenosine triphosphate	Tseng AH	SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage.	Free radical biology & medicine	2013	51
23719382	Adenosine triphosphate	Fang L	Control of angiogenesis by AIBP-mediated cholesterol efflux.	Nature	2013	38
23755363	Adenosine triphosphate	Chaudhuri D	MCU encodes the pore conducting mitochondrial calcium currents.	eLife	2013	42
24021215	Adenosine triphosphate	Stacy AE	Molecular pharmacology of ABCG2 and its role in chemoresistance.	Molecular pharmacology	2013	42
24270265	Adenosine triphosphate	Goncharov DA	Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.	Circulation	2014	38
24344269	Adenosine triphosphate	Kioka H	Evaluation of intramitochondrial ATP levels identifies G0/G1 switch gene 2 as a positive regulator of oxidative phosphorylation.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
24363178	Adenosine triphosphate	Gray LR	Regulation of pyruvate metabolism and human disease.	Cellular and molecular life sciences 	2014	42
24385509	Adenosine triphosphate	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	55
24407029	Adenosine triphosphate	Hewing B	Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	26
24439875	Adenosine triphosphate	Hu D	ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.	International journal of cardiology	2014	29
24464187	Adenosine triphosphate	Huang Y	An abundant dysfunctional apolipoprotein A1 in human atheroma.	Nature medicine	2014	55
24467431	Adenosine triphosphate	Sheng J	Electrophysiology of human cardiac atrial and ventricular telocytes.	Journal of cellular and molecular medicine	2014	25
24481950	Adenosine triphosphate	Allahverdian S	Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.	Circulation	2014	62
24647144	Adenosine triphosphate	Shao B	Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.	Circulation research	2014	45
24658400	Adenosine triphosphate	Kwong JQ	Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy.	Cell death and differentiation	2014	28
24665097	Adenosine triphosphate	Nurse CA	Synaptic and paracrine mechanisms at carotid body arterial chemoreceptors.	The Journal of physiology	2014	21
24813252	Adenosine triphosphate	Wang G	Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.	Nature medicine	2014	139
24911525	Adenosine triphosphate	Pulliam DA	Complex IV-deficient Surf1(-/-) mice initiate mitochondrial stress responses.	The Biochemical journal	2014	24
24969776	Adenosine triphosphate	Gille A	CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.	Arteriosclerosis, thrombosis, and vascular biology	2014	24
24969777	Adenosine triphosphate	Jansen RS	ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report.	Arteriosclerosis, thrombosis, and vascular biology	2014	37
24979777	Adenosine triphosphate	Alavian KN	An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore.	Proceedings of the National Academy of Sciences of the United States of America	2014	110
25017063	Adenosine triphosphate	Quirós PM	ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity.	Cell reports	2014	31
25119037	Adenosine triphosphate	Van Nostrand JL	Inappropriate p53 activation during development induces features of CHARGE syndrome.	Nature	2014	33
25119045	Adenosine triphosphate	Han P	A long noncoding RNA protects the heart from pathological hypertrophy.	Nature	2014	97
25179911	Adenosine triphosphate	Halestrap AP	The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.	Journal of molecular and cellular cardiology	2015	59
25524771	Adenosine triphosphate	Meiler S	MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2015	19
25713188	Adenosine triphosphate	Sharma K	Mitochondrial hormesis and diabetic complications.	Diabetes	2015	25
25772291	Adenosine triphosphate	Shattock MJ	Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.	The Journal of physiology	2015	19
25863249	Adenosine triphosphate	Diebold I	BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension.	Cell metabolism	2015	23
25879284	Adenosine triphosphate	Goldberg EL	Drivers of age-related inflammation and strategies for healthspan extension.	Immunological reviews	2015	18
25901189	Adenosine triphosphate	Baccarelli AA	Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease.	Clinical epigenetics	2015	17
25904599	Adenosine triphosphate	Zhang H	Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	Circulation research	2015	18
26005677	Adenosine triphosphate	Basaranoglu M	Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.	Hepatobiliary surgery and nutrition	2015	20
26168216	Adenosine triphosphate	Wang S	P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction.	The Journal of clinical investigation	2015	21
26323267	Adenosine triphosphate	Rosenson RS	Dysfunctional HDL and atherosclerotic cardiovascular disease.	Nature reviews. Cardiology	2016	51
26387735	Adenosine triphosphate	Shanmughapriya S	SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore.	Molecular cell	2015	25
26404370	Adenosine triphosphate	Gröber U	Magnesium in Prevention and Therapy.	Nutrients	2015	18
26437365	Adenosine triphosphate	Goedeke L	MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.	Nature medicine	2015	28
26501192	Adenosine triphosphate	Wagschal A	Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.	Nature medicine	2015	36
26803500	Adenosine triphosphate	Bhattacharya A	Role of neuro-immunological factors in the pathophysiology of mood disorders.	Psychopharmacology	2016	13
26808348	Adenosine triphosphate	Min SY	Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice.	Nature medicine	2016	21
26818947	Adenosine triphosphate	Imamura M	Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.	Nature communications	2016	13
26892966	Adenosine triphosphate	Sorci-Thomas MG	Microdomains, Inflammation, and Atherosclerosis.	Circulation research	2016	18
27038735	Adenosine triphosphate	Zhang Y	Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways.	Free radical biology & medicine	2016	15
27050306	Adenosine triphosphate	Tohyama S	Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells.	Cell metabolism	2016	11
27230643	Adenosine triphosphate	Shah MS	Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.	Circulation research	2016	24
27879251	Adenosine triphosphate	Milewicz DM	Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections.	Arteriosclerosis, thrombosis, and vascular biology	2017	10
28057794	Adenosine triphosphate	Burnstock G	Purinergic Signaling in the Cardiovascular System.	Circulation research	2017	17
28223517	Adenosine triphosphate	Rohde JA	Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.	Proceedings of the National Academy of Sciences of the United States of America	2017	6
28333713	Adenosine triphosphate	Aryal B	MicroRNAs and lipid metabolism.	Current opinion in lipidology	2017	5
28437620	Adenosine triphosphate	Jellinger PS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.	Endocrine practice 	2017	14
9727051	Guanosine triphosphate	Laufs U	Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.	The Journal of biological chemistry	1998	177
16257999	Guanosine triphosphate	Birukova AA	GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction.	American journal of physiology. Lung cellular and molecular physiology	2006	69
17468766	Guanosine triphosphate	Carè A	MicroRNA-133 controls cardiac hypertrophy.	Nature medicine	2007	498
17666911	Guanosine triphosphate	Liao JK	Rho kinase (ROCK) inhibitors.	Journal of cardiovascular pharmacology	2007	78
17679617	Guanosine triphosphate	Xu J	Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.	Circulation	2007	62
17686471	Guanosine triphosphate	Garrett TA	VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.	Experimental cell research	2007	64
18068482	Guanosine triphosphate	Wang CY	Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.	Trends in molecular medicine	2008	119
19011239	Guanosine triphosphate	Crabtree MJ	Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression.	The Journal of biological chemistry	2009	64
21730307	Guanosine triphosphate	Antoniades C	Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.	Circulation	2011	42
21867484	Guanosine triphosphate	Werner ER	Tetrahydrobiopterin: biochemistry and pathophysiology.	The Biochemical journal	2011	60
22286105	Guanosine triphosphate	Smrcka AV	Role of phospholipase Cε in physiological phosphoinositide signaling networks.	Cellular signalling	2012	37
22745122	Guanosine triphosphate	Gawlowski T	Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.	The Journal of biological chemistry	2012	47
23137377	Guanosine triphosphate	Ohtsuki S	Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.	Molecular pharmaceutics	2013	28
24976919	Guanosine triphosphate	Mangge H	Antioxidants, inflammation and cardiovascular disease.	World journal of cardiology	2014	44
26838319	Guanosine triphosphate	Shimokawa H	RhoA/Rho-Kinase in the Cardiovascular System.	Circulation research	2016	18
10231453	Urea	Stenvinkel P	Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.	Kidney international	1999	168
17645639	Urea	Durante W	Arginase: a critical regulator of nitric oxide synthesis and vascular function.	Clinical and experimental pharmacology & physiology	2007	107
19214027	Urea	Hsu HJ	Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.	The American journal of the medical sciences	2009	45
19794443	Urea	Imig JD	Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.	Nature reviews. Drug discovery	2009	181
20173117	Urea	Shah SH	Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events.	Circulation. Cardiovascular genetics	2010	94
21082368	Urea	Johanson CE	The blood-cerebrospinal fluid barrier: structure and functional significance.	Methods in molecular biology	2011	41
26822151	Urea	Hartiala JA	Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease.	Nature communications	2016	13
26863521	Urea	Ho JE	Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.	PloS one	2016	16
1517245	Iron	Balla G	Ferritin: a cytoprotective antioxidant strategem of endothelium.	The Journal of biological chemistry	1992	193
8675659	Iron	Watson AD	Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.	The Journal of clinical investigation	1995	137
8721615	Iron	Berliner JA	The role of oxidized lipoproteins in atherogenesis.	Free radical biology & medicine	1996	126
9131263	Iron	Maines MD	The heme oxygenase system: a regulator of second messenger gases.	Annual review of pharmacology and toxicology	1997	368
9151778	Iron	Hazen SL	3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.	The Journal of clinical investigation	1997	138
9326946	Iron	Rötig A	Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.	Nature genetics	1997	200
10443931	Iron	Hempel SL	Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123.	Free radical biology & medicine	1999	102
11015442	Iron	Brouard S	Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis.	The Journal of experimental medicine	2000	188
11473047	Iron	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	400
11563810	Iron	Whitfield JB	Gamma glutamyl transferase.	Critical reviews in clinical laboratory sciences	2001	138
12091240	Iron	Morse D	Heme oxygenase-1: the "emerging molecule" has arrived.	American journal of respiratory cell and molecular biology	2002	84
12130498	Iron	Jeney V	Pro-oxidant and cytotoxic effects of circulating heme.	Blood	2002	121
14668457	Iron	Kolodgie FD	Intraplaque hemorrhage and progression of coronary atheroma.	The New England journal of medicine	2003	195
14871914	Iron	Jiang R	Body iron stores in relation to risk of type 2 diabetes in apparently healthy women.	JAMA	2004	102
15004156	Iron	Soares MP	Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation.	Journal of immunology	2004	82
15346644	Iron	Lee DH	Is serum gamma glutamyltransferase a marker of oxidative stress?	Free radical research	2004	108
15925276	Iron	Abraham NG	Heme oxygenase and the cardiovascular-renal system.	Free radical biology & medicine	2005	89
16919418	Iron	Al-Mahdawi S	GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.	Genomics	2006	76
17101452	Iron	Rouault TA	Brain iron metabolism.	Seminars in pediatric neurology	2006	62
17822372	Iron	Jozkowicz A	Heme oxygenase-1 in tumors: is it a false friend?	Antioxidants & redox signaling	2007	83
18332264	Iron	Terrovitis J	Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.	Circulation	2008	99
18576916	Iron	Loboda A	Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.	Antioxidants & redox signaling	2008	66
18817553	Iron	Modell B	Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.	Journal of cardiovascular magnetic resonance 	2008	93
19144359	Iron	Zamboni P	The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.	Journal of the neurological sciences	2009	50
19559399	Iron	Boissel S	Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations.	American journal of human genetics	2009	75
19781428	Iron	Förhécz Z	Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.	American heart journal	2009	90
19805308	Iron	Huang ML	Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
19937043	Iron	Schrag M	Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.	Acta neuropathologica	2010	57
20189278	Iron	Babitt JL	Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.	American journal of kidney diseases 	2010	44
20378845	Iron	Nagy E	Red cells, hemoglobin, heme, iron, and atherogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2010	57
20728697	Iron	Sawyer DB	Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?	Progress in cardiovascular diseases	2010	44
20870325	Iron	Shovlin CL	Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.	Blood reviews	2010	83
20873749	Iron	Tsai CL	Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex.	Biochemistry	2010	96
21226665	Iron	Tsimikas S	Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease.	Current pharmaceutical design	2011	41
21992109	Iron	Grochot-Przeczek A	Haem oxygenase-1: non-canonical roles in physiology and pathology.	Clinical science	2012	46
22052915	Iron	Boyle JJ	Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.	Circulation research	2012	34
22473328	Iron	Chervona Y	Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium.	Metallomics 	2012	36
23123858	Iron	Straub AC	Endothelial cell expression of haemoglobin α regulates nitric oxide signalling.	Nature	2012	60
23136396	Iron	Hick A	Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.	Disease models & mechanisms	2013	43
23144459	Iron	Kabil O	Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.	The Journal of biological chemistry	2012	33
23908332	Iron	Kloner RA	Current state of clinical translation of cardioprotective agents for acute myocardial infarction.	Circulation research	2013	30
24705334	Iron	Perdomini M	Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.	Nature medicine	2014	32
24904118	Iron	Wu XG	HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.	Blood	2014	21
24982634	Iron	Zhang DL	The physiological functions of iron regulatory proteins in iron homeostasis - an update.	Frontiers in pharmacology	2014	30
25315861	Iron	Simpson IA	A novel model for brain iron uptake: introducing the concept of regulation.	Journal of cerebral blood flow and metabolism 	2015	20
25468387	Iron	Block GA	A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.	American journal of kidney diseases 	2015	20
25825391	Iron	White K	Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.	EMBO molecular medicine	2015	22
25895646	Iron	Rochette L	Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.	Trends in pharmacological sciences	2015	15
26471505	Iron	Pavlides M	Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.	Journal of hepatology	2016	14
26656456	Iron	Maxwell PH	HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.	Nature reviews. Nephrology	2016	27
27887750	Iron	Webster AC	Chronic Kidney Disease.	Lancet	2017	16
28185035	Iron	McGowan JV	Anthracycline Chemotherapy and Cardiotoxicity.	Cardiovascular drugs and therapy	2017	12
28242135	Iron	Gupta N	Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD.	American journal of kidney diseases 	2017	6
15322091	Heme	Ambasta RK	Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase.	The Journal of biological chemistry	2004	163
16424350	Heme	Kim-Shapiro DB	Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics.	Arteriosclerosis, thrombosis, and vascular biology	2006	75
16955146	Heme	Stasch JP	Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.	The Journal of clinical investigation	2006	123
17467679	Heme	Buhaescu I	Mevalonate pathway: a review of clinical and therapeutical implications.	Clinical biochemistry	2007	74
17544386	Heme	Peluffo G	Biochemistry of protein tyrosine nitration in cardiovascular pathology.	Cardiovascular research	2007	56
18195184	Heme	Dulak J	Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.	Circulation	2008	75
18461048	Heme	Förstermann U	Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.	Nature clinical practice. Cardiovascular medicine	2008	88
18992768	Heme	Rohe HJ	PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.	Pharmacology & therapeutics	2009	49
20306272	Heme	Förstermann U	Nitric oxide and oxidative stress in vascular disease.	Pflugers Archiv 	2010	113
21091076	Heme	Wu ML	A central role of heme oxygenase-1 in cardiovascular protection.	Antioxidants & redox signaling	2011	39
21198553	Heme	Förstermann U	Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.	British journal of pharmacology	2011	45
23339042	Heme	Zingg JM	Molecular mechanisms of hypolipidemic effects of curcumin.	BioFactors	2013	29
23608227	Heme	Li H	Oxidative stress in vascular disease and its pharmacological prevention.	Trends in pharmacological sciences	2013	44
23615880	Heme	Wang W	Glycine metabolism in animals and humans: implications for nutrition and health.	Amino acids	2013	45
25827830	Heme	Camus SM	Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.	Blood	2015	32
7744002	Cyclic AMP	Gautel M	Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?	The EMBO journal	1995	117
7775594	Cyclic AMP	Garcia JG	Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation.	Journal of cellular physiology	1995	125
9634236	Cyclic AMP	Ludwig A	A family of hyperpolarization-activated mammalian cation channels.	Nature	1998	218
10835102	Cyclic AMP	Vaudry D	Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.	Pharmacological reviews	2000	164
11013125	Cyclic AMP	Chen MM	CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.	Journal of molecular and cellular cardiology	2000	100
11110765	Cyclic AMP	Kamp TJ	Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.	Circulation research	2000	126
11264475	Cyclic AMP	Steinberg SF	Compartmentation of G protein-coupled signaling pathways in cardiac myocytes.	Annual review of pharmacology and toxicology	2001	92
11342529	Cyclic AMP	Yamagishi SI	Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.	The Journal of biological chemistry	2001	104
11448722	Cyclic AMP	Robbins J	KCNQ potassium channels: physiology, pathophysiology, and pharmacology.	Pharmacology & therapeutics	2001	111
11799244	Cyclic AMP	Marx SO	Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.	Science	2002	205
12933699	Cyclic AMP	Rybalkin SD	Cyclic GMP phosphodiesterases and regulation of smooth muscle function.	Circulation research	2003	97
14615490	Cyclic AMP	Roh J	Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.	The Journal of biological chemistry	2004	76
14657344	Cyclic AMP	Stieber J	The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.	Proceedings of the National Academy of Sciences of the United States of America	2003	93
15136591	Cyclic AMP	SenBanerjee S	KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.	The Journal of experimental medicine	2004	178
15166115	Cyclic AMP	Flashman E	Cardiac myosin binding protein C: its role in physiology and disease.	Circulation research	2004	87
15374886	Cyclic AMP	Cullere X	Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase.	Blood	2005	132
15601837	Cyclic AMP	Fukuhara S	Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway.	Molecular and cellular biology	2005	143
15961389	Cyclic AMP	Head BP	G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes.	The Journal of biological chemistry	2005	72
16102838	Cyclic AMP	Lugnier C	Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.	Pharmacology & therapeutics	2006	170
16115630	Cyclic AMP	Kooistra MR	Epac1 regulates integrity of endothelial cell junctions through VE-cadherin.	FEBS letters	2005	114
16143588	Cyclic AMP	Fang X	Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells.	American journal of physiology. Lung cellular and molecular physiology	2006	72
16177794	Cyclic AMP	Dodge-Kafka KL	The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.	Nature	2005	192
16407510	Cyclic AMP	Milanesi R	Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel.	The New England journal of medicine	2006	88
16809066	Cyclic AMP	McConnachie G	AKAP signaling complexes: getting to the heart of the matter.	Trends in molecular medicine	2006	87
16844790	Cyclic AMP	Liggett SB	A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2006	116
17273168	Cyclic AMP	Leopold JA	Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.	Nature medicine	2007	90
17353197	Cyclic AMP	Sastry KS	Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation.	The Journal of biological chemistry	2007	55
17493609	Cyclic AMP	Birukova AA	Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.	Experimental cell research	2007	83
17599964	Cyclic AMP	Pereira L	The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes.	The Journal of physiology	2007	69
17767158	Cyclic AMP	Zhou W	Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2.	Nature genetics	2007	63
17903308	Cyclic AMP	Gottlieb DJ	Genome-wide association of sleep and circadian phenotypes.	BMC medical genetics	2007	74
18064650	Cyclic AMP	Birukova AA	Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.	Journal of cellular physiology	2008	52
18323524	Cyclic AMP	Métrich M	Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy.	Circulation research	2008	68
18565824	Cyclic AMP	Dejana E	The role of adherens junctions and VE-cadherin in the control of vascular permeability.	Journal of cell science	2008	245
18571301	Cyclic AMP	Pandi-Perumal SR	Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.	Progress in neurobiology	2008	84
19151200	Cyclic AMP	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	116
19386608	Cyclic AMP	Yanagida K	Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.	The Journal of biological chemistry	2009	61
20032304	Cyclic AMP	Noda K	Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells.	Molecular biology of the cell	2010	45
20068138	Cyclic AMP	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20081107	Cyclic AMP	Rajkumar R	Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.	American journal of physiology. Heart and circulatory physiology	2010	57
20167941	Cyclic AMP	DiFrancesco D	The role of the funny current in pacemaker activity.	Circulation research	2010	97
20172966	Cyclic AMP	Ban K	Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.	Endocrinology	2010	54
20224043	Cyclic AMP	Uchinoumi H	Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.	Circulation research	2010	44
20299335	Cyclic AMP	Spindler V	Role of GTPases in control of microvascular permeability.	Cardiovascular research	2010	108
20493887	Cyclic AMP	Lakics V	Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.	Neuropharmacology	2010	63
20593161	Cyclic AMP	Hattori Y	A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells.	Diabetologia	2010	41
20810711	Cyclic AMP	Pedram A	Estrogen receptor-beta prevents cardiac fibrosis.	Molecular endocrinology	2010	43
21118894	Cyclic AMP	Alvarez-Saavedra M	miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock.	Human molecular genetics	2011	68
21474070	Cyclic AMP	Perino A	Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ.	Molecular cell	2011	56
21856912	Cyclic AMP	Diviani D	A-kinase anchoring proteins: scaffolding proteins in the heart.	American journal of physiology. Heart and circulatory physiology	2011	35
21868695	Cyclic AMP	Katare R	Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132.	Circulation research	2011	91
21947498	Cyclic AMP	Morgado M	Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle.	Cellular and molecular life sciences 	2012	43
22136590	Cyclic AMP	Smolenski A	Novel roles of cAMP/cGMP-dependent signaling in platelets.	Journal of thrombosis and haemostasis 	2012	46
22178870	Cyclic AMP	Fatima A	In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.	Cellular physiology and biochemistry 	2011	63
22885100	Cyclic AMP	Chung JH	Resveratrol as a calorie restriction mimetic: therapeutic implications.	Trends in cell biology	2012	44
22900788	Cyclic AMP	Wagner S	Redox regulation of sodium and calcium handling.	Antioxidants & redox signaling	2013	32
23303914	Cyclic AMP	Bathgate RA	Relaxin family peptides and their receptors.	Physiological reviews	2013	81
23589561	Cyclic AMP	Jiang DS	Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.	Hypertension	2013	29
23653680	Cyclic AMP	Pilakka-Kanthikeel S	Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.	PloS one	2013	31
23996003	Cyclic AMP	Akin BL	The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.	The Journal of biological chemistry	2013	25
24145604	Cyclic AMP	Chen ML	Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway.	Autophagy	2013	36
24464482	Cyclic AMP	Leo MD	Dynamic regulation of β1 subunit trafficking controls vascular contractility.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
26095046	Cyclic AMP	Wu H	Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.	Cell stem cell	2015	27
27648837	Cyclic AMP	Hong Z	MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.	American journal of respiratory and critical care medicine	2017	10
27732797	Cyclic AMP	Kokkonen K	Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.	Annual review of pharmacology and toxicology	2017	11
28119465	Cyclic AMP	Qian H	Phosphorylation of Ser1928 mediates the enhanced activity of the L-type Ca2+ channel Cav1.2 by the β2-adrenergic receptor in neurons.	Science signaling	2017	12
11602621	Serotonin	Eddahibi S	Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.	The Journal of clinical investigation	2001	101
11744348	Serotonin	Das UN	Is obesity an inflammatory condition?	Nutrition	2001	128
12082564	Serotonin	Capuron L	Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.	Molecular psychiatry	2002	106
15194174	Serotonin	Humbert M	Cellular and molecular pathobiology of pulmonary arterial hypertension.	Journal of the American College of Cardiology	2004	293
16444258	Serotonin	Binstadt BA	Particularities of the vasculature can promote the organ specificity of autoimmune attack.	Nature immunology	2006	65
17848919	Serotonin	Nasrallah HA	Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.	Molecular psychiatry	2008	79
18199093	Serotonin	De Maeyer JH	5-HT4 receptor agonists: similar but not the same.	Neurogastroenterology and motility 	2008	50
18626066	Serotonin	Duncker DJ	Regulation of coronary blood flow during exercise.	Physiological reviews	2008	140
19555855	Serotonin	Morrell NW	Cellular and molecular basis of pulmonary arterial hypertension.	Journal of the American College of Cardiology	2009	191
19902987	Serotonin	Zhou SF	Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.	Clinical pharmacokinetics	2009	52
20189712	Serotonin	Hatzimouratidis K	Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.	European urology	2010	118
22356640	Serotonin	Tack J	Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.	Alimentary pharmacology & therapeutics	2012	36
22550966	Serotonin	Huang AR	Medication-related falls in the elderly: causative factors and preventive strategies.	Drugs & aging	2012	54
22897747	Serotonin	Simmler LD	Pharmacological characterization of designer cathinones in vitro.	British journal of pharmacology	2013	117
23044468	Serotonin	Hashimoto K	Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.	Progress in neurobiology	2013	39
23165769	Serotonin	Rosario FJ	Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.	The Journal of physiology	2013	39
23468190	Serotonin	Miller AH	Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.	Depression and anxiety	2013	70
24484988	Serotonin	Glennon RA	Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.	Advances in pharmacology	2014	20
25608111	Serotonin	Mair KM	Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.	American journal of respiratory and critical care medicine	2015	18
25739765	Serotonin	Schumacher SM	Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.	Science translational medicine	2015	26
27390338	Serotonin	Vanhoutte PM	Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.	Circulation research	2016	29
8676080	Prostaglandin E2	Fossiez F	T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.	The Journal of experimental medicine	1996	337
10807504	Prostaglandin E2	Knolle PA	Local control of the immune response in the liver.	Immunological reviews	2000	126
16395396	Prostaglandin E2	Grosser T	Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.	The Journal of clinical investigation	2006	194
17640394	Prostaglandin E2	Howe LR	Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.	Breast cancer research 	2007	83
17659528	Prostaglandin E2	Gordon GR	Astrocyte control of the cerebrovasculature.	Glia	2007	78
17878749	Prostaglandin E2	Chiamvimonvat N	The soluble epoxide hydrolase as a pharmaceutical target for hypertension.	Journal of cardiovascular pharmacology	2007	74
20234320	Prostaglandin E2	Shimizu K	Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.	Journal of thoracic oncology 	2010	49
22889633	Prostaglandin E2	Johnson GH	Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials.	Journal of the Academy of Nutrition and Dietetics	2012	31
23401547	Prostaglandin E2	Jiang J	Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2013	44
24793239	Prostaglandin E2	Motz GT	Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.	Nature medicine	2014	80
27074574	Prostaglandin E2	Guillem-Llobat P	Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.	Oncotarget	2016	18
12791703	Adenosine monophosphate	Morrow VA	Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells.	The Journal of biological chemistry	2003	95
14557259	Adenosine monophosphate	Ouchi N	Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.	The Journal of biological chemistry	2004	200
14709557	Adenosine monophosphate	Browne GJ	Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398.	The Journal of biological chemistry	2004	88
14752031	Adenosine monophosphate	Kobayashi H	Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin.	Circulation research	2004	129
15371448	Adenosine monophosphate	Zang M	AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells.	The Journal of biological chemistry	2004	103
15673802	Adenosine monophosphate	Arad M	Glycogen storage diseases presenting as hypertrophic cardiomyopathy.	The New England journal of medicine	2005	90
16407220	Adenosine monophosphate	Xie Z	Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells.	The Journal of biological chemistry	2006	64
16443786	Adenosine monophosphate	Davis BJ	Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.	Diabetes	2006	114
17021375	Adenosine monophosphate	Ahima RS	Adipose tissue as an endocrine organ.	Obesity	2006	127
17085580	Adenosine monophosphate	Xie M	A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway.	Proceedings of the National Academy of Sciences of the United States of America	2006	97
17116771	Adenosine monophosphate	Sun W	Statins activate AMP-activated protein kinase in vitro and in vivo.	Circulation	2006	67
17287464	Adenosine monophosphate	Cheng KK	Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.	Diabetes	2007	78
18235500	Adenosine monophosphate	Miller EJ	Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart.	Nature	2008	140
18390897	Adenosine monophosphate	Bertrand L	Insulin signalling in the heart.	Cardiovascular research	2008	51
18482975	Adenosine monophosphate	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	218
18977694	Adenosine monophosphate	Lage R	AMPK: a metabolic gauge regulating whole-body energy homeostasis.	Trends in molecular medicine	2008	101
19029992	Adenosine monophosphate	Goldstein BJ	Protective vascular and myocardial effects of adiponectin.	Nature clinical practice. Cardiovascular medicine	2009	75
19261992	Adenosine monophosphate	Shibata R	Adiponectin and cardiovascular disease.	Circulation journal 	2009	53
19273282	Adenosine monophosphate	Viollet B	Targeting the AMPK pathway for the treatment of Type 2 diabetes.	Frontiers in bioscience	2009	52
19442239	Adenosine monophosphate	Colombo SL	AMPKalpha1 regulates the antioxidant status of vascular endothelial cells.	The Biochemical journal	2009	61
19468337	Adenosine monophosphate	Dzeja P	Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.	International journal of molecular sciences	2009	59
19483724	Adenosine monophosphate	Taliaferro-Smith L	LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells.	Oncogene	2009	47
19584320	Adenosine monophosphate	Steinberg GR	AMPK in Health and Disease.	Physiological reviews	2009	389
19592618	Adenosine monophosphate	Li XN	Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.	Diabetes	2009	53
20010958	Adenosine monophosphate	Li J	Effects of AMP-activated protein kinase in cerebral ischemia.	Journal of cerebral blood flow and metabolism 	2010	45
20080987	Adenosine monophosphate	Lu H	MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.	Cardiovascular research	2010	68
20124121	Adenosine monophosphate	Dong Y	Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.	Circulation	2010	74
20167927	Adenosine monophosphate	Wang S	AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.	Circulation research	2010	109
20371735	Adenosine monophosphate	Lira VA	PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.	American journal of physiology. Endocrinology and metabolism	2010	67
21170742	Adenosine monophosphate	Sciarretta S	Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart?	Pediatric cardiology	2011	38
21186369	Adenosine monophosphate	Holland WL	Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.	Nature medicine	2011	232
21233449	Adenosine monophosphate	Chandra SM	Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension.	Arteriosclerosis, thrombosis, and vascular biology	2011	40
21514279	Adenosine monophosphate	Yamawaki H	Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells.	Biochemical and biophysical research communications	2011	43
21576456	Adenosine monophosphate	Dávalos A	miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.	Proceedings of the National Academy of Sciences of the United States of America	2011	188
21623793	Adenosine monophosphate	Salminen A	AMP-activated protein kinase: a potential player in Alzheimer's disease.	Journal of neurochemistry	2011	46
21840335	Adenosine monophosphate	Speakman JR	Caloric restriction.	Molecular aspects of medicine	2011	152
21980456	Adenosine monophosphate	Wang Q	Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.	PloS one	2011	36
22245452	Adenosine monophosphate	Li H	Cardiovascular effects and molecular targets of resveratrol.	Nitric oxide 	2012	34
22560219	Adenosine monophosphate	Min HK	Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.	Cell metabolism	2012	90
23104101	Adenosine monophosphate	Morris BJ	Seven sirtuins for seven deadly diseases of aging.	Free radical biology & medicine	2013	72
23186644	Adenosine monophosphate	Noyan-Ashraf MH	A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.	Circulation	2013	49
23197693	Adenosine monophosphate	Sato A	Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.	Stem cells translational medicine	2012	40
23258295	Adenosine monophosphate	Maillet M	Molecular basis of physiological heart growth: fundamental concepts and new players.	Nature reviews. Molecular cell biology	2013	97
23863634	Adenosine monophosphate	Ruderman NB	AMPK, insulin resistance, and the metabolic syndrome.	The Journal of clinical investigation	2013	141
23932046	Adenosine monophosphate	Palomer X	An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.	International journal of cardiology	2013	35
24026768	Adenosine monophosphate	Matsuda M	Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	20
24314860	Adenosine monophosphate	Wang S	Novel insights of dietary polyphenols and obesity.	The Journal of nutritional biochemistry	2014	80
24366076	Adenosine monophosphate	Xu X	Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.	Hypertension	2014	21
24401231	Adenosine monophosphate	Batchuluun B	Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells.	Atherosclerosis	2014	22
24583766	Adenosine monophosphate	Hardie DG	AMPK: regulating energy balance at the cellular and whole body levels.	Physiology	2014	43
24768874	Adenosine monophosphate	Kataoka Y	Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms.	Journal of the American College of Cardiology	2014	21
24957699	Adenosine monophosphate	Fisman EZ	Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?	Cardiovascular diabetology	2014	38
25047736	Adenosine monophosphate	Jin X	Delphinidin-3-glucoside protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury by autophagy upregulation via the AMPK/SIRT1 signaling pathway.	Molecular nutrition & food research	2014	25
25345753	Adenosine monophosphate	Esser N	Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.	Expert opinion on investigational drugs	2015	29
25354528	Adenosine monophosphate	Weikel KA	Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells.	American journal of physiology. Cell physiology	2015	15
25451966	Adenosine monophosphate	Zordoky BN	Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.	Biochimica et biophysica acta	2015	27
25794703	Adenosine monophosphate	Scheen AJ	Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control.	Diabetes & metabolism	2015	17
25799226	Adenosine monophosphate	Wu Y	Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo.	Nature medicine	2015	26
26110512	Adenosine monophosphate	Skeffington KL	Hypoxia, AMPK activation and uterine artery vasoreactivity.	The Journal of physiology	2016	11
26160707	Adenosine monophosphate	Qi D	AMPK: energy sensor and survival mechanism in the ischemic heart.	Trends in endocrinology and metabolism	2015	24
26202455	Adenosine monophosphate	Hung CH	Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation.	Molecular nutrition & food research	2015	17
26643070	Adenosine monophosphate	Osman I	Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.	Biochemical pharmacology	2016	13
26772531	Adenosine monophosphate	Daskalopoulos EP	AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.	Journal of molecular and cellular cardiology	2016	10
26931135	Adenosine monophosphate	Cleasby ME	Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.	The Journal of endocrinology	2016	15
27418629	Adenosine monophosphate	Cameron AR	Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.	Circulation research	2016	20
28467931	Adenosine monophosphate	Cokorinos EC	Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.	Cell metabolism	2017	9
11348997	NAD	Lassègue B	Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.	Circulation research	2001	197
15539615	NAD	Madamanchi NR	Oxidative stress and vascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2005	266
15879305	NAD	Münzel T	Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase.	Arteriosclerosis, thrombosis, and vascular biology	2005	72
16207712	NAD	Pillai JB	Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity.	The Journal of biological chemistry	2005	123
17938244	NAD	Potente M	SIRT1 controls endothelial angiogenic functions during vascular growth.	Genes & development	2007	161
18599801	NAD	Sun Q	Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK.	Arteriosclerosis, thrombosis, and vascular biology	2008	71
20027304	NAD	Nasrin N	JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.	PloS one	2009	98
22479251	NAD	Yamakuchi M	MicroRNA Regulation of SIRT1.	Frontiers in physiology	2012	42
22575091	NAD	Chapple SJ	Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging.	The international journal of biochemistry & cell biology	2012	45
23075334	NAD	Kitada M	Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.	Clinical science	2013	40
23417962	NAD	Donmez G	SIRT1 and SIRT2: emerging targets in neurodegeneration.	EMBO molecular medicine	2013	58
24439680	NAD	Hubbard BP	Small molecule SIRT1 activators for the treatment of aging and age-related diseases.	Trends in pharmacological sciences	2014	89
26232232	NAD	Matsushima S	The role of sirtuins in cardiac disease.	American journal of physiology. Heart and circulatory physiology	2015	25
9438410	Prostaglandin I2	L'Heureux N	A completely biological tissue-engineered human blood vessel.	FASEB journal 	1998	182
11166270	Prostaglandin I2	Zachary I	Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.	Cardiovascular research	2001	128
11509060	Prostaglandin I2	Mukherjee D	Risk of cardiovascular events associated with selective COX-2 inhibitors.	JAMA	2001	209
16195486	Prostaglandin I2	Münzel T	Explaining the phenomenon of nitrate tolerance.	Circulation research	2005	98
16632549	Prostaglandin I2	Félétou M	Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).	American journal of physiology. Heart and circulatory physiology	2006	166
17200437	Prostaglandin I2	Campbell WB	Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors.	Hypertension	2007	72
18055511	Prostaglandin I2	Gilbert JS	Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.	American journal of physiology. Heart and circulatory physiology	2008	118
19187341	Prostaglandin I2	Félétou M	Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?	British journal of pharmacology	2009	65
19302590	Prostaglandin I2	Grgic I	Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.	British journal of pharmacology	2009	55
21838680	Prostaglandin I2	Folli F	The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.	Current diabetes reviews	2011	44
21845431	Prostaglandin I2	van Hinsbergh VW	Endothelium--role in regulation of coagulation and inflammation.	Seminars in immunopathology	2012	59
22484314	Prostaglandin I2	Mazzuca MQ	Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.	Biochemical pharmacology	2012	31
23669822	Prostaglandin I2	Tapson VF	Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.	Chest	2013	40
23878368	Prostaglandin I2	Gliemann L	Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.	The Journal of physiology	2013	47
15072974	Acetylcholine 	Brodsky SV	Endothelium-derived microparticles impair endothelial function in vitro.	American journal of physiology. Heart and circulatory physiology	2004	73
17711996	Acetylcholine 	Basu A	Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.	American journal of physiology. Endocrinology and metabolism	2007	63
19297385	Acetylcholine 	Antoniades C	Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.	European heart journal	2009	54
21244363	Acetylcholine 	Seals DR	Aging and vascular endothelial function in humans.	Clinical science	2011	130
21746786	Acetylcholine 	Donato AJ	SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans.	The Journal of physiology	2011	43
18625666	4,4'-Methylenedianiline	Dorkova Z	Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome.	Chest	2008	65
20188164	4,4'-Methylenedianiline	Banerjee A	HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide.	Free radical biology & medicine	2010	42
21321970	4,4'-Methylenedianiline	Jomova K	Arsenic: toxicity, oxidative stress and human disease.	Journal of applied toxicology 	2011	92
23122790	4,4'-Methylenedianiline	Tsimikas S	Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events.	Journal of the American College of Cardiology	2012	44
23620807	4,4'-Methylenedianiline	Duan J	Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint.	PloS one	2013	26
25525116	4,4'-Methylenedianiline	Tsiantoulas D	Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.	Journal of lipid research	2015	19
28178330	4,4'-Methylenedianiline	Rasool M	Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress.	PloS one	2017	5
7519131	Calcium	Otto CM	Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.	Circulation	1994	190
8381058	Calcium	Ungerer M	Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.	Circulation	1993	148
9351447	Calcium	Shaw RM	Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling.	Circulation research	1997	174
9399960	Calcium	Papapetropoulos A	Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.	The Journal of clinical investigation	1997	207
9486651	Calcium	Gunn MD	A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1.	Nature	1998	163
9568714	Calcium	Molkentin JD	A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.	Cell	1998	578
10227295	Calcium	Gerszten RE	MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.	Nature	1999	211
10499587	Calcium	Ames RS	Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.	Nature	1999	101
10504268	Calcium	Kuschert GS	Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.	Biochemistry	1999	126
10519554	Calcium	Fisslthaler B	Cytochrome P450 2C is an EDHF synthase in coronary arteries.	Nature	1999	190
10523015	Calcium	Ozata M	Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects.	The Journal of clinical endocrinology and metabolism	1999	129
10639159	Calcium	Miyamoto MI	Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2000	102
10684258	Calcium	Hazan RB	Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.	The Journal of cell biology	2000	195
10830164	Calcium	Marx SO	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	Cell	2000	504
10851239	Calcium	Heise CE	Characterization of the human cysteinyl leukotriene 2 receptor.	The Journal of biological chemistry	2000	114
10862640	Calcium	Guérin AP	Arterial stiffening and vascular calcifications in end-stage renal disease.	Nephrology, dialysis, transplantation 	2000	98
10934088	Calcium	Schulz R	Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.	American journal of respiratory and critical care medicine	2000	99
10977869	Calcium	de Gasparo M	International union of pharmacology. XXIII. The angiotensin II receptors.	Pharmacological reviews	2000	346
11009570	Calcium	Jono S	Phosphate regulation of vascular smooth muscle cell calcification.	Circulation research	2000	233
11029403	Calcium	Haynes MP	Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.	Circulation research	2000	98
11130523	Calcium	Neal B	Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.	Lancet	2000	194
11157710	Calcium	Laitinen PJ	Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.	Circulation	2001	116
11158974	Calcium	Golovina VA	Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation.	American journal of physiology. Heart and circulatory physiology	2001	106
11159936	Calcium	Tiso N	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	Human molecular genetics	2001	111
11181474	Calcium	Guerin AP	Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.	Circulation	2001	118
11544157	Calcium	Donaldson K	Ambient particle inhalation and the cardiovascular system: potential mechanisms.	Environmental health perspectives	2001	116
11717165	Calcium	Bang ML	The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system.	Circulation research	2001	154
11742876	Calcium	Dhore CR	Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.	Arteriosclerosis, thrombosis, and vascular biology	2001	121
11826287	Calcium	Shaul PW	Regulation of endothelial nitric oxide synthase: location, location, location.	Annual review of physiology	2002	129
11941371	Calcium	Runnels LW	The TRPM7 channel is inactivated by PIP(2) hydrolysis.	Nature cell biology	2002	151
11967535	Calcium	Sehnert AJ	Cardiac troponin T is essential in sarcomere assembly and cardiac contractility.	Nature genetics	2002	175
11983154	Calcium	Crabtree GR	NFAT signaling: choreographing the social lives of cells.	Cell	2002	366
12081584	Calcium	Chertow GM	Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.	Kidney international	2002	187
12093242	Calcium	Kirpichnikov D	Metformin: an update.	Annals of internal medicine	2002	188
12172548	Calcium	Robitaille J	Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.	Nature genetics	2002	106
12372846	Calcium	Chambliss KL	Estrogen modulation of endothelial nitric oxide synthase.	Endocrine reviews	2002	85
12571597	Calcium	Mohler PJ	Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.	Nature	2003	232
12610310	Calcium	Schmitt JP	Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.	Science	2003	154
12742992	Calcium	Mummery C	Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.	Circulation	2003	256
12759325	Calcium	Psaty BM	Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.	JAMA	2003	150
12801951	Calcium	West J	Seroprevalence, correlates, and characteristics of undetected coeliac disease in England.	Gut	2003	83
14615107	Calcium	Turnbull F	Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.	Lancet	2003	309
14633152	Calcium	Larsson T	Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.	Kidney international	2003	149
14976002	Calcium	Ceriello A	Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.	Arteriosclerosis, thrombosis, and vascular biology	2004	198
14993422	Calcium	Xie Z	Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function.	Molecular interventions	2003	104
15016728	Calcium	Wehrens XH	Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.	Circulation research	2004	182
15050380	Calcium	Beard NA	Calsequestrin and the calcium release channel of skeletal and cardiac muscle.	Progress in biophysics and molecular biology	2004	75
15073377	Calcium	Wehrens XH	Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.	Science	2004	126
15076798	Calcium	Pescatello LS	American College of Sports Medicine position stand. Exercise and hypertension.	Medicine and science in sports and exercise	2004	198
15102615	Calcium	Vattikuti R	Osteogenic regulation of vascular calcification: an early perspective.	American journal of physiology. Endocrinology and metabolism	2004	76
15141227	Calcium	Van Petegem F	Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain.	Nature	2004	147
15178757	Calcium	Mohler PJ	A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.	Proceedings of the National Academy of Sciences of the United States of America	2004	81
15229356	Calcium	Xu W	Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro.	Experimental biology and medicine	2004	71
15258588	Calcium	Bezzerides VJ	Rapid vesicular translocation and insertion of TRP channels.	Nature cell biology	2004	160
15284307	Calcium	Block GA	Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.	Journal of the American Society of Nephrology 	2004	423
15504939	Calcium	Reynolds JL	Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.	Journal of the American Society of Nephrology 	2004	147
15671429	Calcium	Olson TM	Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.	JAMA	2005	118
15698460	Calcium	Young EW	Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.	Kidney international	2005	118
15765134	Calcium	Dorn GW 2nd	Protein kinase cascades in the regulation of cardiac hypertrophy.	The Journal of clinical investigation	2005	183
15863612	Calcium	Splawski I	Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.	Proceedings of the National Academy of Sciences of the United States of America	2005	171
15878870	Calcium	McLaughlin JN	Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.	The Journal of biological chemistry	2005	78
15879332	Calcium	Schrader J	Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).	Stroke	2005	67
15914466	Calcium	Hawkins BT	The blood-brain barrier/neurovascular unit in health and disease.	Pharmacological reviews	2005	508
15941879	Calcium	Noakes M	Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.	The American journal of clinical nutrition	2005	73
15992651	Calcium	Arad Y	Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study.	Journal of the American College of Cardiology	2005	145
16025100	Calcium	Garg V	Mutations in NOTCH1 cause aortic valve disease.	Nature	2005	323
16025101	Calcium	Yasuda S	Dystrophic heart failure blocked by membrane sealant poloxamer.	Nature	2005	92
16213210	Calcium	Lehnart SE	Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.	Cell	2005	148
16258029	Calcium	Larsen BT	Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.	American journal of physiology. Heart and circulatory physiology	2006	69
16267791	Calcium	Li F	Winding through the WNT pathway during cellular development and demise.	Histology and histopathology	2006	67
16368881	Calcium	Kleinbongard P	Red blood cells express a functional endothelial nitric oxide synthase.	Blood	2006	101
16581043	Calcium	Zima AV	Redox regulation of cardiac calcium channels and transporters.	Cardiovascular research	2006	134
16601233	Calcium	Shao JS	Molecular mechanisms of vascular calcification: lessons learned from the aorta.	Arteriosclerosis, thrombosis, and vascular biology	2006	83
16614312	Calcium	Wamhoff BR	Excitation-transcription coupling in arterial smooth muscle.	Circulation research	2006	69
16618821	Calcium	Wallace TW	Prevalence and determinants of troponin T elevation in the general population.	Circulation	2006	68
16631011	Calcium	Caira FC	Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.	Journal of the American College of Cardiology	2006	96
16767219	Calcium	Backs J	CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.	The Journal of clinical investigation	2006	155
16885167	Calcium	Oikonomopoulou K	Proteinase-activated receptors, targets for kallikrein signaling.	The Journal of biological chemistry	2006	61
16949361	Calcium	Grueter CE	L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII.	Molecular cell	2006	90
17008604	Calcium	Alvarez DF	Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury.	Circulation research	2006	75
17081980	Calcium	Gomez-Ospina N	The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor.	Cell	2006	122
17091124	Calcium	Levin A	Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.	Kidney international	2007	262
17095733	Calcium	Johnson RC	Vascular calcification: pathobiological mechanisms and clinical implications.	Circulation research	2006	152
17157285	Calcium	Maier LS	Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart.	Cardiovascular research	2007	93
17275676	Calcium	BelAiba RS	NOX5 variants are functionally active in endothelial cells.	Free radical biology & medicine	2007	69
17286271	Calcium	Periasamy M	SERCA pump isoforms: their role in calcium transport and disease.	Muscle & nerve	2007	109
17363707	Calcium	Gerthoffer WT	Mechanisms of vascular smooth muscle cell migration.	Circulation research	2007	118
17452316	Calcium	Zhang DW	Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.	The Journal of biological chemistry	2007	146
17466956	Calcium	Murphy E	Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury.	Cardiovascular research	2007	59
17470693	Calcium	Pleger ST	Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.	Circulation	2007	63
17502528	Calcium	Dhingra R	Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.	Archives of internal medicine	2007	185
17570692	Calcium	Carman CV	Transcellular diapedesis is initiated by invasive podosomes.	Immunity	2007	150
17631856	Calcium	Halestrap AP	The role of mitochondria in protection of the heart by preconditioning.	Biochimica et biophysica acta	2007	86
17717292	Calcium	Scatena M	Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2007	148
17804441	Calcium	Scirica BM	Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.	Circulation	2007	91
17872499	Calcium	Liu J	Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation.	Stem cells	2007	80
17965233	Calcium	Rota M	Bone marrow cells adopt the cardiomyogenic fate in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2007	114
18230622	Calcium	Otsuguro K	Isoform-specific inhibition of TRPC4 channel by phosphatidylinositol 4,5-bisphosphate.	The Journal of biological chemistry	2008	53
18256367	Calcium	Becker C	Use of antihypertensives and the risk of Parkinson disease.	Neurology	2008	54
18337493	Calcium	Chang KC	CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart.	Proceedings of the National Academy of Sciences of the United States of America	2008	51
18420943	Calcium	Schulz B	ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.	Circulation research	2008	70
18514987	Calcium	Tentori F	Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).	American journal of kidney diseases 	2008	163
18574091	Calcium	Folsom AR	Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).	Archives of internal medicine	2008	188
18579197	Calcium	Buell JS	Vitamin D and neurocognitive dysfunction: preventing "D"ecline?	Molecular aspects of medicine	2008	59
18591664	Calcium	Ueda K	Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.	Proceedings of the National Academy of Sciences of the United States of America	2008	115
18688283	Calcium	Toyama K	The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.	The Journal of clinical investigation	2008	75
18801384	Calcium	Holick MF	The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.	Molecular aspects of medicine	2008	61
18832659	Calcium	Braun A	Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation.	Blood	2009	53
18838561	Calcium	Shroff RC	Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.	Circulation	2008	96
19050195	Calcium	Kesselheim AS	Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.	JAMA	2008	68
19122847	Calcium	Delpón E	Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.	Circulation. Arrhythmia and electrophysiology	2008	93
19139381	Calcium	Pokreisz P	Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.	Circulation	2009	61
19150949	Calcium	Izzedine H	Management of hypertension in angiogenesis inhibitor-treated patients.	Annals of oncology 	2009	62
19161884	Calcium	Budoff MJ	Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis).	Journal of the American College of Cardiology	2009	68
19179659	Calcium	Haas E	Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity.	Circulation research	2009	102
19236889	Calcium	Siu ER	Cadmium-induced testicular injury.	Toxicology and applied pharmacology	2009	59
19265036	Calcium	AbouAlaiwi WA	Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades.	Circulation research	2009	86
19333131	Calcium	Bers DM	Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels.	Journal of cardiovascular pharmacology	2009	57
19359599	Calcium	Thodeti CK	TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling.	Circulation research	2009	84
19451355	Calcium	Hagström E	Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.	Circulation	2009	86
19481088	Calcium	Nicolaou P	Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.	Journal of molecular and cellular cardiology	2009	50
19520338	Calcium	Blaha M	Absence of coronary artery calcification and all-cause mortality.	JACC. Cardiovascular imaging	2009	72
19556521	Calcium	Liu Q	Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.	Circulation research	2009	51
19563700	Calcium	Kumar P	Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.	Expert reviews in molecular medicine	2009	97
19593102	Calcium	Judd SE	Vitamin D deficiency and risk for cardiovascular disease.	The American journal of the medical sciences	2009	48
19615803	Calcium	Meijers BK	The uremic retention solute p-cresyl sulfate and markers of endothelial damage.	American journal of kidney diseases 	2009	54
19620505	Calcium	Croce K	Myeloid-related protein-8/14 is critical for the biological response to vascular injury.	Circulation	2009	66
19786048	Calcium	Fan X	The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury.	Brain research reviews	2009	47
19805772	Calcium	Helfand M	Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.	Annals of internal medicine	2009	63
19877084	Calcium	Rho YH	Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.	Arthritis and rheumatism	2009	49
19913545	Calcium	Minamino T	ER stress in cardiovascular disease.	Journal of molecular and cellular cardiology	2010	85
19961855	Calcium	Koitabashi N	Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.	Journal of molecular and cellular cardiology	2010	50
20042720	Calcium	Wang W	Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS.	Blood	2010	56
20075334	Calcium	Du J	TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation.	Circulation research	2010	70
20078230	Calcium	Lipskaia L	Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.	Expert opinion on biological therapy	2010	45
20087875	Calcium	Desquilbet L	Dose-response analyses using restricted cubic spline functions in public health research.	Statistics in medicine	2010	151
20110531	Calcium	Navedo MF	Increased coupled gating of L-type Ca2+ channels during hypertension and Timothy syndrome.	Circulation research	2010	59
20169111	Calcium	Hong TT	BIN1 localizes the L-type calcium channel to cardiac T-tubules.	PLoS biology	2010	66
20176609	Calcium	Nasrallah MM	Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.	Nephrology, dialysis, transplantation 	2010	46
20224870	Calcium	Campbell WB	Epoxyeicosatrienoic acids and endothelium-dependent responses.	Pflugers Archiv 	2010	83
20227497	Calcium	Haussler MR	The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging.	The Journal of steroid biochemistry and molecular biology	2010	50
20400620	Calcium	Bates DO	Vascular endothelial growth factors and vascular permeability.	Cardiovascular research	2010	71
20668910	Calcium	Nunes KP	RhoA/Rho-kinase and vascular diseases: what is the link?	Cellular and molecular life sciences 	2010	41
20716671	Calcium	Francis SH	cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.	Pharmacological reviews	2010	178
20731583	Calcium	Wang S	Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza.	The Journal of infectious diseases	2010	40
20795941	Calcium	Holick MF	Vitamin D: evolutionary, physiological and health perspectives.	Current drug targets	2011	67
20861820	Calcium	Wesseling-Perry K	Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.	Kidney international	2011	48
20921433	Calcium	Flack JM	Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.	Hypertension	2010	85
20961976	Calcium	Lanner JT	Ryanodine receptors: structure, expression, molecular details, and function in calcium release.	Cold Spring Harbor perspectives in biology	2010	148
21067953	Calcium	Guillot X	Vitamin D and inflammation.	Joint, bone, spine 	2010	78
21131953	Calcium	Baig SM	Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness.	Nature neuroscience	2011	72
21193740	Calcium	Boström KI	Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.	Circulation research	2011	57
21216834	Calcium	Landstrom AP	Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.	Circulation. Heart failure	2011	40
21282332	Calcium	Kirchhof P	PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression.	Circulation. Cardiovascular genetics	2011	68
21307850	Calcium	Yazawa M	Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.	Nature	2011	218
21311504	Calcium	Harris RA	Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults.	American journal of hypertension	2011	43
21323907	Calcium	Félétou M	Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.	British journal of pharmacology	2011	65
21383000	Calcium	Templin C	Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6).	European heart journal	2011	42
21406649	Calcium	Palmer SC	Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.	JAMA	2011	132
21408028	Calcium	Crossman DJ	Changes in the organization of excitation-contraction coupling structures in failing human heart.	PloS one	2011	52
21451044	Calcium	Cavanaugh DJ	Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells.	The Journal of neuroscience 	2011	119
21483779	Calcium	Itzhaki I	Calcium handling in human induced pluripotent stem cell derived cardiomyocytes.	PloS one	2011	51
21485744	Calcium	Wolkowitz OM	Of sound mind and body: depression, disease, and accelerated aging.	Dialogues in clinical neuroscience	2011	56
21569778	Calcium	Ren Y	Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells.	Journal of molecular and cellular cardiology	2011	45
21576492	Calcium	Verardi R	Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method.	Proceedings of the National Academy of Sciences of the United States of America	2011	65
21640757	Calcium	Jorde R	Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.	Progress in lipid research	2011	57
21697531	Calcium	Sutendra G	The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension.	Science translational medicine	2011	56
21775667	Calcium	Pleger ST	Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.	Science translational medicine	2011	54
21778431	Calcium	Bos FL	CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.	Circulation research	2011	39
21792295	Calcium	Kones R	Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy	2011	42
21804201	Calcium	Kawabata A	Prostaglandin E2 and pain--an update.	Biological & pharmaceutical bulletin	2011	37
21856482	Calcium	Blaha MJ	Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.	Lancet	2011	62
21900893	Calcium	Kho C	SUMO1-dependent modulation of SERCA2a in heart failure.	Nature	2011	83
22028871	Calcium	Schaaf S	Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.	PloS one	2011	85
22088239	Calcium	Liu LS	2010 Chinese guidelines for the management of hypertension.	Zhonghua xin xue guan bing za zhi	2011	115
22110751	Calcium	Acharya A	Inhibitory role of Notch1 in calcific aortic valve disease.	PloS one	2011	41
22112350	Calcium	Tousoulis D	The role of nitric oxide on endothelial function.	Current vascular pharmacology	2012	78
22138472	Calcium	Hong TT	BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes.	Heart rhythm	2012	45
22174035	Calcium	Jung CB	Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.	EMBO molecular medicine	2012	99
22394518	Calcium	Yu K	Explaining calcium-dependent gating of anoctamin-1 chloride channels requires a revised topology.	Circulation research	2012	59
22421513	Calcium	Quarles LD	Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.	Experimental cell research	2012	48
22422768	Calcium	Roux-Buisson N	Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.	Human molecular genetics	2012	51
22431676	Calcium	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	65
22473330	Calcium	Thompson B	Arterial calcification and bone physiology: role of the bone-vascular axis.	Nature reviews. Endocrinology	2012	47
22516444	Calcium	Dweck MR	Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.	Journal of the American College of Cardiology	2012	55
22537188	Calcium	Van Der Meijden PE	Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.	Journal of thrombosis and haemostasis 	2012	37
22733215	Calcium	Venetucci L	Inherited calcium channelopathies in the pathophysiology of arrhythmias.	Nature reviews. Cardiology	2012	45
22749309	Calcium	Itzhaki I	Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.	Journal of the American College of Cardiology	2012	65
22782502	Calcium	Haussler MR	Molecular mechanisms of vitamin D action.	Calcified tissue international	2013	118
22789936	Calcium	Sillesen H	Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.	JACC. Cardiovascular imaging	2012	37
22820791	Calcium	Subramanian S	Arterial inflammation in patients with HIV.	JAMA	2012	141
22871241	Calcium	Carnicer R	Nitric oxide synthases in heart failure.	Antioxidants & redox signaling	2013	36
22872152	Calcium	Bulley S	TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries.	Circulation research	2012	43
22910756	Calcium	Yeboah J	Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.	JAMA	2012	163
22922412	Calcium	McCurley A	Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.	Nature medicine	2012	71
22962621	Calcium	Kujala K	Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.	PloS one	2012	41
23007404	Calcium	Cortese-Krott MM	Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease.	Blood	2012	32
23092679	Calcium	Mozaffarieh M	New insights in the pathogenesis and treatment of normal tension glaucoma.	Current opinion in pharmacology	2013	35
23130158	Calcium	Santulli G	CaMK4 Gene Deletion Induces Hypertension.	Journal of the American Heart Association	2012	79
23229924	Calcium	Louvet L	Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells.	Nephrology, dialysis, transplantation 	2013	28
23261219	Calcium	Rao C	The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.	Biomaterials	2013	32
23281406	Calcium	McNally EM	Genetic mutations and mechanisms in dilated cardiomyopathy.	The Journal of clinical investigation	2013	87
23281409	Calcium	Marks AR	Calcium cycling proteins and heart failure: mechanisms and therapeutics.	The Journal of clinical investigation	2013	85
23334860	Calcium	Hong Z	Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus.	Circulation research	2013	32
23354045	Calcium	Kim C	Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.	Nature	2013	108
23389416	Calcium	Scialla JJ	Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.	Kidney international	2013	61
23443925	Calcium	Touchberry CD	FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.	American journal of physiology. Endocrinology and metabolism	2013	39
23461462	Calcium	Lundy SD	Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.	Stem cells and development	2013	151
23487791	Calcium	Nam YJ	Reprogramming of human fibroblasts toward a cardiac fate.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
23506867	Calcium	Khananshvili D	The SLC8 gene family of sodium-calcium exchangers (NCX) - structure, function, and regulation in health and disease.	Molecular aspects of medicine	2013	32
23512989	Calcium	Shinde AV	STIM1 controls endothelial barrier function independently of Orai1 and Ca2+ entry.	Science signaling	2013	26
23616621	Calcium	New SE	Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques.	Circulation research	2013	67
23684427	Calcium	Zhang XH	Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.	Cell calcium	2013	29
23690542	Calcium	Harris K	Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays.	Toxicological sciences 	2013	37
23732649	Calcium	Colman MA	Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria.	The Journal of physiology	2013	36
23832699	Calcium	Ivashchenko CY	Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.	American journal of physiology. Heart and circulatory physiology	2013	34
23845067	Calcium	Kröller-Schön S	Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models.	Antioxidants & redox signaling	2014	42
23877588	Calcium	Silver J	FGF-23 and secondary hyperparathyroidism in chronic kidney disease.	Nature reviews. Nephrology	2013	25
23922354	Calcium	Bouillon R	Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine.	The Journal of clinical endocrinology and metabolism	2013	42
24092942	Calcium	Blood Pressure Lowering Treatment Trialists' Collaboration.	Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.	BMJ	2013	38
24113177	Calcium	Di Pasquale E	CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.	Cell death & disease	2013	31
24180474	Calcium	Konior A	NADPH oxidases in vascular pathology.	Antioxidants & redox signaling	2014	52
24194499	Calcium	Kanaya AM	Mediators of Atherosclerosis in South Asians Living in America (MASALA) study: objectives, methods, and cohort description.	Clinical cardiology	2013	36
24284821	Calcium	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	31
24319660	Calcium	Fu JD	Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state.	Stem cell reports	2013	101
24332854	Calcium	Hoffman NE	MICU1 motifs define mitochondrial calcium uniporter binding and activity.	Cell reports	2013	35
24355759	Calcium	Wolk MJ	ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.	Journal of the American College of Cardiology	2014	67
24370480	Calcium	Baker JV	Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.	AIDS	2014	38
24395921	Calcium	Tao Y	Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes.	Circulation. Cardiovascular genetics	2014	23
24436433	Calcium	Norman PE	Vitamin D and cardiovascular disease.	Circulation research	2014	53
24473329	Calcium	Williams MC	Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality.	Thorax	2014	24
24530899	Calcium	Luczak ED	CaMKII oxidative activation and the pathogenesis of cardiac disease.	Journal of molecular and cellular cardiology	2014	27
24552833	Calcium	Jeltsch M	CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.	Circulation	2014	25
24563457	Calcium	Hwang HS	Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.	Circulation research	2014	26
24621794	Calcium	Braunwald E	Heart failure.	JACC. Heart failure	2013	96
24641882	Calcium	Brault M	Statin treatment and new-onset diabetes: a review of proposed mechanisms.	Metabolism	2014	28
24668259	Calcium	Kestenbaum B	Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.	Circulation. Heart failure	2014	23
24670661	Calcium	Wahlquist C	Inhibition of miR-25 improves cardiac contractility in the failing heart.	Nature	2014	78
24691204	Calcium	Longenecker CT	Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.	AIDS	2014	48
24735830	Calcium	Yang X	Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells.	Journal of molecular and cellular cardiology	2014	55
24906643	Calcium	Evanson KW	LRRC26 is a functional BK channel auxiliary γ subunit in arterial smooth muscle cells.	Circulation research	2014	24
24928681	Calcium	Montaigne D	Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients.	Circulation	2014	33
24997452	Calcium	Varga ZV	Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.	Biochimica et biophysica acta	2015	38
25023795	Calcium	Eberhardt M	H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.	Nature communications	2014	51
25054430	Calcium	Johannesen L	Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.	Clinical pharmacology and therapeutics	2014	22
25069991	Calcium	Harman SM	Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.	Annals of internal medicine	2014	46
25162667	Calcium	Silverberg SJ	Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.	The Journal of clinical endocrinology and metabolism	2014	23
25239140	Calcium	Makara MA	Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo.	Circulation research	2014	27
25260352	Calcium	Boczek NJ	Novel Timothy syndrome mutation leading to increase in CACNA1C window current.	Heart rhythm	2015	16
25362192	Calcium	McKibben RA	Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.	The Journal of infectious diseases	2015	38
25528431	Calcium	Pugliese G	The dark and bright side of atherosclerotic calcification.	Atherosclerosis	2015	19
25543971	Calcium	Ho CY	Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.	JACC. Heart failure	2015	22
25569087	Calcium	Gehlert S	Ca2+-dependent regulations and signaling in skeletal muscle: from electro-mechanical coupling to adaptation.	International journal of molecular sciences	2015	22
25622091	Calcium	Lewis HD	Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.	Nature chemical biology	2015	48
25632041	Calcium	Smith SA	Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.	Circulation	2015	19
25654582	Calcium	Beauchamp P	Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.	Tissue engineering. Part C, Methods	2015	24
25711438	Calcium	Kapustin AN	Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.	Circulation research	2015	51
25801675	Calcium	Zhang Y	MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.	Scientific reports	2015	23
25834230	Calcium	Carlström M	Renal autoregulation in health and disease.	Physiological reviews	2015	44
25835438	Calcium	Puri R	Impact of statins on serial coronary calcification during atheroma progression and regression.	Journal of the American College of Cardiology	2015	34
25870186	Calcium	Vicente J	Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.	Journal of the American Heart Association	2015	21
25916871	Calcium	Schlieper G	Vascular calcification in chronic kidney disease: an update.	Nephrology, dialysis, transplantation 	2016	11
25917875	Calcium	Selvaraj S	Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway.	Molecular carcinogenesis	2016	19
25925688	Calcium	Keyzer CA	Calcification Propensity and Survival among Renal Transplant Recipients.	Journal of the American Society of Nephrology 	2016	11
26153245	Calcium	Ding J	Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.	Diabetes	2015	19
26262795	Calcium	Basaria S	Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.	JAMA	2015	19
26362469	Calcium	Zamponi GW	The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.	Pharmacological reviews	2015	72
26499181	Calcium	Zhao Y	Vascular nitric oxide: Beyond eNOS.	Journal of pharmacological sciences	2015	33
26678809	Calcium	Jia G	Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.	Nature reviews. Endocrinology	2016	42
26750181	Calcium	Ellulu MS	Atherosclerotic cardiovascular disease: a review of initiators and protective factors.	Inflammopharmacology	2016	13
26803443	Calcium	Greenberg B	Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.	Lancet	2016	36
26899994	Calcium	Li X	miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1.	Scientific reports	2016	14
26908770	Calcium	Brandenburg VM	Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.	Nephrology, dialysis, transplantation 	2017	9
27028912	Calcium	Hodis HN	Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.	The New England journal of medicine	2016	31
27059077	Calcium	Vaidyanathan R	IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes.	American journal of physiology. Heart and circulatory physiology	2016	18
27184445	Calcium	Dempsey GT	Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging.	Journal of pharmacological and toxicological methods	2016	22
27662816	Calcium	Wimalawansa SJ	Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.	The Journal of steroid biochemistry and molecular biology	2018	5
27784679	Calcium	Szabo C	Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications.	American journal of physiology. Cell physiology	2017	12
27845201	Calcium	Tarantini S	Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.	Experimental gerontology	2017	13
27984724	Calcium	Ang YS	Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis.	Cell	2016	16
28069694	Calcium	Gao L	Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.	Circulation research	2017	10
28097356	Calcium	Block GA	Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.	JAMA	2017	7
28137840	Calcium	Zeng Q	Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice.	Proceedings of the National Academy of Sciences of the United States of America	2017	12
28406212	Calcium	Saleheen D	Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity.	Nature	2017	20
28504650	Calcium	Kraakman MJ	Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.	The Journal of clinical investigation	2017	10
9245797	Glutathione	Dawson DW	CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.	The Journal of cell biology	1997	172
10569628	Glutathione	Brigelius-Flohé R	Tissue-specific functions of individual glutathione peroxidases.	Free radical biology & medicine	1999	132
10963718	Glutathione	Dhalla NS	Status of myocardial antioxidants in ischemia-reperfusion injury.	Cardiovascular research	2000	91
11031201	Glutathione	Griendling KK	Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology.	Arteriosclerosis, thrombosis, and vascular biology	2000	137
12808161	Glutathione	Locatelli F	Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.	Nephrology, dialysis, transplantation 	2003	93
15123696	Glutathione	Adachi T	S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells.	The Journal of biological chemistry	2004	85
15161665	Glutathione	Dernbach E	Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress.	Blood	2004	91
16020798	Glutathione	Schwartz J	Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction.	American journal of respiratory and critical care medicine	2005	72
16127462	Glutathione	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	68
16765337	Glutathione	Paravicini TM	Redox signaling in hypertension.	Cardiovascular research	2006	120
17064675	Glutathione	Park HS	Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells.	Cardiovascular research	2006	61
17172268	Glutathione	Berndt C	Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system.	American journal of physiology. Heart and circulatory physiology	2007	88
17360173	Glutathione	Seifried HE	A review of the interaction among dietary antioxidants and reactive oxygen species.	The Journal of nutritional biochemistry	2007	79
17632546	Glutathione	Martinez Molina D	Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase.	Nature	2007	55
17878511	Glutathione	Samuelsson B	Membrane prostaglandin E synthase-1: a novel therapeutic target.	Pharmacological reviews	2007	117
18007994	Glutathione	Chahine T	Particulate air pollution, oxidative stress genes, and heart rate variability in an elderly cohort.	Environmental health perspectives	2007	65
18574092	Glutathione	Dobnig H	Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.	Archives of internal medicine	2008	278
18629312	Glutathione	Delfino RJ	Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease.	Environmental health perspectives	2008	101
18757483	Glutathione	Csiszar A	Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice.	American journal of physiology. Heart and circulatory physiology	2008	66
19268692	Glutathione	Steinbrenner H	Protection against reactive oxygen species by selenoproteins.	Biochimica et biophysica acta	2009	54
19327385	Glutathione	Rayman MP	Selenoproteins and human health: insights from epidemiological data.	Biochimica et biophysica acta	2009	54
19672402	Glutathione	Delfino RJ	Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms.	Environmental health perspectives	2009	72
19749157	Glutathione	Ungvari Z	Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells.	American journal of physiology. Heart and circulatory physiology	2009	95
20032990	Glutathione	Uitto J	Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms.	The Journal of investigative dermatology	2010	54
20083859	Glutathione	Spanier G	Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).	Journal of physiology and pharmacology 	2009	51
20524845	Glutathione	Cheng X	Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway.	Antioxidants & redox signaling	2011	43
21087145	Glutathione	Lubos E	Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.	Antioxidants & redox signaling	2011	86
21385671	Glutathione	Madrigano J	Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men.	Environmental health perspectives	2011	68
21554949	Glutathione	Flora SJ	Arsenic-induced oxidative stress and its reversibility.	Free radical biology & medicine	2011	88
22020111	Glutathione	Hybertson BM	Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.	Molecular aspects of medicine	2011	120
22375253	Glutathione	Matough FA	The role of oxidative stress and antioxidants in diabetic complications.	Sultan Qaboos University medical journal	2012	36
22525041	Glutathione	Crawford A	Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.	Gene	2012	31
23633659	Glutathione	Zhong Q	Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.	Investigative ophthalmology & visual science	2013	27
24102912	Glutathione	Mitranun W	Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients.	Scandinavian journal of medicine & science in sports	2014	30
24692350	Glutathione	Bhattacharyya A	Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.	Physiological reviews	2014	99
25244505	Glutathione	Li H	Vascular oxidative stress, nitric oxide and atherosclerosis.	Atherosclerosis	2014	76
25364233	Glutathione	Wang YY	Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.	Drug design, development and therapy	2014	24
25759575	Glutathione	Guo C	Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-κB signaling.	International journal of nanomedicine	2015	20
26233704	Glutathione	Espinosa-Diez C	Antioxidant responses and cellular adjustments to oxidative stress.	Redox biology	2015	77
26673559	Glutathione	Patel RS	Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease.	Circulation	2016	14
26792059	Glutathione	Amir Aslani B	Studies on oxidants and antioxidants with a brief glance at their relevance to the immune system.	Life sciences	2016	13
27245224	Glutathione	Peiró C	Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway.	Cardiovascular diabetology	2016	11
1279431	Oxygen	Shweiki D	Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.	Nature	1992	672
4057091	Oxygen	Andersen P	Maximal perfusion of skeletal muscle in man.	The Journal of physiology	1985	217
7641334	Oxygen	Liu Y	Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer.	Circulation research	1995	170
8144582	Oxygen	Yan SD	Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.	The Journal of biological chemistry	1994	170
8790408	Oxygen	Lebovitz RM	Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1996	226
8958220	Oxygen	Rajagopalan S	Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.	The Journal of clinical investigation	1996	170
9521897	Oxygen	Benjamin LE	A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.	Development	1998	245
9622162	Oxygen	De Keulenaer GW	Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase.	Circulation research	1998	121
10385613	Oxygen	Bouloumie A	Leptin induces oxidative stress in human endothelial cells.	FASEB journal 	1999	107
10398599	Oxygen	Dawson DW	Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.	Science	1999	303
10430608	Oxygen	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	114
10545952	Oxygen	Papadopoulou LC	Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene.	Nature genetics	1999	101
10581086	Oxygen	Jones MK	Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.	Nature medicine	1999	105
10720054	Oxygen	Vgontzas AN	Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.	The Journal of clinical endocrinology and metabolism	2000	186
10720409	Oxygen	Griendling KK	NAD(P)H oxidase: role in cardiovascular biology and disease.	Circulation research	2000	477
10896648	Oxygen	Ross R	Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial.	Annals of internal medicine	2000	212
10924857	Oxygen	Hubbard AK	Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades.	Free radical biology & medicine	2000	92
11214321	Oxygen	Pawloski JR	Export by red blood cells of nitric oxide bioactivity.	Nature	2001	117
11287350	Oxygen	Wautier MP	Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.	American journal of physiology. Endocrinology and metabolism	2001	161
11304501	Oxygen	Dzau VJ	Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.	Hypertension	2001	96
11424232	Oxygen	Rösen P	The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society.	Diabetes/metabolism research and reviews	2001	115
11516994	Oxygen	Semenza GL	Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.	Trends in molecular medicine	2001	162
11566918	Oxygen	London GM	Arterial wave reflections and survival in end-stage renal failure.	Hypertension	2001	112
11719508	Oxygen	Colavitti R	Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.	The Journal of biological chemistry	2002	89
11734454	Oxygen	Bhatt AJ	Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.	American journal of respiratory and critical care medicine	2001	122
11874812	Oxygen	Ip MS	Obstructive sleep apnea is independently associated with insulin resistance.	American journal of respiratory and critical care medicine	2002	207
11893732	Oxygen	Li JM	Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells.	The Journal of biological chemistry	2002	89
11934717	Oxygen	Dyugovskaya L	Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.	American journal of respiratory and critical care medicine	2002	112
12027880	Oxygen	Xie Z	Na(+)/K(+)-ATPase as a signal transducer.	European journal of biochemistry	2002	112
12042776	Oxygen	McMahon TJ	Nitric oxide in the human respiratory cycle.	Nature medicine	2002	96
12147534	Oxygen	Ballinger SW	Mitochondrial integrity and function in atherogenesis.	Circulation	2002	104
12171785	Oxygen	Brasier AR	Vascular inflammation and the renin-angiotensin system.	Arteriosclerosis, thrombosis, and vascular biology	2002	90
12176889	Oxygen	Dekker RJ	Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2).	Blood	2002	160
12480817	Oxygen	Ushio-Fukai M	Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.	Circulation research	2002	134
12500267	Oxygen	Li J	Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix.	Microscopy research and technique	2003	88
12586529	Oxygen	Lavie L	Obstructive sleep apnoea syndrome--an oxidative stress disorder.	Sleep medicine reviews	2003	140
12663857	Oxygen	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	88
12668498	Oxygen	Dechend R	AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.	Circulation	2003	76
12821241	Oxygen	Heymes C	Increased myocardial NADPH oxidase activity in human heart failure.	Journal of the American College of Cardiology	2003	119
12855411	Oxygen	Lassègue B	Vascular NAD(P)H oxidases: specific features, expression, and regulation.	American journal of physiology. Regulatory, integrative and comparative physiology	2003	201
12874436	Oxygen	Inoguchi T	Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase.	Journal of the American Society of Nephrology 	2003	80
12885586	Oxygen	Fattman CL	Extracellular superoxide dismutase in biology and medicine.	Free radical biology & medicine	2003	104
12933700	Oxygen	Weiss JN	Role of the mitochondrial permeability transition in myocardial disease.	Circulation research	2003	125
12967772	Oxygen	Cai H	The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.	Trends in pharmacological sciences	2003	148
14526383	Oxygen	Giaccia A	HIF-1 as a target for drug development.	Nature reviews. Drug discovery	2003	123
14573732	Oxygen	Blankenberg S	Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.	The New England journal of medicine	2003	104
14578299	Oxygen	Quagliaro L	Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.	Diabetes	2003	134
14597738	Oxygen	Schioppa T	Regulation of the chemokine receptor CXCR4 by hypoxia.	The Journal of experimental medicine	2003	193
14604834	Oxygen	Delafontaine P	Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.	Arteriosclerosis, thrombosis, and vascular biology	2004	100
14633847	Oxygen	Tripathy D	Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects.	Diabetes	2003	124
14656731	Oxygen	Alp NJ	Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2004	115
14670934	Oxygen	Hilenski LL	Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells.	Arteriosclerosis, thrombosis, and vascular biology	2004	198
14694147	Oxygen	Berry CE	Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.	The Journal of physiology	2004	152
14713953	Oxygen	Miyauchi H	Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway.	The EMBO journal	2004	82
14718399	Oxygen	Ago T	Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase.	Circulation	2004	111
14985465	Oxygen	Zimmer M	Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.	Molecular cancer research 	2004	82
15123530	Oxygen	Peterson LR	Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women.	Circulation	2004	130
15128745	Oxygen	Schulze PC	Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.	The Journal of biological chemistry	2004	95
15173060	Oxygen	Landmesser U	Endothelial function: a critical determinant in atherosclerosis?	Circulation	2004	119
15475499	Oxygen	Li JM	Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology.	American journal of physiology. Regulatory, integrative and comparative physiology	2004	172
15544038	Oxygen	Ushio-Fukai M	Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase.	Molecular and cellular biochemistry	2004	106
15569841	Oxygen	Nagaya N	Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.	Circulation	2004	75
15572675	Oxygen	Pedruzzi E	NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells.	Molecular and cellular biology	2004	116
15640347	Oxygen	Shao MX	Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	68
15706079	Oxygen	Van Buul JD	Expression and localization of NOX2 and NOX4 in primary human endothelial cells.	Antioxidants & redox signaling	2005	105
15820197	Oxygen	Brandes RP	Endothelial aging.	Cardiovascular research	2005	123
15837952	Oxygen	Larkin EK	Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration.	Circulation	2005	70
15855252	Oxygen	Karelis AD	The metabolically healthy but obese individual presents a favorable inflammation profile.	The Journal of clinical endocrinology and metabolism	2005	117
15879174	Oxygen	Schriner SE	Extension of murine life span by overexpression of catalase targeted to mitochondria.	Science	2005	458
15914121	Oxygen	Valle I	PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.	Cardiovascular research	2005	123
16009356	Oxygen	Cai H	Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences.	Cardiovascular research	2005	143
16123335	Oxygen	Kim YM	A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.	Circulation research	2005	80
16141358	Oxygen	Hunyady L	Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.	Molecular endocrinology	2006	121
16179589	Oxygen	Cucoranu I	NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.	Circulation research	2005	225
16204625	Oxygen	Haorah J	Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction.	Journal of leukocyte biology	2005	76
16227320	Oxygen	Sturrock A	Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells.	American journal of physiology. Lung cellular and molecular physiology	2006	146
16254208	Oxygen	Hemdahl AL	Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.	Arteriosclerosis, thrombosis, and vascular biology	2006	66
16290020	Oxygen	Kang SW	2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications.	Trends in molecular medicine	2005	77
16324151	Oxygen	Kuroda J	The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.	Genes to cells 	2005	100
16336196	Oxygen	Frühbeck G	Intracellular signalling pathways activated by leptin.	The Biochemical journal	2006	166
16375736	Oxygen	Glantzounis GK	Uric acid and oxidative stress.	Current pharmaceutical design	2005	106
16394109	Oxygen	Galkina E	Leukocyte recruitment and vascular injury in diabetic nephropathy.	Journal of the American Society of Nephrology 	2006	73
16443044	Oxygen	Opie LH	Controversies in ventricular remodelling.	Lancet	2006	152
16446448	Oxygen	Vartanian V	The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.	Proceedings of the National Academy of Sciences of the United States of America	2006	80
16506274	Oxygen	Cersosimo E	Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.	Diabetes/metabolism research and reviews	2006	64
16514078	Oxygen	Hordijk PL	Regulation of NADPH oxidases: the role of Rac proteins.	Circulation research	2006	168
16580655	Oxygen	Zweier JL	The role of oxidants and free radicals in reperfusion injury.	Cardiovascular research	2006	150
16585403	Oxygen	Förstermann U	Endothelial nitric oxide synthase in vascular disease: from marvel to menace.	Circulation	2006	344
16678181	Oxygen	Hunt NH	Immunopathogenesis of cerebral malaria.	International journal for parasitology	2006	84
16713904	Oxygen	Guzik TJ	Vascular NADPH oxidases as drug targets for novel antioxidant strategies.	Drug discovery today	2006	62
16716598	Oxygen	Hirota K	Regulation of angiogenesis by hypoxia-inducible factor 1.	Critical reviews in oncology/hematology	2006	122
16735674	Oxygen	Bonnet S	An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.	Circulation	2006	157
16765921	Oxygen	Geiszt M	NADPH oxidases: new kids on the block.	Cardiovascular research	2006	61
16771662	Oxygen	Cave AC	NADPH oxidases in cardiovascular health and disease.	Antioxidants & redox signaling	2006	164
16781692	Oxygen	Ushio-Fukai M	Redox signaling in angiogenesis: role of NADPH oxidase.	Cardiovascular research	2006	127
16870827	Oxygen	Mehta PK	Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.	American journal of physiology. Cell physiology	2007	439
16894049	Oxygen	Goldin A	Advanced glycation end products: sparking the development of diabetic vascular injury.	Circulation	2006	336
17034340	Oxygen	Frangogiannis NG	The mechanistic basis of infarct healing.	Antioxidants & redox signaling	2006	66
17045587	Oxygen	Diez H	Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.	Experimental cell research	2007	63
17079761	Oxygen	Birks EJ	Left ventricular assist device and drug therapy for the reversal of heart failure.	The New England journal of medicine	2006	108
17174230	Oxygen	Sokos GG	Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.	Journal of cardiac failure	2006	133
17237347	Oxygen	Bedard K	The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.	Physiological reviews	2007	1434
17250680	Oxygen	Haorah J	Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.	Journal of neurochemistry	2007	79
17272744	Oxygen	Bonello S	Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site.	Arteriosclerosis, thrombosis, and vascular biology	2007	166
17303919	Oxygen	Brasier AR	The NF-kappaB regulatory network.	Cardiovascular toxicology	2006	116
17329180	Oxygen	Takemura G	Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.	Progress in cardiovascular diseases	2007	127
17404154	Oxygen	Horke S	Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation.	Circulation	2007	66
17428837	Oxygen	Sautin YY	Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.	American journal of physiology. Cell physiology	2007	124
17494630	Oxygen	Schoner W	Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.	American journal of physiology. Cell physiology	2007	123
17555404	Oxygen	Schmidt TS	Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.	Clinical science	2007	58
17585072	Oxygen	Mittal M	Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.	Circulation research	2007	124
17586614	Oxygen	Cooper SA	Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.	American journal of physiology. Heart and circulatory physiology	2007	67
17643088	Oxygen	Jain RK	Angiogenesis in brain tumours.	Nature reviews. Neuroscience	2007	335
17673675	Oxygen	Miller FJ Jr	Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3.	Circulation research	2007	76
17898080	Oxygen	Belaiba RS	Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells.	Molecular biology of the cell	2007	107
18048767	Oxygen	Fan Y	Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells.	Arteriosclerosis, thrombosis, and vascular biology	2008	51
18086956	Oxygen	Heumüller S	Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.	Hypertension	2008	258
18094066	Oxygen	Wei Y	Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	52
18227481	Oxygen	Paravicini TM	NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.	Diabetes care	2008	159
18259200	Oxygen	Loor G	Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion.	Cell death and differentiation	2008	63
18261470	Oxygen	Wood KC	Sickle cell disease vasculopathy: a state of nitric oxide resistance.	Free radical biology & medicine	2008	54
18264786	Oxygen	Legg JA	Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.	Angiogenesis	2008	54
18323464	Oxygen	Solomon TP	Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults.	Journal of applied physiology	2008	52
18340017	Oxygen	Ungvari Z	Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging.	Circulation research	2008	72
18375743	Oxygen	Koff JL	Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium.	American journal of physiology. Lung cellular and molecular physiology	2008	74
18382884	Oxygen	Münzel T	Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.	Annals of medicine	2008	78
18448380	Oxygen	Pournaras CJ	Regulation of retinal blood flow in health and disease.	Progress in retinal and eye research	2008	98
18466778	Oxygen	Jay DB	Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells.	Free radical biology & medicine	2008	50
18573911	Oxygen	Chen K	Regulation of ROS signal transduction by NADPH oxidase 4 localization.	The Journal of cell biology	2008	170
18599677	Oxygen	Csiszar A	Inflammation and endothelial dysfunction during aging: role of NF-kappaB.	Journal of applied physiology	2008	133
18620057	Oxygen	Frangogiannis NG	The immune system and cardiac repair.	Pharmacological research	2008	163
18673303	Oxygen	Tjønna AE	Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents.	Clinical science	2009	48
18751914	Oxygen	Adibhatla RM	Altered lipid metabolism in brain injury and disorders.	Sub-cellular biochemistry	2008	78
18767184	Oxygen	Niebruegge S	Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.	Biotechnology and bioengineering	2009	65
18783311	Oxygen	Pendyala S	Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells.	Antioxidants & redox signaling	2009	71
18783313	Oxygen	Frey RS	NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.	Antioxidants & redox signaling	2009	128
18854381	Oxygen	Tsutsui H	Mitochondrial oxidative stress and dysfunction in myocardial remodelling.	Cardiovascular research	2009	78
19022160	Oxygen	Guzik TJ	Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease.	Journal of the American College of Cardiology	2008	82
19036873	Oxygen	Ismail S	NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3.	American journal of physiology. Lung cellular and molecular physiology	2009	68
19047340	Oxygen	Hori M	Oxidative stress and left ventricular remodelling after myocardial infarction.	Cardiovascular research	2009	95
19059306	Oxygen	Garrido AM	NADPH oxidases and angiotensin II receptor signaling.	Molecular and cellular endocrinology	2009	99
19106411	Oxygen	Blair P	Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.	Circulation research	2009	49
19118493	Oxygen	Zhang H	Role of TNF-alpha in vascular dysfunction.	Clinical science	2009	108
19149564	Oxygen	Potenza MA	Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.	Current medicinal chemistry	2009	66
19179352	Oxygen	Gao L	Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.	Cardiovascular research	2009	91
19211823	Oxygen	Nicklas BJ	Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: a randomized, controlled trial.	The American journal of clinical nutrition	2009	55
19255424	Oxygen	Scheer FA	Adverse metabolic and cardiovascular consequences of circadian misalignment.	Proceedings of the National Academy of Sciences of the United States of America	2009	384
19265035	Oxygen	Rane S	Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.	Circulation research	2009	186
19273217	Oxygen	Wittchen ES	Endothelial signaling in paracellular and transcellular leukocyte transmigration.	Frontiers in bioscience	2009	48
19281826	Oxygen	Roberts CK	Oxidative stress and metabolic syndrome.	Life sciences	2009	114
19293146	Oxygen	Toda N	Cerebral blood flow regulation by nitric oxide: recent advances.	Pharmacological reviews	2009	66
19302038	Oxygen	Galkina E	Immune and inflammatory mechanisms of atherosclerosis (*).	Annual review of immunology	2009	310
19417078	Oxygen	Zingaretti MC	The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue.	FASEB journal 	2009	198
19460403	Oxygen	Porter KE	Cardiac fibroblasts: at the heart of myocardial remodeling.	Pharmacology & therapeutics	2009	243
19505186	Oxygen	Sarsour EH	Redox control of the cell cycle in health and disease.	Antioxidants & redox signaling	2009	79
19520972	Oxygen	Eisenhardt SU	Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.	Circulation research	2009	55
19574552	Oxygen	Lyle AN	Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells.	Circulation research	2009	164
19584191	Oxygen	Nadeau KJ	Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.	The Journal of clinical endocrinology and metabolism	2009	51
19622751	Oxygen	Doroudgar S	Ischemia activates the ATF6 branch of the endoplasmic reticulum stress response.	The Journal of biological chemistry	2009	52
19633358	Oxygen	Monaghan-Benson E	The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species.	The Journal of biological chemistry	2009	69
19652871	Oxygen	Schuett H	How much is too much? Interleukin-6 and its signalling in atherosclerosis.	Thrombosis and haemostasis	2009	55
19654589	Oxygen	Ramirez SH	Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.	Journal of cerebral blood flow and metabolism 	2009	59
19712802	Oxygen	Caminiti G	Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.	Journal of the American College of Cardiology	2009	59
19720058	Oxygen	Serena E	Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species.	Experimental cell research	2009	52
19789524	Oxygen	Misra MK	Oxidative stress and ischemic myocardial syndromes.	Medical science monitor 	2009	66
19833897	Oxygen	Yao D	Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.	Diabetes	2010	99
19889414	Oxygen	Salpea KD	Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.	Atherosclerosis	2010	75
19909994	Oxygen	Andropoulos DB	Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoring.	The Journal of thoracic and cardiovascular surgery	2010	54
19910640	Oxygen	Lassègue B	NADPH oxidases: functions and pathologies in the vasculature.	Arteriosclerosis, thrombosis, and vascular biology	2010	180
19915016	Oxygen	Nadeau KJ	Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.	The Journal of clinical endocrinology and metabolism	2010	82
19942623	Oxygen	Mukhopadhyay P	CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.	Cardiovascular research	2010	42
19995913	Oxygen	von Löhneysen K	Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization.	Molecular and cellular biology	2010	49
20028977	Oxygen	Ohashi K	Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype.	The Journal of biological chemistry	2010	141
20038740	Oxygen	De Angelis A	Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.	Circulation	2010	70
20040868	Oxygen	Wang M	Arterial aging: a journey into subclinical arterial disease.	Current opinion in nephrology and hypertension	2010	51
20062930	Oxygen	Beckers CM	Driving Rho GTPase activity in endothelial cells regulates barrier integrity.	Thrombosis and haemostasis	2010	72
20082930	Oxygen	Farpour-Lambert NJ	Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children.	Journal of the American College of Cardiology	2009	48
20164116	Oxygen	Rey S	Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling.	Cardiovascular research	2010	107
20164424	Oxygen	Denny MF	A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.	Journal of immunology	2010	125
20179104	Oxygen	Mai S	Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1.	Journal of cell science	2010	49
20299674	Oxygen	Yan SF	The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.	Circulation research	2010	98
20424957	Oxygen	Briones AM	Oxidative stress and hypertension: current concepts.	Current hypertension reports	2010	66
20462866	Oxygen	Becker BF	Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential.	Cardiovascular research	2010	62
20486275	Oxygen	Yu MA	Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.	Journal of hypertension	2010	75
20622120	Oxygen	Lu X	PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.	American journal of physiology. Lung cellular and molecular physiology	2010	59
20732359	Oxygen	Semenza GL	Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.	Biochimica et biophysica acta	2011	90
20819950	Oxygen	de Cavanagh EM	Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?	Cardiovascular research	2011	37
20942471	Oxygen	Laleu B	First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.	Journal of medicinal chemistry	2010	75
20981034	Oxygen	Touyz RM	Reactive oxygen species and vascular biology: implications in human hypertension.	Hypertension research 	2011	86
21074607	Oxygen	Martin-Garrido A	NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.	Free radical biology & medicine	2011	38
21144973	Oxygen	Rajesh M	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.	Journal of the American College of Cardiology	2010	61
21148429	Oxygen	Dorn GW 2nd	MARF and Opa1 control mitochondrial and cardiac function in Drosophila.	Circulation research	2011	47
21196259	Oxygen	Chrissobolis S	Oxidative stress and endothelial dysfunction in cerebrovascular disease.	Frontiers in bioscience	2011	41
21215757	Oxygen	Maejima Y	Regulation of myocardial growth and death by NADPH oxidase.	Journal of molecular and cellular cardiology	2011	49
21228261	Oxygen	Jiang F	NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair.	Pharmacological reviews	2011	146
21236334	Oxygen	Santos CX	Redox signaling in cardiac myocytes.	Free radical biology & medicine	2011	83
21293192	Oxygen	Stein S	Protective roles of SIRT1 in atherosclerosis.	Cell cycle	2011	60
21296189	Oxygen	Hüttemann M	The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis.	Mitochondrion	2011	58
21307839	Oxygen	Barnes JL	Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.	Kidney international	2011	108
21335095	Oxygen	Rabbani N	Glyoxalase in diabetes, obesity and related disorders.	Seminars in cell & developmental biology	2011	63
21486813	Oxygen	Sato K	The distribution of blood flow in the carotid and vertebral arteries during dynamic exercise in humans.	The Journal of physiology	2011	43
21494607	Oxygen	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	129
21497090	Oxygen	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	52
21507901	Oxygen	Hulsmans M	MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis.	FASEB journal 	2011	60
21586323	Oxygen	Csányi G	Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2.	Free radical biology & medicine	2011	50
21593862	Oxygen	Carmeliet P	Molecular mechanisms and clinical applications of angiogenesis.	Nature	2011	923
21606348	Oxygen	Billia F	PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
21629295	Oxygen	Drummond GR	Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.	Nature reviews. Drug discovery	2011	207
21637285	Oxygen	Martin SK	The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.	Leukemia	2011	44
21660297	Oxygen	Kent BD	Hypoxemia in patients with COPD: cause, effects, and disease progression.	International journal of chronic obstructive pulmonary disease	2011	43
21670228	Oxygen	Goossens GH	Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation.	Circulation	2011	61
21697548	Oxygen	Edin ML	Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.	FASEB journal 	2011	46
21712087	Oxygen	Fraser PA	The role of free radical generation in increasing cerebrovascular permeability.	Free radical biology & medicine	2011	37
21742796	Oxygen	Goel S	Normalization of the vasculature for treatment of cancer and other diseases.	Physiological reviews	2011	317
21747057	Oxygen	Shenouda SM	Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus.	Circulation	2011	105
21756109	Oxygen	Chung AS	Developmental and pathological angiogenesis.	Annual review of cell and developmental biology	2011	158
21775390	Oxygen	Bouitbir J	Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.	European heart journal	2012	37
21844076	Oxygen	Reilly SN	Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.	Circulation	2011	60
21860391	Oxygen	Herbert SP	Molecular control of endothelial cell behaviour during blood vessel morphogenesis.	Nature reviews. Molecular cell biology	2011	177
21878340	Oxygen	Darley-Usmar VM	Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.	Journal of molecular and cellular cardiology	2012	31
21883939	Oxygen	Montezano AC	Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.	Basic & clinical pharmacology & toxicology	2012	43
21940680	Oxygen	Xiang M	Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells.	Journal of immunology	2011	49
21969016	Oxygen	Chen J	Wnt signaling mediates pathological vascular growth in proliferative retinopathy.	Circulation	2011	36
21969601	Oxygen	Wu C	Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2.	Molecular and cellular biology	2011	46
22052057	Oxygen	Hong Y	Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles.	Journal of the American Society of Nephrology 	2012	32
22068265	Oxygen	Simonson TS	Genetic determinants of Tibetan high-altitude adaptation.	Human genetics	2012	31
22071588	Oxygen	Takac I	The Nox family of NADPH oxidases: friend or foe of the vascular system?	Current hypertension reports	2012	44
22079549	Oxygen	Toda N	Age-related changes in endothelial function and blood flow regulation.	Pharmacology & therapeutics	2012	34
22101528	Oxygen	Poole DC	Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance.	American journal of physiology. Heart and circulatory physiology	2012	66
22170620	Oxygen	Gwathmey TM	Novel roles of nuclear angiotensin receptors and signaling mechanisms.	American journal of physiology. Regulatory, integrative and comparative physiology	2012	43
22200433	Oxygen	Vaziri ND	Effect of uremia on structure and function of immune system.	Journal of renal nutrition 	2012	42
22223731	Oxygen	Derwall M	Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2012	51
22350585	Oxygen	Hulsmans M	Mitochondrial reactive oxygen species and risk of atherosclerosis.	Current atherosclerosis reports	2012	30
22405985	Oxygen	Schramm A	Targeting NADPH oxidases in vascular pharmacology.	Vascular pharmacology	2012	47
22443458	Oxygen	Dikalov SI	Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.	Antioxidants & redox signaling	2013	40
22445098	Oxygen	Montezano AC	Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.	The Canadian journal of cardiology	2012	44
22455351	Oxygen	Chen AF	Free radical biology of the cardiovascular system.	Clinical science	2012	32
22495584	Oxygen	Willie CK	Regional brain blood flow in man during acute changes in arterial blood gases.	The Journal of physiology	2012	89
22530599	Oxygen	Nguyen Dinh Cat A	Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.	Antioxidants & redox signaling	2013	55
22533670	Oxygen	Giralt A	SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.	The Biochemical journal	2012	50
22595400	Oxygen	Scoditti E	Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer.	Archives of biochemistry and biophysics	2012	49
22614980	Oxygen	Jones LW	Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.	Journal of clinical oncology 	2012	49
22632748	Oxygen	Vendramini-Costa DB	Molecular link mechanisms between inflammation and cancer.	Current pharmaceutical design	2012	101
22648375	Oxygen	Altenhöfer S	The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.	Cellular and molecular life sciences 	2012	84
22657349	Oxygen	Schulz E	Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress.	Antioxidants & redox signaling	2014	46
22693349	Oxygen	Paneni F	Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.	Circulation research	2012	38
22713144	Oxygen	Montezano AC	Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.	Annals of medicine	2012	42
22745131	Oxygen	Ho JJ	Functional importance of Dicer protein in the adaptive cellular response to hypoxia.	The Journal of biological chemistry	2012	42
22787113	Oxygen	Maron BA	Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.	Circulation	2012	38
22800800	Oxygen	Ong SG	Hypoxia-inducible factor as a therapeutic target for cardioprotection.	Pharmacology & therapeutics	2012	30
22811423	Oxygen	Prabhakar NR	Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.	Physiological reviews	2012	126
22843705	Oxygen	Kröller-Schön S	Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.	Cardiovascular research	2012	42
22875704	Oxygen	Shaw PX	Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids.	Proceedings of the National Academy of Sciences of the United States of America	2012	38
22896706	Oxygen	Li H	Characterization of the mechanism and magnitude of cytoglobin-mediated nitrite reduction and nitric oxide generation under anaerobic conditions.	The Journal of biological chemistry	2012	33
23018917	Oxygen	Hurdman J	Pulmonary hypertension in COPD: results from the ASPIRE registry.	The European respiratory journal	2013	30
23085514	Oxygen	Urao N	Redox regulation of stem/progenitor cells and bone marrow niche.	Free radical biology & medicine	2013	44
23087362	Oxygen	Csányi G	Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.	Arteriosclerosis, thrombosis, and vascular biology	2012	31
23128427	Oxygen	Shulman LM	Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.	JAMA neurology	2013	40
23152680	Oxygen	Pasquale MK	Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.	International journal of chronic obstructive pulmonary disease	2012	39
23216817	Oxygen	Polet F	Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force.	Journal of internal medicine	2013	32
23220211	Oxygen	Wu M	The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems.	Journal of theoretical biology	2013	39
23220288	Oxygen	Prosser BL	X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates Ca²⁺i.	Journal of molecular and cellular cardiology	2013	28
23248151	Oxygen	Sun B	Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.	Hypertension	2013	28
23276949	Oxygen	Yin Y	Inflammasomes: sensors of metabolic stresses for vascular inflammation.	Frontiers in bioscience	2013	37
23325084	Oxygen	Ruiz S	Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.	Kidney international	2013	78
23341580	Oxygen	Jansen F	High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.	Cardiovascular research	2013	35
23349484	Oxygen	Sukumar P	Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.	Diabetes	2013	35
23357108	Oxygen	Stenvinkel P	Chronic kidney disease: a clinical model of premature aging.	American journal of kidney diseases 	2013	29
23374346	Oxygen	Mugoni V	Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis.	Cell	2013	38
23379642	Oxygen	Wilkinson-Berka JL	Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.	Clinical science	2013	32
23436141	Oxygen	Lucas K	Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.	Molecular neurobiology	2013	51
23469005	Oxygen	Bye A	Circulating microRNAs and aerobic fitness--the HUNT-Study.	PloS one	2013	41
23472786	Oxygen	Santos CX	Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.	Antioxidants & redox signaling	2014	25
23480168	Oxygen	Kim GH	The role of redox signaling in epigenetics and cardiovascular disease.	Antioxidants & redox signaling	2013	34
23589885	Oxygen	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	148
23619421	Oxygen	Davies PF	The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo.	Cardiovascular research	2013	53
23643589	Oxygen	Youn JY	Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.	Journal of molecular and cellular cardiology	2013	35
23649437	Oxygen	Brunelli A	Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.	Chest	2013	41
23685237	Oxygen	Deng X	PM2.5-induced oxidative stress triggers autophagy in human lung epithelial A549 cells.	Toxicology in vitro 	2013	25
23702245	Oxygen	Dodson M	Cellular metabolic and autophagic pathways: traffic control by redox signaling.	Free radical biology & medicine	2013	81
23722747	Oxygen	Yi J	Visible-light optical coherence tomography for retinal oximetry.	Optics letters	2013	41
23774812	Oxygen	Brown NJ	Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.	Nature reviews. Nephrology	2013	33
23807220	Oxygen	Estrada JC	Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy.	Cell death & disease	2013	42
23841983	Oxygen	Yu E	Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.	Circulation	2013	34
23851032	Oxygen	El Assar M	Oxidative stress and vascular inflammation in aging.	Free radical biology & medicine	2013	64
23856679	Oxygen	Taimeh Z	Vascular endothelial growth factor in heart failure.	Nature reviews. Cardiology	2013	31
23859953	Oxygen	Rochette L	Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?	Pharmacology & therapeutics	2013	46
23861904	Oxygen	Salomon C	Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis.	PloS one	2013	59
23880293	Oxygen	Cheng X	Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.	Free radical biology & medicine	2013	43
23899566	Oxygen	Hopkins PN	Molecular biology of atherosclerosis.	Physiological reviews	2013	70
23975169	Oxygen	Magenta A	Oxidative stress and microRNAs in vascular diseases.	International journal of molecular sciences	2013	40
23977848	Oxygen	Jarman ER	An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.	American journal of respiratory cell and molecular biology	2014	24
23988176	Oxygen	Semenza GL	Hypoxia-inducible factor 1 and cardiovascular disease.	Annual review of physiology	2014	71
23993959	Oxygen	Buelna-Chontal M	Redox activation of Nrf2 & NF-κB: a double end sword?	Cellular signalling	2013	31
24009231	Oxygen	Hottz ED	Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation.	Blood	2013	40
24030498	Oxygen	Purohit A	Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation.	Circulation	2013	50
24037780	Oxygen	Elnakish MT	Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase.	The Journal of pathology	2013	34
24043248	Oxygen	Dikalov SI	Role of mitochondrial oxidative stress in hypertension.	American journal of physiology. Heart and circulatory physiology	2013	34
24070090	Oxygen	Maugeri N	Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.	Antioxidants & redox signaling	2014	22
24084731	Oxygen	Daffu G	Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.	International journal of molecular sciences	2013	37
24133204	Oxygen	Kang T	MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells.	The Journal of biological chemistry	2013	33
24163425	Oxygen	Olson TP	Influence of locomotor muscle afferent inhibition on the ventilatory response to exercise in heart failure.	Experimental physiology	2014	21
24180381	Oxygen	Karbach S	eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation.	Current pharmaceutical design	2014	41
24217221	Oxygen	Kim S	Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways.	Innate immunity	2014	25
24281743	Oxygen	Jickling GC	Hemorrhagic transformation after ischemic stroke in animals and humans.	Journal of cerebral blood flow and metabolism 	2014	49
24285680	Oxygen	Uberti F	Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways.	The Journal of clinical endocrinology and metabolism	2014	30
24355644	Oxygen	McLaughlin VV	Treatment goals of pulmonary hypertension.	Journal of the American College of Cardiology	2013	44
24406274	Oxygen	Alvarez-Suarez JM	One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humans.	The Journal of nutritional biochemistry	2014	29
24418464	Oxygen	Pieper C	Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro.	Brain research	2014	27
24436432	Oxygen	Pillai VB	Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.	Circulation research	2014	38
24438903	Oxygen	Bura A	Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.	Cytotherapy	2014	47
24457954	Oxygen	Yan F	Nox4 and redox signaling mediate TGF-β-induced endothelial cell apoptosis and phenotypic switch.	Cell death & disease	2014	25
24462787	Oxygen	Huynh K	Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.	Pharmacology & therapeutics	2014	72
24511132	Oxygen	Jha JC	Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	51
24578389	Oxygen	Virdis A	Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.	European heart journal	2015	17
24595981	Oxygen	Nguyen AQ	Erythropoietin: powerful protection of ischemic and post-ischemic brain.	Experimental biology and medicine	2014	22
24610033	Oxygen	Ramakrishnan S	Vascular endothelial growth factor signaling in hypoxia and inflammation.	Journal of neuroimmune pharmacology 	2014	22
24663091	Oxygen	Frangogiannis NG	The inflammatory response in myocardial injury, repair, and remodelling.	Nature reviews. Cardiology	2014	115
24671377	Oxygen	Billaud M	Regulation of cellular communication by signaling microdomains in the blood vessel wall.	Pharmacological reviews	2014	22
24760441	Oxygen	Montezano AC	Angiotensin II and vascular injury.	Current hypertension reports	2014	27
24835170	Oxygen	Trangmar SJ	Dehydration affects cerebral blood flow but not its metabolic rate for oxygen during maximal exercise in trained humans.	The Journal of physiology	2014	20
24865512	Oxygen	Abdul-Muneer PM	Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.	Molecular neurobiology	2015	36
24918289	Oxygen	Zhang Y	Erythropoietin action in stress response, tissue maintenance and metabolism.	International journal of molecular sciences	2014	26
24968272	Oxygen	Steyers CM 3rd	Endothelial dysfunction in chronic inflammatory diseases.	International journal of molecular sciences	2014	45
25066192	Oxygen	Drummond GR	Endothelial NADPH oxidases: which NOX to target in vascular disease?	Trends in endocrinology and metabolism	2014	48
25078148	Oxygen	Marcos-Ramiro B	TNF-induced endothelial barrier disruption: beyond actin and Rho.	Thrombosis and haemostasis	2014	22
25129147	Oxygen	Lorenzo FR	A genetic mechanism for Tibetan high-altitude adaptation.	Nature genetics	2014	64
25143940	Oxygen	Wu J	The role of oxidative stress and inflammation in cardiovascular aging.	BioMed research international	2014	27
25145928	Oxygen	Dou L	The cardiovascular effect of the uremic solute indole-3 acetic acid.	Journal of the American Society of Nephrology 	2015	17
25238263	Oxygen	Chen MF	IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.	Oncotarget	2014	23
25253673	Oxygen	Ebert AD	Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.	Science translational medicine	2014	27
25315652	Oxygen	Aras S	MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism.	Mitochondrion	2015	21
25466887	Oxygen	Guan H	Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.	FASEB journal 	2015	15
25538153	Oxygen	Planavila A	Fibroblast growth factor 21 protects the heart from oxidative stress.	Cardiovascular research	2015	29
25561470	Oxygen	Ma X	Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress.	Molecular and cellular biology	2015	18
25564678	Oxygen	Sullivan MN	Localized TRPA1 channel Ca2+ signals stimulated by reactive oxygen species promote cerebral artery dilation.	Science signaling	2015	23
25651941	Oxygen	Hind WH	Endocannabinoids modulate human blood-brain barrier permeability in vitro.	British journal of pharmacology	2015	15
25755115	Oxygen	Quillard T	TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion.	European heart journal	2015	22
25767287	Oxygen	McMaster WG	Inflammation, immunity, and hypertensive end-organ damage.	Circulation research	2015	83
25782072	Oxygen	Zeng H	High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.	Journal of cellular and molecular medicine	2015	17
25791797	Oxygen	van Tellingen O	Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.	Drug resistance updates 	2015	44
25814684	Oxygen	Eelen G	Endothelial cell metabolism in normal and diseased vasculature.	Circulation research	2015	52
25822152	Oxygen	Ikeda M	Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress.	PloS one	2015	19
25876056	Oxygen	Rui W	PM2.5-induced oxidative stress increases adhesion molecules expression in human endothelial cells through the ERK/AKT/NF-κB-dependent pathway.	Journal of applied toxicology 	2016	14
25904646	Oxygen	Raaz U	Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development.	Circulation	2015	15
25950484	Oxygen	Roca-Alonso L	Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis.	Cell death & disease	2015	21
26079210	Oxygen	Mikhed Y	Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair.	Redox biology	2015	27
26146622	Oxygen	Zimna A	Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies.	BioMed research international	2015	18
26169582	Oxygen	Xie W	Mitochondrial oxidative stress promotes atrial fibrillation.	Scientific reports	2015	36
26210446	Oxygen	O'Neill S	Genetic disorders coupled to ROS deficiency.	Redox biology	2015	19
26246395	Oxygen	Rainsford KD	Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.	Inflammopharmacology	2015	23
26300260	Oxygen	Chen H	MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype.	Molecular cell	2015	21
26543043	Oxygen	Camici GG	Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.	European heart journal	2015	22
26598532	Oxygen	Erapaneedi R	A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level.	The EMBO journal	2016	13
26649319	Oxygen	Akter R	Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.	Journal of diabetes research	2016	11
26660451	Oxygen	Daiber A	Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.	British journal of pharmacology	2017	19
26705059	Oxygen	Russo I	Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.	Journal of molecular and cellular cardiology	2016	22
26711459	Oxygen	Love S	Cerebrovascular disease in ageing and Alzheimer's disease.	Acta neuropathologica	2016	21
26715682	Oxygen	Gray SP	Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2016	25
26742780	Oxygen	Santos CX	Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signaling.	The EMBO journal	2016	11
26799794	Oxygen	Pan W	Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK.	PloS one	2016	15
26801191	Oxygen	Patching SG	Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.	Molecular neurobiology	2017	7
26872674	Oxygen	Marín-García J	Mitochondrial dynamics and cell death in heart failure.	Heart failure reviews	2016	13
26904936	Oxygen	Hawkins KE	NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.	Cell reports	2016	17
26926996	Oxygen	Shirai T	The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease.	The Journal of experimental medicine	2016	34
26949123	Oxygen	Rubio-Araiz A	Disruption of blood-brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model.	Addiction biology	2017	15
26990284	Oxygen	Di Lisa F	New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.	British journal of pharmacology	2017	8
27000754	Oxygen	Kelley RC	Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology.	Heart failure reviews	2017	6
27006445	Oxygen	Xi H	Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells.	Circulation research	2016	18
27127546	Oxygen	Minutoli L	ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.	Oxidative medicine and cellular longevity	2016	17
27337104	Oxygen	Walport LJ	Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases.	Nature communications	2016	17
27368101	Oxygen	Briggs KJ	Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.	Cell	2016	20
27480885	Oxygen	Nguyen KL	MRI with ferumoxytol: A single center experience of safety across the age spectrum.	Journal of magnetic resonance imaging 	2017	6
27523917	Oxygen	Qin S	Multiple regulations of Keap1/Nrf2 system by dietary phytochemicals.	Molecular nutrition & food research	2016	12
27579823	Oxygen	Keene JD	Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.	American journal of respiratory and critical care medicine	2017	10
27878313	Oxygen	Vallon V	Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.	Diabetologia	2017	15
27892954	Oxygen	Plovier H	A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.	Nature medicine	2017	36
27932512	Oxygen	Jin JK	ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart.	Circulation research	2017	8
28108279	Oxygen	Wenzel P	Redox regulation of cardiovascular inflammation - Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species.	Free radical biology & medicine	2017	8
28108310	Oxygen	Bartlett JJ	Autophagic dysregulation in doxorubicin cardiomyopathy.	Journal of molecular and cellular cardiology	2017	9
28209797	Oxygen	Förstermann U	Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.	Circulation research	2017	25
28288320	Oxygen	Dinda B	Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders.	European journal of medicinal chemistry	2017	7
28424170	Oxygen	Kim YM	ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.	American journal of physiology. Cell physiology	2017	8
15094069	Dexamethasone	Banks WA	The source of cerebral insulin.	European journal of pharmacology	2004	90
15470214	Dexamethasone	Petrylak DP	Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.	The New England journal of medicine	2004	692
19906240	Dexamethasone	Manenschijn L	Clinical features associated with glucocorticoid receptor polymorphisms. An overview.	Annals of the New York Academy of Sciences	2009	51
26509855	Dexamethasone	Goodman NF	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.	Endocrine practice 	2015	18
27646843	Dexamethasone	Yee AJ	Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.	The Lancet. Oncology	2016	14
11124751	Folic acid	Fung TT	Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk.	The American journal of clinical nutrition	2001	132
12387655	Folic acid	Klerk M	MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.	JAMA	2002	129
12446535	Folic acid	Wald DS	Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.	BMJ	2002	246
16401840	Folic acid	Gurol ME	Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.	Neurology	2006	123
16702348	Folic acid	Refsum H	The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.	The Journal of nutrition	2006	69
19131384	Folic acid	de Ruijter W	Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.	BMJ	2009	78
19248856	Folic acid	Holt EM	Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents.	Journal of the American Dietetic Association	2009	55
20404913	Folic acid	Golden E	Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.	PloS one	2010	50
20446114	Folic acid	Ueland PM	Choline and betaine in health and disease.	Journal of inherited metabolic disease	2011	60
20571015	Folic acid	Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group.	Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.	JAMA	2010	60
24451681	Folic acid	Nilsson R	Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.	Nature communications	2014	73
25498997	Folic acid	Catena C	Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients.	American journal of hypertension	2015	15
17596340	4-Aminohippuric acid	Bonnet S	The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.	Proceedings of the National Academy of Sciences of the United States of America	2007	93
17947237	4-Aminohippuric acid	Lagna G	Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors.	The Journal of biological chemistry	2007	60
18082509	4-Aminohippuric acid	Hunter KS	Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension.	American heart journal	2008	59
18382765	4-Aminohippuric acid	Hansmann G	An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.	The Journal of clinical investigation	2008	131
18420966	4-Aminohippuric acid	Perros F	Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2008	75
19047320	4-Aminohippuric acid	Zamanian RT	Insulin resistance in pulmonary arterial hypertension.	The European respiratory journal	2009	57
19628780	4-Aminohippuric acid	Toshner M	Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2009	62
19801450	4-Aminohippuric acid	Guignabert C	Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.	American journal of physiology. Lung cellular and molecular physiology	2009	53
20110569	4-Aminohippuric acid	Caruso P	Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.	Arteriosclerosis, thrombosis, and vascular biology	2010	111
20581168	4-Aminohippuric acid	Aldred MA	Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2010	47
21321078	4-Aminohippuric acid	Courboulin A	Role for miR-204 in human pulmonary arterial hypertension.	The Journal of experimental medicine	2011	151
21382889	4-Aminohippuric acid	Paulin R	Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.	Circulation	2011	45
21821917	4-Aminohippuric acid	Alastalo TP	Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.	The Journal of clinical investigation	2011	59
22215724	4-Aminohippuric acid	Bauer PM	Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.	Cardiovascular research	2012	31
22715469	4-Aminohippuric acid	Caruso P	A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.	Circulation research	2012	78
22859525	4-Aminohippuric acid	de Man FS	Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2012	39
22859684	4-Aminohippuric acid	White K	Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.	Circulation	2012	35
23071643	4-Aminohippuric acid	Jalali S	Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation.	PloS one	2012	38
23220912	4-Aminohippuric acid	Rhodes CJ	Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2013	37
23263626	4-Aminohippuric acid	Kim J	An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension.	Nature medicine	2013	90
23502781	4-Aminohippuric acid	Germain M	Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.	Nature genetics	2013	28
23509326	4-Aminohippuric acid	Lundgrin EL	Fasting 2-deoxy-2-18Ffluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.	Annals of the American Thoracic Society	2013	34
23853098	4-Aminohippuric acid	Kang K	MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.	The Journal of biological chemistry	2013	28
23867624	4-Aminohippuric acid	Spiekerkoetter E	FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.	The Journal of clinical investigation	2013	75
24056688	4-Aminohippuric acid	Rain S	Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.	Circulation	2013	51
24951764	4-Aminohippuric acid	Paulin R	The metabolic theory of pulmonary arterial hypertension.	Circulation research	2014	42
25284742	4-Aminohippuric acid	Paulin R	Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans.	Cell metabolism	2014	37
15536109	Hydrochlorothiazide	Bakris GL	Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.	JAMA	2004	72
19052124	Hydrochlorothiazide	Jamerson K	Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.	The New England journal of medicine	2008	243
20170948	Hydrochlorothiazide	Bakris GL	Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.	Lancet	2010	54
24002278	Hydrochlorothiazide	Thom S	Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.	JAMA	2013	37
24797667	Hydrochlorothiazide	Andrukhova O	FGF23 regulates renal sodium handling and blood pressure.	EMBO molecular medicine	2014	33
27217403	Hydrochlorothiazide	Itani HA	Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.	Hypertension	2016	18
28093466	Hydrochlorothiazide	Williams B	Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.	Hypertension	2017	5
2138525	Nitroglycerin	Pfeffer MA	Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.	Circulation	1990	416
10598133	Nitroglycerin	Ignarro LJ	Nitric oxide as a signaling molecule in the vascular system: an overview.	Journal of cardiovascular pharmacology	1999	108
12390945	Nitroglycerin	Hürlimann D	Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.	Circulation	2002	86
12512688	Nitroglycerin	Ignarro LJ	Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.	Journal of physiology and pharmacology 	2002	146
12860835	Nitroglycerin	Ouchi N	Association of hypoadiponectinemia with impaired vasoreactivity.	Hypertension	2003	84
17893272	Nitroglycerin	Dejam A	Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation.	Circulation	2007	107
20613714	Nitroglycerin	Yilmaz MI	FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.	Kidney international	2010	44
7542286	Cyclic GMP	De Caterina R	Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.	The Journal of clinical investigation	1995	239
10567269	Cyclic GMP	Surks HK	Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha.	Science	1999	127
12186793	Cyclic GMP	Verma S	A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.	Circulation	2002	121
12234944	Cyclic GMP	Venugopal SK	Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.	Circulation	2002	103
16289003	Cyclic GMP	Nishikimi T	The role of natriuretic peptides in cardioprotection.	Cardiovascular research	2006	76
16371594	Cyclic GMP	Hofmann F	Function of cGMP-dependent protein kinases as revealed by gene deletion.	Physiological reviews	2006	119
16408059	Cyclic GMP	Bryan NS	Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues.	Nature chemical biology	2005	116
19023132	Cyclic GMP	Krüger M	Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.	Circulation research	2009	94
19934029	Cyclic GMP	Gu J	Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).	Journal of clinical pharmacology	2010	50
19969085	Cyclic GMP	Rohini A	Molecular targets and regulators of cardiac hypertrophy.	Pharmacological research	2010	58
21375692	Cyclic GMP	Potter LR	Natriuretic peptide metabolism, clearance and degradation.	The FEBS journal	2011	36
22806632	Cyclic GMP	van Heerebeek L	Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.	Circulation	2012	63
23910461	Cyclic GMP	Guo DC	Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.	American journal of human genetics	2013	43
25799991	Cyclic GMP	Lee DI	Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.	Nature	2015	35
26682792	Cyclic GMP	Franssen C	Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.	JACC. Heart failure	2016	32
27030537	Cyclic GMP	Kuhn M	Molecular Physiology of Membrane Guanylyl Cyclase Receptors.	Physiological reviews	2016	23
15652605	Vitamin D3	Casas JP	Homocysteine and stroke: evidence on a causal link from mendelian randomisation.	Lancet	2005	76
15795327	Vitamin D3	Somjen D	25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds.	Circulation	2005	74
22865902	Vitamin D3	Wood AD	Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT.	The Journal of clinical endocrinology and metabolism	2012	47
25801871	Vitamin D3	Pilz S	Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.	Hypertension	2015	24
1709839	Potassium	Luo CH	A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction.	Circulation research	1991	159
8587608	Potassium	Smith PL	The inward rectification mechanism of the HERG cardiac potassium channel.	Nature	1996	202
9020846	Potassium	Neyroud N	A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome.	Nature genetics	1997	132
9348075	Potassium	Maruyama T	2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release.	Journal of biochemistry	1997	213
10835033	Potassium	Nerbonne JM	Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium.	The Journal of physiology	2000	99
12522251	Potassium	Chen YH	KCNQ1 gain-of-function mutation in familial atrial fibrillation.	Science	2003	235
12775586	Potassium	Ficker E	Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG.	Circulation research	2003	95
14981009	Potassium	Nikolaidis LA	Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.	Circulation	2004	184
15189956	Potassium	Salpeter SR	Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.	Chest	2004	73
15269337	Potassium	Birnbaum SG	Structure and function of Kv4-family transient potassium channels.	Physiological reviews	2004	118
16109388	Potassium	Hong K	De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.	Cardiovascular research	2005	77
16258232	Potassium	Miyata N	Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.	Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi	2005	74
16287990	Potassium	Jespersen T	The KCNQ1 potassium channel: from gene to physiological function.	Physiology	2005	74
16412224	Potassium	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	129
16554806	Potassium	Sanguinetti MC	hERG potassium channels and cardiac arrhythmia.	Nature	2006	301
16772329	Potassium	Olson TM	Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.	Human molecular genetics	2006	131
17360457	Potassium	Ocorr K	KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging.	Proceedings of the National Academy of Sciences of the United States of America	2007	98
17984165	Potassium	Barter PJ	Effects of torcetrapib in patients at high risk for coronary events.	The New England journal of medicine	2007	527
18603586	Potassium	Roepke TK	Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).	FASEB journal 	2008	51
18616963	Potassium	Hancox JC	The hERG potassium channel and hERG screening for drug-induced torsades de pointes.	Pharmacology & therapeutics	2008	67
18701466	Potassium	Anzai N	Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.	The Journal of biological chemistry	2008	60
19949402	Potassium	Wulff H	Voltage-gated potassium channels as therapeutic targets.	Nature reviews. Drug discovery	2009	168
19959133	Potassium	Girmatsion Z	Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.	Heart rhythm	2009	51
20056717	Potassium	Wang FE	MicroRNA-204/211 alters epithelial physiology.	FASEB journal 	2010	92
20173747	Potassium	Ellinor PT	Common variants in KCNN3 are associated with lone atrial fibrillation.	Nature genetics	2010	168
20392939	Potassium	Glasscock E	Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy.	The Journal of neuroscience 	2010	51
20560207	Potassium	Yang Y	Identification of a Kir3.4 mutation in congenital long QT syndrome.	American journal of human genetics	2010	42
20597104	Potassium	Benigni A	Angiotensin II revisited: new roles in inflammation, immunology and aging.	EMBO molecular medicine	2010	71
20624791	Potassium	Zhong XZ	Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.	The Journal of physiology	2010	48
20657029	Potassium	Voigt N	Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.	Circulation. Arrhythmia and electrophysiology	2010	53
20660394	Potassium	Moretti A	Patient-specific induced pluripotent stem-cell models for long-QT syndrome.	The New England journal of medicine	2010	355
20840535	Potassium	Ng FL	Expression and function of the K+ channel KCNQ genes in human arteries.	British journal of pharmacology	2011	47
20962273	Potassium	Nakajo K	Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
21051417	Potassium	Yu Q	Insulin says NO to cardiovascular disease.	Cardiovascular research	2011	39
21349352	Potassium	Giudicessi JR	Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.	Heart rhythm	2011	62
21367833	Potassium	Matsa E	Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.	European heart journal	2011	117
21511879	Potassium	Chinchilla A	PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis.	Circulation. Cardiovascular genetics	2011	52
21841064	Potassium	Furth SL	Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2011	40
22052944	Potassium	Lahti AL	Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.	Disease models & mechanisms	2012	93
22199116	Potassium	Amin AS	Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.	European heart journal	2012	36
22387049	Potassium	Wolburg H	The disturbed blood-brain barrier in human glioblastoma.	Molecular aspects of medicine	2012	43
22473710	Potassium	Irani SR	Morvan syndrome: clinical and serological observations in 29 cases.	Annals of neurology	2012	64
22946617	Potassium	Zemzemi N	Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials.	British journal of pharmacology	2013	31
23121378	Potassium	Parving HH	Cardiorenal end points in a trial of aliskiren for type 2 diabetes.	The New England journal of medicine	2012	152
23525437	Potassium	Chang PC	Heterogeneous upregulation of apamin-sensitive potassium currents in failing human ventricles.	Journal of the American Heart Association	2013	29
23543060	Potassium	Luo X	MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation.	The Journal of clinical investigation	2013	54
23753408	Potassium	Savard S	Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.	Hypertension	2013	38
23933981	Potassium	Bittner S	Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.	Nature medicine	2013	33
24137016	Potassium	Nagelhus EA	Physiological roles of aquaporin-4 in brain.	Physiological reviews	2013	75
24623279	Potassium	Mehta A	Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes.	Cardiovascular research	2014	22
24692356	Potassium	Schmitt N	Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.	Physiological reviews	2014	42
24866132	Potassium	Fernandes-Rosa FL	Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.	Hypertension	2014	42
25035150	Potassium	Vausort M	Long noncoding RNAs in patients with acute myocardial infarction.	Circulation research	2014	51
25540137	Potassium	de Baaij JH	Magnesium in man: implications for health and disease.	Physiological reviews	2015	67
25598355	Potassium	Morris G	The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.	Molecular neurobiology	2016	13
26093152	Potassium	Holzem KM	Reduced response to IKr blockade and altered hERG1a/1b stoichiometry in human heart failure.	Journal of molecular and cellular cardiology	2016	11
26414968	Potassium	Williams B	Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.	Lancet	2015	53
26500246	Potassium	Luo J	Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.	Clinical journal of the American Society of Nephrology 	2016	17
26863326	Potassium	Hadchouel J	Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.	Annual review of physiology	2016	17
27043774	Potassium	McMurray JJ	Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.	The New England journal of medicine	2016	19
27357636	Potassium	Navickas R	Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.	Cardiovascular research	2016	25
1695010	L-Methionine	Cushing SD	Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.	Proceedings of the National Academy of Sciences of the United States of America	1990	155
2011158	L-Methionine	Clarke R	Hyperhomocysteinemia: an independent risk factor for vascular disease.	The New England journal of medicine	1991	175
11001804	L-Methionine	Lucock M	Folic acid: nutritional biochemistry, molecular biology, and role in disease processes.	Molecular genetics and metabolism	2000	107
15128854	L-Methionine	Chen ZY	Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.	The Journal of neuroscience 	2004	188
15298442	L-Methionine	Stover PJ	Physiology of folate and vitamin B12 in health and disease.	Nutrition reviews	2004	91
19853062	L-Methionine	Spindler SR	Caloric restriction: from soup to nuts.	Ageing research reviews	2010	59
23908111	L-Methionine	Huang Y	Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.	The Journal of clinical investigation	2013	44
27523608	L-Methionine	Damgaard RB	The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.	Cell	2016	25
10366192	Deoxyuridine triphosphate	Heo JH	Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.	Journal of cerebral blood flow and metabolism 	1999	103
16473959	Deoxyuridine triphosphate	Berry MF	Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.	American journal of physiology. Heart and circulatory physiology	2006	165
17526595	Deoxyuridine triphosphate	Masri FA	Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension.	American journal of physiology. Lung cellular and molecular physiology	2007	109
24875884	Deoxyuridine triphosphate	Wang S	BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro.	European journal of cardio-thoracic surgery 	2015	17
7807658	Progesterone	-	Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.	JAMA	1995	135
12904517	Progesterone	Manson JE	Estrogen plus progestin and the risk of coronary heart disease.	The New England journal of medicine	2003	247
15987800	Progesterone	Hallmann R	Expression and function of laminins in the embryonic and mature vasculature.	Physiological reviews	2005	112
22028449	Progesterone	Hammes SR	Minireview: Recent advances in extranuclear steroid receptor actions.	Endocrinology	2011	50
22495674	Progesterone	Filardo EJ	Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.	Endocrinology	2012	73
28412963	Progesterone	Knutson TP	Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.	Journal of hematology & oncology	2017	6
12480795	Eicosapentaenoic acid	Simopoulos AP	Omega-3 fatty acids in inflammation and autoimmune diseases.	Journal of the American College of Nutrition	2002	201
12583947	Eicosapentaenoic acid	Thies F	Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.	Lancet	2003	106
12821543	Eicosapentaenoic acid	Pischon T	Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women.	Circulation	2003	97
15753205	Eicosapentaenoic acid	Arita M	Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.	The Journal of experimental medicine	2005	223
16234304	Eicosapentaenoic acid	Ferrucci L	Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.	The Journal of clinical endocrinology and metabolism	2006	130
17045449	Eicosapentaenoic acid	Simopoulos AP	Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases.	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie	2006	118
17622276	Eicosapentaenoic acid	Plourde M	Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements.	Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	2007	63
19148276	Eicosapentaenoic acid	Tanaka T	Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study.	PLoS genetics	2009	130
19244379	Eicosapentaenoic acid	Harris WS	Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.	The Journal of nutrition	2009	54
19660687	Eicosapentaenoic acid	Lavie CJ	Omega-3 polyunsaturated fatty acids and cardiovascular diseases.	Journal of the American College of Cardiology	2009	92
21159789	Eicosapentaenoic acid	Skulas-Ray AC	Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.	The American journal of clinical nutrition	2011	54
21349231	Eicosapentaenoic acid	Cottin SC	The differential effects of EPA and DHA on cardiovascular risk factors.	The Proceedings of the Nutrition Society	2011	37
21762726	Eicosapentaenoic acid	Poudyal H	Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.	Progress in lipid research	2011	46
22361189	Eicosapentaenoic acid	Siriwardhana N	Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.	Advances in food and nutrition research	2012	37
22591894	Eicosapentaenoic acid	Delgado-Lista J	Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.	The British journal of nutrition	2012	57
22819432	Eicosapentaenoic acid	Ballantyne CM	Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study).	The American journal of cardiology	2012	40
23034965	Eicosapentaenoic acid	Itariu BK	Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.	The American journal of clinical nutrition	2012	43
23481688	Eicosapentaenoic acid	Hjorth E	Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers.	Journal of Alzheimer's disease 	2013	30
24351702	Eicosapentaenoic acid	de Oliveira Otto MC	Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.	Journal of the American Heart Association	2013	32
26667367	Eicosapentaenoic acid	Niki T	Effects of the Addition of Eicosapentaenoic Acid to Strong Statin Therapy on Inflammatory Cytokines and Coronary Plaque Components Assessed by Integrated Backscatter Intravascular Ultrasound.	Circulation journal 	2016	11
27281302	Eicosapentaenoic acid	Allaire J	A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.	The American journal of clinical nutrition	2016	20
27565734	Eicosapentaenoic acid	Sawada T	Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.	Cardiovascular diabetology	2016	10
11818477	Ceramide (d18:1/12:0)	Unger RH	Lipotoxic diseases.	Annual review of medicine	2002	179
14557812	Ceramide (d18:1/12:0)	Gulbins E	Raft ceramide in molecular medicine.	Oncogene	2003	101
17339025	Ceramide (d18:1/12:0)	Holland WL	Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.	Cell metabolism	2007	330
18319352	Ceramide (d18:1/12:0)	Dubé JJ	Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited.	American journal of physiology. Endocrinology and metabolism	2008	105
18451260	Ceramide (d18:1/12:0)	Holland WL	Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.	Endocrine reviews	2008	147
18567738	Ceramide (d18:1/12:0)	Smith EL	The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.	FASEB journal 	2008	67
19798445	Ceramide (d18:1/12:0)	Hicks AA	Genetic determinants of circulating sphingolipid concentrations in European populations.	PLoS genetics	2009	54
20110572	Ceramide (d18:1/12:0)	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	46
20361178	Ceramide (d18:1/12:0)	DeFronzo RA	Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.	Diabetologia	2010	140
21498783	Ceramide (d18:1/12:0)	Badin PM	Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.	Diabetes	2011	39
22778441	Ceramide (d18:1/12:0)	Czarnota GJ	Tumor radiation response enhancement by acoustical stimulation of the vasculature.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
23550081	Ceramide (d18:1/12:0)	Hocking S	Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.	Endocrine reviews	2013	33
25295789	Ceramide (d18:1/12:0)	Raichur S	CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.	Cell metabolism	2014	56
26412155	Ceramide (d18:1/12:0)	Chaurasia B	Ceramides - Lipotoxic Inducers of Metabolic Disorders.	Trends in endocrinology and metabolism	2015	50
26565952	Ceramide (d18:1/12:0)	Huang S	A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells.	Autophagy	2015	18
26670557	Ceramide (d18:1/12:0)	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	37
26676316	Ceramide (d18:1/12:0)	Chakravarthy H	Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.	Stem cells	2016	10
26780287	Ceramide (d18:1/12:0)	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
9537338	Mevalonic acid	Laufs U	Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.	Circulation	1998	221
20696928	Mevalonic acid	Clendening JW	Dysregulation of the mevalonate pathway promotes transformation.	Proceedings of the National Academy of Sciences of the United States of America	2010	85
23901824	Mevalonic acid	Andres AM	Mitophagy is required for acute cardioprotection by simvastatin.	Antioxidants & redox signaling	2014	35
27270400	Mevalonic acid	Akula MK	Control of the innate immune response by the mevalonate pathway.	Nature immunology	2016	16
27270401	Mevalonic acid	Park YH	Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.	Nature immunology	2016	26
10899906	L-Leucine	Simon DI	Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).	The Journal of experimental medicine	2000	94
10969042	L-Leucine	Donoghue M	A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.	Circulation research	2000	261
12181319	L-Leucine	Huss JM	Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha.	The Journal of biological chemistry	2002	140
17463046	L-Leucine	Roos S	Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.	The Journal of physiology	2007	72
18403713	L-Leucine	Chereau D	Leiomodin is an actin filament nucleator in muscle cells.	Science	2008	89
21885739	L-Leucine	Schlessinger A	Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
21982649	L-Leucine	Ridker PM	Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).	American heart journal	2011	184
22261194	L-Leucine	Barallobre-Barreiro J	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	Circulation	2012	50
23471228	L-Leucine	Shimabukuro M	Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2013	25
25520363	L-Leucine	Van Aelst LN	Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.	Circulation research	2015	15
26965621	L-Leucine	Zanoni P	Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.	Science	2016	61
26966279	L-Leucine	Reyes-Soffer G	Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.	Arteriosclerosis, thrombosis, and vascular biology	2016	11
27295191	L-Leucine	Maishi N	Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.	Scientific reports	2016	11
27898682	L-Leucine	Lotta LA	Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.	PLoS medicine	2016	13
28436964	L-Leucine	Zhang Y	SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature cell biology	2017	6
12186805	Asymmetric dimethylarginine	Lin KY	Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.	Circulation	2002	106
12805079	Asymmetric dimethylarginine	Achan V	Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.	Arteriosclerosis, thrombosis, and vascular biology	2003	86
17273169	Asymmetric dimethylarginine	Leiper J	Disruption of methylarginine metabolism impairs vascular homeostasis.	Nature medicine	2007	97
17928410	Asymmetric dimethylarginine	Baylis C	Nitric oxide deficiency in chronic kidney disease.	American journal of physiology. Renal physiology	2008	91
17933965	Asymmetric dimethylarginine	Palm F	Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.	American journal of physiology. Heart and circulatory physiology	2007	75
17967978	Asymmetric dimethylarginine	Gozal D	Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy.	Circulation	2007	58
19289633	Asymmetric dimethylarginine	Böger RH	Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.	Circulation	2009	67
19682580	Asymmetric dimethylarginine	Teerlink T	Cellular ADMA: regulation and action.	Pharmacological research	2009	59
21455237	Asymmetric dimethylarginine	Leiper J	The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.	Nature reviews. Drug discovery	2011	38
10555146	Sphing-4-enine-1-phosphate	Lee MJ	Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.	Cell	1999	233
12639843	Sphing-4-enine-1-phosphate	Birukov KG	Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch.	American journal of physiology. Lung cellular and molecular physiology	2003	88
14966566	Sphing-4-enine-1-phosphate	Nofer JR	HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.	The Journal of clinical investigation	2004	118
15056655	Sphing-4-enine-1-phosphate	Dudek SM	Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase.	The Journal of biological chemistry	2004	116
15196057	Sphing-4-enine-1-phosphate	Brinkmann V	FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.	American journal of transplantation 	2004	102
15626732	Sphing-4-enine-1-phosphate	Feistritzer C	Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.	Blood	2005	150
15710622	Sphing-4-enine-1-phosphate	Finigan JH	Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.	The Journal of biological chemistry	2005	135
16623665	Sphing-4-enine-1-phosphate	Venkataraman K	Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient.	The Biochemical journal	2006	77
17078925	Sphing-4-enine-1-phosphate	Meyer zu Heringdorf D	Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.	Biochimica et biophysica acta	2007	87
17158356	Sphing-4-enine-1-phosphate	Walter DH	Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.	Arteriosclerosis, thrombosis, and vascular biology	2007	57
17561264	Sphing-4-enine-1-phosphate	Brinkmann V	Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.	Pharmacology & therapeutics	2007	152
18000237	Sphing-4-enine-1-phosphate	Komarova YA	Dual regulation of endothelial junctional permeability.	Science's STKE 	2007	65
18245172	Sphing-4-enine-1-phosphate	Tan W	An essential role for Rac1 in endothelial cell function and vascular development.	FASEB journal 	2008	77
18367532	Sphing-4-enine-1-phosphate	Gavrilovskaya IN	Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.	Journal of virology	2008	59
19164813	Sphing-4-enine-1-phosphate	Gaengel K	Endothelial-mural cell signaling in vascular development and angiogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2009	212
19430484	Sphing-4-enine-1-phosphate	Mullershausen F	Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.	Nature chemical biology	2009	93
20570726	Sphing-4-enine-1-phosphate	Tonelli F	FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.	Cellular signalling	2010	58
21606363	Sphing-4-enine-1-phosphate	Christoffersen C	Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.	Proceedings of the National Academy of Sciences of the United States of America	2011	114
21783193	Sphing-4-enine-1-phosphate	Norata GD	Emerging role of high density lipoproteins as a player in the immune system.	Atherosclerosis	2012	39
22986288	Sphing-4-enine-1-phosphate	Xiang SY	Lysophospholipid receptor activation of RhoA and lipid signaling pathways.	Biochimica et biophysica acta	2013	29
23723450	Sphing-4-enine-1-phosphate	Zhang G	Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.	Blood	2013	26
23921254	Sphing-4-enine-1-phosphate	Nishi T	Molecular and physiological functions of sphingosine 1-phosphate transporters.	Biochimica et biophysica acta	2014	23
24504738	Sphing-4-enine-1-phosphate	Panchatcharam M	Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability.	Arteriosclerosis, thrombosis, and vascular biology	2014	22
26268607	Sphing-4-enine-1-phosphate	Galvani S	HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.	Science signaling	2015	34
26970273	Sphing-4-enine-1-phosphate	Pyne S	Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.	Progress in lipid research	2016	15
27714763	Sphing-4-enine-1-phosphate	Sugahara K	Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.	British journal of pharmacology	2017	8
10330141	L-Alanine	Wang Q	Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts.	Molecular and cellular biology	1999	107
11397791	L-Alanine	Fleming I	Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.	Circulation research	2001	141
15867021	L-Alanine	Schwimmer JB	Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.	Pediatrics	2005	83
16682043	L-Alanine	Schindhelm RK	Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.	Atherosclerosis	2007	76
16832839	L-Alanine	Schindhelm RK	Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.	Diabetes/metabolism research and reviews	2006	69
17074766	L-Alanine	Kizhatil K	Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells.	The Journal of biological chemistry	2007	57
18053320	L-Alanine	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	153
18637092	L-Alanine	Pai M	Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.	The American journal of gastroenterology	2008	54
19010326	L-Alanine	Goessling W	Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.	Gastroenterology	2008	66
19100265	L-Alanine	Ruhl CE	Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.	Gastroenterology	2009	66
19291789	L-Alanine	Gastaldelli A	Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.	Hepatology	2009	64
19414484	L-Alanine	Johnson AD	Genome-wide association meta-analysis for total serum bilirubin levels.	Human molecular genetics	2009	57
19679839	L-Alanine	Hidalgo C	PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness.	Circulation research	2009	85
20658466	L-Alanine	Ghouri N	Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.	Hepatology	2010	47
20813865	L-Alanine	Yang SS	SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.	Journal of the American Society of Nephrology 	2010	90
21109302	L-Alanine	Athyros VG	Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.	Lancet	2010	103
21525259	L-Alanine	Azadbakht L	The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.	The Journal of nutrition	2011	42
21602530	L-Alanine	Wong VW	Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.	Gut	2011	40
21688282	L-Alanine	Bhala N	The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.	Hepatology	2011	88
22426755	L-Alanine	Montonen J	Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress.	European journal of nutrition	2013	29
23444397	L-Alanine	HPS2-THRIVE Collaborative Group.	HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.	European heart journal	2013	104
23824655	L-Alanine	Fall T	The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis.	PLoS medicine	2013	53
23991091	L-Alanine	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	35
24290406	L-Alanine	Bateman DN	Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.	Lancet	2014	21
24585778	L-Alanine	Wijnker PJ	Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.	American journal of physiology. Heart and circulatory physiology	2014	20
24930728	L-Alanine	Newby LK	Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial.	Lancet	2014	23
24973316	L-Alanine	Pirola CJ	Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.	Gut	2015	68
25187518	L-Alanine	Tanno M	Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2).	The Journal of biological chemistry	2014	22
25251399	L-Alanine	Dongiovanni P	Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.	Hepatology	2015	52
25449138	L-Alanine	Liew SC	Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.	European journal of medical genetics	2015	20
25645567	L-Alanine	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	17
25893821	L-Alanine	Grandone A	TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.	Pediatric obesity	2016	11
26234526	L-Alanine	Faghihzadeh F	The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.	The British journal of nutrition	2015	19
26457389	L-Alanine	Goffredo M	Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.	Hepatology	2016	14
26650570	L-Alanine	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	17
26973324	L-Alanine	Kim DW	Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.	The Lancet. Oncology	2016	70
27022112	L-Alanine	Urata Y	Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.	Journal of clinical oncology 	2016	13
28119464	L-Alanine	Nystoriak MA	Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.	Science signaling	2017	9
9439492	Homocysteine	Ridker PM	Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.	Lancet	1998	143
10733371	Homocysteine	Ridker PM	C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.	The New England journal of medicine	2000	830
11071182	Homocysteine	Anand SS	Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)	Lancet	2000	188
11801260	Homocysteine	Black PH	Stress, inflammation and cardiovascular disease.	Journal of psychosomatic research	2002	125
12371953	Homocysteine	Himmelfarb J	The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.	Kidney international	2002	192
15234425	Homocysteine	Chrysohoou C	Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.	Journal of the American College of Cardiology	2004	101
16551713	Homocysteine	Mora S	Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.	JAMA	2006	77
16723443	Homocysteine	Wong TY	Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).	Investigative ophthalmology & visual science	2006	100
16762949	Homocysteine	Nettleton JA	Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA).	The American journal of clinical nutrition	2006	141
17101823	Homocysteine	Akomolafe A	Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.	Archives of neurology	2006	68
17182988	Homocysteine	Wang TJ	Multiple biomarkers for the prediction of first major cardiovascular events and death.	The New England journal of medicine	2006	248
17200940	Homocysteine	Greenwald SE	Ageing of the conduit arteries.	The Journal of pathology	2007	113
17428730	Homocysteine	Rubenstrunk A	Safety issues and prospects for future generations of PPAR modulators.	Biochimica et biophysica acta	2007	70
17962588	Homocysteine	Khatri M	Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).	Stroke	2007	60
17967770	Homocysteine	Mora S	Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms.	Circulation	2007	150
18048406	Homocysteine	Broadbent HM	Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.	Human molecular genetics	2008	151
18703981	Homocysteine	Purnell C	Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.	Alzheimer disease and associated disorders	2009	47
19261609	Homocysteine	Chiku T	H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia.	The Journal of biological chemistry	2009	97
20100888	Homocysteine	Roy B	Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA).	Psychosomatic medicine	2010	51
21683931	Homocysteine	D'haeseleer M	Vascular aspects of multiple sclerosis.	The Lancet. Neurology	2011	41
21903574	Homocysteine	Kendrick J	FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.	Journal of the American Society of Nephrology 	2011	129
23704105	Homocysteine	Rundek T	Traditional risk factors are not major contributors to the variance in carotid intima-media thickness.	Stroke	2013	25
23704675	Homocysteine	TODAY Study Group.	Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial.	Diabetes care	2013	28
24401164	Homocysteine	Wiseman S	Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis.	Cerebrovascular diseases	2014	28
25274000	Homocysteine	Xanthakis V	Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.	Circulation	2014	32
25639781	Homocysteine	Shivappa N	Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study.	The British journal of nutrition	2015	46
26640616	Homocysteine	Nagpure BV	Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System.	Oxidative medicine and cellular longevity	2016	15
26667407	Homocysteine	Yadav PK	Biosynthesis and Reactivity of Cysteine Persulfides in Signaling.	Journal of the American Chemical Society	2016	23
27289364	Homocysteine	Beck BB	Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.	Pediatric nephrology	2017	6
12676175	Vasopressin	McKinley MJ	The brain renin-angiotensin system: location and physiological roles.	The international journal of biochemistry & cell biology	2003	102
17384437	Vasopressin	Konstam MA	Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.	JAMA	2007	188
17384438	Vasopressin	Gheorghiade M	Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.	JAMA	2007	113
25753944	Vasopressin	McKinley MJ	The median preoptic nucleus: front and centre for the regulation of body fluid, sodium, temperature, sleep and cardiovascular homeostasis.	Acta physiologica	2015	17
11788824	Dichloromethane	Gerull B	Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.	Nature genetics	2002	91
15345656	Dichloromethane	Makarenko I	Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.	Circulation research	2004	81
20458010	Dichloromethane	van Spaendonck-Zwarts KY	Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy.	Circulation	2010	41
21289070	Dichloromethane	Nguyen AT	DOT1L regulates dystrophin expression and is critical for cardiac function.	Genes & development	2011	38
22713251	Dichloromethane	Li CJ	Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.	Cardiovascular diabetology	2012	35
24558114	Dichloromethane	van Spaendonck-Zwarts KY	Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy.	European heart journal	2014	20
25163546	Dichloromethane	Haas J	Atlas of the clinical genetics of human dilated cardiomyopathy.	European heart journal	2015	31
26406308	Dichloromethane	Marston S	OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency.	PloS one	2015	19
11052966	Palmitic acid	Belke DD	Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.	American journal of physiology. Endocrinology and metabolism	2000	94
20068143	Palmitic acid	de Kreutzenberg SV	Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.	Diabetes	2010	64
24424032	Palmitic acid	Hara T	Calcium efflux from the endoplasmic reticulum leads to β-cell death.	Endocrinology	2014	22
24670599	Palmitic acid	Pirazzi C	PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.	Human molecular genetics	2014	43
24947355	Palmitic acid	Tubbs E	Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.	Diabetes	2014	36
26122028	Palmitic acid	Togliatto G	Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications.	International journal of obesity	2016	11
9391166	17a-Ethynylestradiol	Gehm BD	Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.	Proceedings of the National Academy of Sciences of the United States of America	1997	105
10220041	17a-Ethynylestradiol	Baumgartner RN	Predictors of skeletal muscle mass in elderly men and women.	Mechanisms of ageing and development	1999	107
10591334	17a-Ethynylestradiol	Visser M	Elevated C-reactive protein levels in overweight and obese adults.	JAMA	1999	351
11844745	17a-Ethynylestradiol	Pfeilschifter J	Changes in proinflammatory cytokine activity after menopause.	Endocrine reviews	2002	151
12270858	17a-Ethynylestradiol	Wallerath T	Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.	Circulation	2002	99
12468591	17a-Ethynylestradiol	Setchell KD	The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.	The Journal of nutrition	2002	153
12682286	17a-Ethynylestradiol	Li L	Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2003	115
12788835	17a-Ethynylestradiol	Carr MC	The emergence of the metabolic syndrome with menopause.	The Journal of clinical endocrinology and metabolism	2003	216
15024130	17a-Ethynylestradiol	Yang SH	Mitochondrial localization of estrogen receptor beta.	Proceedings of the National Academy of Sciences of the United States of America	2004	123
15136311	17a-Ethynylestradiol	Ford DE	Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey.	Archives of internal medicine	2004	102
15734144	17a-Ethynylestradiol	Kalaitzidis D	Transcription factor cross-talk: the estrogen receptor and NF-kappaB.	Trends in endocrinology and metabolism	2005	84
15857973	17a-Ethynylestradiol	Koehler KF	Reflections on the discovery and significance of estrogen receptor beta.	Endocrine reviews	2005	68
16053959	17a-Ethynylestradiol	Khera A	Race and gender differences in C-reactive protein levels.	Journal of the American College of Cardiology	2005	153
16139959	17a-Ethynylestradiol	Kajantie E	The effects of sex and hormonal status on the physiological response to acute psychosocial stress.	Psychoneuroendocrinology	2006	162
16394250	17a-Ethynylestradiol	Hall JM	Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.	Molecular interventions	2005	75
16511588	17a-Ethynylestradiol	Deroo BJ	Estrogen receptors and human disease.	The Journal of clinical investigation	2006	283
16923436	17a-Ethynylestradiol	Lakoski SG	Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort.	American heart journal	2006	65
16946015	17a-Ethynylestradiol	Moriarty K	Minireview: estrogen receptor-mediated rapid signaling.	Endocrinology	2006	61
19061896	17a-Ethynylestradiol	Sihag S	PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.	Journal of molecular and cellular cardiology	2009	60
19221203	17a-Ethynylestradiol	Xing D	Estrogen and mechanisms of vascular protection.	Arteriosclerosis, thrombosis, and vascular biology	2009	69
19233248	17a-Ethynylestradiol	Turunen MP	Epigenetics and atherosclerosis.	Biochimica et biophysica acta	2009	66
19351729	17a-Ethynylestradiol	Lakoski SG	Genetic and metabolic determinants of plasma PCSK9 levels.	The Journal of clinical endocrinology and metabolism	2009	78
19498003	17a-Ethynylestradiol	Paulsson J	Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.	The American journal of pathology	2009	59
20031276	17a-Ethynylestradiol	Rasgon NL	Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.	Neurobiology of aging	2011	48
20181970	17a-Ethynylestradiol	Cummings SR	Lasofoxifene in postmenopausal women with osteoporosis.	The New England journal of medicine	2010	60
20395295	17a-Ethynylestradiol	Motiani RK	A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells.	The Journal of biological chemistry	2010	75
20876186	17a-Ethynylestradiol	Suzuki HI	Emerging complexity of microRNA generation cascades.	Journal of biochemistry	2011	38
21178615	17a-Ethynylestradiol	Yang XP	Estrogen, hormonal replacement therapy and cardiovascular disease.	Current opinion in nephrology and hypertension	2011	41
21689398	17a-Ethynylestradiol	Patnaik JL	Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.	Breast cancer research 	2011	87
21742056	17a-Ethynylestradiol	Meyer MR	The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.	Vascular pharmacology	2011	38
22993197	17a-Ethynylestradiol	Motiani RK	Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis.	FASEB journal 	2013	45
23883676	17a-Ethynylestradiol	Xue B	Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen.	American journal of physiology. Regulatory, integrative and comparative physiology	2013	27
24971815	17a-Ethynylestradiol	Paterni I	Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.	Steroids	2014	34
26303083	17a-Ethynylestradiol	Jia M	Estrogen receptor alpha and beta in health and disease.	Best practice & research. Clinical endocrinology & metabolism	2015	31
26311719	17a-Ethynylestradiol	Deng L	MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.	Circulation research	2015	26
27029038	17a-Ethynylestradiol	Micucci C	Current perspectives between metabolic syndrome and cancer.	Oncotarget	2016	13
9393975	Thymidine	Rousseau S	p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.	Oncogene	1997	162
11502704	Thymidine	Morrell NW	Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.	Circulation	2001	104
12070119	Thymidine	Arita Y	Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.	Circulation	2002	91
18162040	Thymidine	Kirn DH	Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.	PLoS medicine	2007	83
19240794	Thymidine	van Leeuwen WM	Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.	PloS one	2009	87
20522802	Thymidine	Kajstura J	Cardiomyogenesis in the adult human heart.	Circulation research	2010	105
7929439	L-Tyrosine	Waltenberger J	Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.	The Journal of biological chemistry	1994	264
8257797	L-Tyrosine	Meredith JE Jr	The extracellular matrix as a cell survival factor.	Molecular biology of the cell	1993	252
8617204	L-Tyrosine	Joukov V	A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.	The EMBO journal	1996	212
8663424	L-Tyrosine	Clauss M	The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.	The Journal of biological chemistry	1996	122
8980223	L-Tyrosine	Davis S	Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.	Cell	1996	329
9143707	L-Tyrosine	Taga T	Gp130 and the interleukin-6 family of cytokines.	Annual review of immunology	1997	266
9204896	L-Tyrosine	Maisonpierre PC	Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.	Science	1997	609
9295307	L-Tyrosine	Gerber HP	Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.	The Journal of biological chemistry	1997	110
9435229	L-Tyrosine	Achen MG	Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).	Proceedings of the National Academy of Sciences of the United States of America	1998	194
9529250	L-Tyrosine	Soker S	Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.	Cell	1998	495
9625748	L-Tyrosine	Esser S	Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.	Journal of cell science	1998	164
9815153	L-Tyrosine	Bouloumié A	Leptin, the product of Ob gene, promotes angiogenesis.	Circulation research	1998	110
9892193	L-Tyrosine	Fong TA	SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.	Cancer research	1999	147
10589679	L-Tyrosine	Streblow DN	The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.	Cell	1999	116
10699153	L-Tyrosine	Kim S	Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.	Pharmacological reviews	2000	156
10747347	L-Tyrosine	Zeng G	Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.	Circulation	2000	114
10948069	L-Tyrosine	van Nieuw Amerongen GP	Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases.	Circulation research	2000	107
11121512	L-Tyrosine	Touyz RM	Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.	Pharmacological reviews	2000	154
11146556	L-Tyrosine	Ogawa K	The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.	Oncogene	2000	96
11331884	L-Tyrosine	Miao H	Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.	Nature cell biology	2001	92
11416160	L-Tyrosine	Hendrix MJ	Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.	Proceedings of the National Academy of Sciences of the United States of America	2001	101
11560995	L-Tyrosine	Kriehuber E	Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages.	The Journal of experimental medicine	2001	119
11983165	L-Tyrosine	Palmer A	EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase.	Molecular cell	2002	81
11984589	L-Tyrosine	Crone SA	ErbB2 is essential in the prevention of dilated cardiomyopathy.	Nature medicine	2002	178
12029087	L-Tyrosine	Kim YM	Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.	The Journal of biological chemistry	2002	83
12072561	L-Tyrosine	Ozcelik C	Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy.	Proceedings of the National Academy of Sciences of the United States of America	2002	95
12398893	L-Tyrosine	Hiratsuka S	MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.	Cancer cell	2002	185
12482957	L-Tyrosine	Liu ZJ	Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.	Molecular and cellular biology	2003	138
12511559	L-Tyrosine	Mineo C	High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases.	The Journal of biological chemistry	2003	81
12771128	L-Tyrosine	Grazia Lampugnani M	Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.	The Journal of cell biology	2003	121
12778165	L-Tyrosine	Ferrara N	The biology of VEGF and its receptors.	Nature medicine	2003	1788
12887919	L-Tyrosine	Seo DW	TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.	Cell	2003	127
14976056	L-Tyrosine	Fiedler U	The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies.	Blood	2004	156
15276015	L-Tyrosine	Oudit GY	The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.	Journal of molecular and cellular cardiology	2004	109
15302870	L-Tyrosine	Deora AB	An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface.	The Journal of biological chemistry	2004	72
15768830	L-Tyrosine	Williams TM	The Caveolin genes: from cell biology to medicine.	Annals of medicine	2004	121
15902258	L-Tyrosine	Choi MH	Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II.	Nature	2005	105
16301836	L-Tyrosine	Zachary I	Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential.	Neuro-Signals	2005	68
16336962	L-Tyrosine	Shibuya M	Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.	Experimental cell research	2006	233
16413489	L-Tyrosine	Foo SS	Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.	Cell	2006	145
16828580	L-Tyrosine	Borzychowski AM	Inflammation and pre-eclampsia.	Seminars in fetal & neonatal medicine	2006	93
16909109	L-Tyrosine	Wallez Y	Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.	Oncogene	2007	58
17346182	L-Tyrosine	Laviola L	The IGF-I signaling pathway.	Current pharmaceutical design	2007	66
17574121	L-Tyrosine	Kuijper S	Regulation of angiogenesis by Eph-ephrin interactions.	Trends in cardiovascular medicine	2007	80
17627510	L-Tyrosine	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	63
17644065	L-Tyrosine	Ling Y	Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.	Biochemical and biophysical research communications	2007	58
17717289	L-Tyrosine	Datla SR	Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro.	Arteriosclerosis, thrombosis, and vascular biology	2007	66
17785844	L-Tyrosine	Allingham MJ	ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration.	Journal of immunology	2007	114
17943726	L-Tyrosine	Matsui J	E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.	International journal of cancer	2008	54
18079166	L-Tyrosine	Orimo S	Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.	Brain 	2008	77
18093986	L-Tyrosine	Adya R	Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.	Cardiovascular research	2008	74
18264713	L-Tyrosine	Dickson DW	Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.	Acta neuropathologica	2008	68
18430438	L-Tyrosine	Fuller SJ	ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.	Journal of molecular and cellular cardiology	2008	51
18445579	L-Tyrosine	Zabrouskov V	Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry.	Molecular & cellular proteomics 	2008	56
18451337	L-Tyrosine	Nakamura Y	Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.	Circulation research	2008	61
18477770	L-Tyrosine	Porkka K	Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.	Blood	2008	64
18483217	L-Tyrosine	Andrae J	Role of platelet-derived growth factors in physiology and medicine.	Genes & development	2008	482
18559524	L-Tyrosine	Hilberg F	BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.	Cancer research	2008	140
18772329	L-Tyrosine	Agouni A	Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome.	The American journal of pathology	2008	54
19147653	L-Tyrosine	Oudit GY	Cardiac regulation by phosphoinositide 3-kinases and PTEN.	Cardiovascular research	2009	61
19223473	L-Tyrosine	Yuan HT	Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.	Molecular and cellular biology	2009	92
19411631	L-Tyrosine	Salvucci O	EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.	Blood	2009	47
19449109	L-Tyrosine	Thomas M	The role of the Angiopoietins in vascular morphogenesis.	Angiogenesis	2009	87
19501581	L-Tyrosine	Meshkani R	Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.	Clinical biochemistry	2009	68
19808973	L-Tyrosine	Qian F	Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.	Cancer research	2009	73
20007921	L-Tyrosine	Albini A	Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.	Journal of the National Cancer Institute	2010	104
20103629	L-Tyrosine	Huang D	Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.	Cancer research	2010	63
20130423	L-Tyrosine	Lurje G	EGFR signaling and drug discovery.	Oncology	2009	109
20332118	L-Tyrosine	Schaller MD	Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions.	Journal of cell science	2010	173
20501804	L-Tyrosine	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	56
20644016	L-Tyrosine	Noori M	Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.	Circulation	2010	62
20716670	L-Tyrosine	Mimeault M	Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.	Pharmacological reviews	2010	48
21586748	L-Tyrosine	Ballmer-Hofer K	Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output.	Blood	2011	63
21777652	L-Tyrosine	Wright JW	Brain renin-angiotensin--a new look at an old system.	Progress in neurobiology	2011	46
21885862	L-Tyrosine	Taeger J	Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.	Molecular cancer therapeutics	2011	35
21976538	L-Tyrosine	Taniguchi K	Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas.	Clinical cancer research 	2011	85
22144665	L-Tyrosine	Ying W	Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.	Molecular cancer therapeutics	2012	64
22170610	L-Tyrosine	Png KJ	A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.	Nature	2011	151
22187964	L-Tyrosine	Korshunov VA	Axl-dependent signalling: a clinical update.	Clinical science	2012	36
22219194	L-Tyrosine	Shao B	Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.	The Journal of biological chemistry	2012	48
22361079	L-Tyrosine	Ky B	Multiple biomarkers for risk prediction in chronic heart failure.	Circulation. Heart failure	2012	33
22366328	L-Tyrosine	Eichmann A	VEGF signaling inside vascular endothelial cells and beyond.	Current opinion in cell biology	2012	61
22399811	L-Tyrosine	dela Paz NG	Role of shear-stress-induced VEGF expression in endothelial cell survival.	Journal of cell science	2012	37
22573349	L-Tyrosine	Griffioen AW	Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.	Clinical cancer research 	2012	40
22844075	L-Tyrosine	Nakagawa T	Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.	Molecular cancer therapeutics	2012	31
22898678	L-Tyrosine	Leboulleux S	Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.	The Lancet. Oncology	2012	62
22966038	L-Tyrosine	Liby KT	Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.	Pharmacological reviews	2012	75
23104879	L-Tyrosine	Odiete O	Neuregulin in cardiovascular development and disease.	Circulation research	2012	46
23108136	L-Tyrosine	Terme M	VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer.	Cancer research	2013	70
23341106	L-Tyrosine	Haas J	Alterations in cardiac DNA methylation in human dilated cardiomyopathy.	EMBO molecular medicine	2013	38
23391309	L-Tyrosine	Chong JJ	Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart.	Stem cells and development	2013	35
23720580	L-Tyrosine	Chintalgattu V	Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity.	Science translational medicine	2013	28
23798385	L-Tyrosine	Buraschi S	Decorin causes autophagy in endothelial cells via Peg3.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
23951022	L-Tyrosine	Wu YC	Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan.	PloS one	2013	26
23989717	L-Tyrosine	Ky B	Emerging paradigms in cardiomyopathies associated with cancer therapies.	Circulation research	2013	35
24215724	L-Tyrosine	Gieseler F	Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.	Cell communication and signaling 	2013	37
24291281	L-Tyrosine	Ky B	Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.	Journal of the American College of Cardiology	2014	52
24737315	L-Tyrosine	Poluzzi C	Endorepellin evokes autophagy in endothelial cells.	The Journal of biological chemistry	2014	21
24866019	L-Tyrosine	Gonzales AL	A PLCγ1-dependent, force-sensitive signaling network in the myogenic constriction of cerebral arteries.	Science signaling	2014	24
25175099	L-Tyrosine	Seto T	Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.	The Lancet. Oncology	2014	95
25180601	L-Tyrosine	Shen J	Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.	The Journal of clinical investigation	2014	31
25249658	L-Tyrosine	Gonzalez DM	Signaling mechanisms of the epithelial-mesenchymal transition.	Science signaling	2014	170
25381264	L-Tyrosine	Ciamporcero E	Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.	Molecular cancer therapeutics	2015	19
25381426	L-Tyrosine	Jackson AM	Endothelial cell antibodies associated with novel targets and increased rejection.	Journal of the American Society of Nephrology 	2015	15
26295376	L-Tyrosine	Marchetti A	Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.	Journal of thoracic oncology 	2015	37
26678713	L-Tyrosine	Uchida J	Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment.	Cancer science	2016	11
26802179	L-Tyrosine	New LA	Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture.	Journal of the American Society of Nephrology 	2016	13
26831193	L-Tyrosine	Spradley FT	Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.	Hypertension	2016	12
26916631	L-Tyrosine	Marchetti A	ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.	Journal of thoracic oncology 	2016	16
26936507	L-Tyrosine	Turro E	A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.	Science translational medicine	2016	10
26973209	L-Tyrosine	Imamura F	Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer.	Lung cancer	2016	14
27461391	L-Tyrosine	Simons M	Mechanisms and regulation of endothelial VEGF receptor signalling.	Nature reviews. Molecular cell biology	2016	46
27650556	L-Tyrosine	Liu S	AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus.	Circulation research	2016	25
28115513	L-Tyrosine	Onda K	Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.	Hypertension	2017	6
18579779	L-Lysine	Villeneuve LM	Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2008	106
19208907	L-Lysine	Brasacchio D	Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.	Diabetes	2009	113
19483677	L-Lysine	Nimura K	A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.	Nature	2009	109
19903865	L-Lysine	Chen S	Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.	American journal of physiology. Endocrinology and metabolism	2010	50
22025602	L-Lysine	Movassagh M	Distinct epigenomic features in end-stage failing human hearts.	Circulation	2011	61
22241783	L-Lysine	Donlin LT	Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization.	Genes & development	2012	46
23314172	L-Lysine	Gomez D	Detection of histone modifications at specific gene loci in single cells in histological sections.	Nature methods	2013	46
23434587	L-Lysine	Hohl M	HDAC4 controls histone methylation in response to elevated cardiac load.	The Journal of clinical investigation	2013	43
24344202	L-Lysine	Samant SA	SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress.	Molecular and cellular biology	2014	46
25472959	L-Lysine	Paneni F	Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.	Circulation. Cardiovascular genetics	2015	20
12702503	Phosphate	Heeschen C	Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.	Blood	2003	136
16037577	Phosphate	Hruska KA	Bone morphogenetic proteins in vascular calcification.	Circulation research	2005	82
16527991	Phosphate	Li X	Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification.	Circulation research	2006	109
17075009	Phosphate	Kawamoto A	CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.	Circulation	2006	87
17272749	Phosphate	Mor A	Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2007	66
17379599	Phosphate	Zhao Y	Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.	The Journal of biological chemistry	2007	61
18179800	Phosphate	Li X	BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.	Atherosclerosis	2008	66
18417722	Phosphate	Mathew S	The mechanism of phosphorus as a cardiovascular risk factor in CKD.	Journal of the American Society of Nephrology 	2008	66
18843258	Phosphate	Ravani P	Vitamin D levels and patient outcome in chronic kidney disease.	Kidney international	2009	95
19247306	Phosphate	Beenken A	The FGF family: biology, pathophysiology and therapy.	Nature reviews. Drug discovery	2009	342
19395730	Phosphate	Jean G	High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.	Nephrology, dialysis, transplantation 	2009	75
19524924	Phosphate	Mirza MA	Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.	Atherosclerosis	2009	87
20037143	Phosphate	Bai X	Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction.	European heart journal	2010	46
20507943	Phosphate	Wolf M	Forging forward with 10 burning questions on FGF23 in kidney disease.	Journal of the American Society of Nephrology 	2010	71
20525642	Phosphate	Seiler S	FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.	Nephrology, dialysis, transplantation 	2010	52
20850451	Phosphate	Copeland O	Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle.	Journal of molecular and cellular cardiology	2010	47
20945332	Phosphate	Krasnodembskaya A	Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.	Stem cells	2010	138
20966399	Phosphate	Mirza MA	Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.	Arteriosclerosis, thrombosis, and vascular biology	2011	40
21115613	Phosphate	Hu MC	Klotho deficiency causes vascular calcification in chronic kidney disease.	Journal of the American Society of Nephrology 	2011	197
21436289	Phosphate	Wolf M	Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.	Journal of the American Society of Nephrology 	2011	70
21733911	Phosphate	Seiler S	The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.	European heart journal	2011	38
22034506	Phosphate	Gutiérrez OM	Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.	Clinical journal of the American Society of Nephrology 	2011	42
22622492	Phosphate	Wolf M	Update on fibroblast growth factor 23 in chronic kidney disease.	Kidney international	2012	68
23197758	Phosphate	Oskouei BN	Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.	Stem cells translational medicine	2012	31
23431388	Phosphate	Kitagawa M	A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.	PloS one	2013	37
24665125	Phosphate	Demer LL	Inflammatory, metabolic, and genetic mechanisms of vascular calcification.	Arteriosclerosis, thrombosis, and vascular biology	2014	37
24686452	Phosphate	Scialla JJ	Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.	Nature reviews. Nephrology	2014	30
24695641	Phosphate	Six I	Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.	PloS one	2014	21
24867675	Phosphate	Wolf M	Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.	Current opinion in nephrology and hypertension	2014	23
24920722	Phosphate	Mathew JS	Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).	Circulation	2014	22
25418337	Phosphate	Opal SM	Endothelial barrier dysfunction in septic shock.	Journal of internal medicine	2015	30
26059012	Phosphate	Moe SM	Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.	Circulation	2015	30
26567701	Phosphate	Degirolamo C	Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.	Nature reviews. Drug discovery	2016	29
26681731	Phosphate	Leifheit-Nestler M	Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.	Nephrology, dialysis, transplantation 	2016	16
15814915	Gadolinium	Gu T	PC VIPR: a high-speed 3D phase-contrast method for flow quantification and high-resolution angiography.	AJNR. American journal of neuroradiology	2005	69
18703004	Gadolinium	Segal BM	Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.	The Lancet. Neurology	2008	95
19442942	Gadolinium	Carlsson M	Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.	JACC. Cardiovascular imaging	2009	49
20035078	Gadolinium	Barr TL	Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.	Stroke	2010	46
20818890	Gadolinium	Ho CY	Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.	The New England journal of medicine	2010	111
22160404	Gadolinium	La Gerche A	Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes.	European heart journal	2012	68
23071146	Gadolinium	Dass S	Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.	Circulation. Cardiovascular imaging	2012	60
23594591	Gadolinium	Robbers LF	Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.	European heart journal	2013	27
24829362	Gadolinium	Chin CW	High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis.	European heart journal	2014	33
25388867	Gadolinium	Ferreira PF	In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.	Journal of cardiovascular magnetic resonance 	2014	27
11956120	Warfarin	Wannamethee SG	Physical activity and hemostatic and inflammatory variables in elderly men.	Circulation	2002	86
15817606	Warfarin	Wannamethee SG	Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.	European heart journal	2005	75
17989110	Warfarin	Anderson JL	Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.	Circulation	2007	137
19255343	Warfarin	Go AS	Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.	Circulation	2009	53
19683639	Warfarin	Holmes DR	Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.	Lancet	2009	179
20435227	Warfarin	Ashley EA	Clinical assessment incorporating a personal genome.	Lancet	2010	234
20934556	Warfarin	Ruff CT	Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).	American heart journal	2010	58
21873708	Warfarin	Fox KA	Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.	European heart journal	2011	70
22431865	Warfarin	Anderson JL	A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).	Circulation	2012	53
22575324	Warfarin	Lip GY	Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.	Journal of the American College of Cardiology	2012	41
23562920	Warfarin	Larsen TB	Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.	Journal of the American College of Cardiology	2013	66
23583249	Warfarin	Reddy VY	Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).	Journal of the American College of Cardiology	2013	64
23743976	Warfarin	Hori M	Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation.	Stroke	2013	34
23808982	Warfarin	Agnelli G	Oral apixaban for the treatment of acute venous thromboembolism.	The New England journal of medicine	2013	172
24211508	Warfarin	Flaker G	Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).	Journal of the American College of Cardiology	2014	28
24251359	Warfarin	Giugliano RP	Edoxaban versus warfarin in patients with atrial fibrillation.	The New England journal of medicine	2013	368
24552831	Warfarin	Sherwood MW	Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).	Circulation	2014	30
25988464	Warfarin	Lip GY	Stroke prevention in atrial fibrillation: a systematic review.	JAMA	2015	36
26890676	Warfarin	Veitch AM	Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.	Endoscopy	2016	16
8895578	Fenofibrate	Schoonjans K	PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.	The EMBO journal	1996	188
9655393	Fenofibrate	Staels B	Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.	Nature	1998	149
17599422	Fenofibrate	ACCORD Study Group.	Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.	The American journal of cardiology	2007	113
24428677	Fenofibrate	Sahebkar A	New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.	Expert opinion on pharmacotherapy	2014	26
25471221	Fenofibrate	Tenenbaum A	Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.	Cardiovascular diabetology	2014	23
1309946	Sodium	Gellens ME	Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.	Proceedings of the National Academy of Sciences of the United States of America	1992	146
7651517	Sodium	Bennett PB	Molecular mechanism for an inherited cardiac arrhythmia.	Nature	1995	201
11230313	Sodium	Weinberger MH	Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.	Hypertension	2001	121
11486343	Sodium	Isom LL	Sodium channel beta subunits: anything but auxiliary.	The Neuroscientist 	2001	94
15263023	Sodium	Kögler G	A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.	The Journal of experimental medicine	2004	186
15655131	Sodium	Antzelevitch C	Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.	Circulation	2005	223
17002597	Sodium	Schneider MP	Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease.	Annual review of pharmacology and toxicology	2007	72
17060380	Sodium	Vatta M	Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.	Circulation	2006	143
17090678	Sodium	Crowley SD	Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.	Proceedings of the National Academy of Sciences of the United States of America	2006	197
17942703	Sodium	Bodyak N	Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.	Proceedings of the National Academy of Sciences of the United States of America	2007	74
18413553	Sodium	Fung TT	Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.	Archives of internal medicine	2008	191
18439620	Sodium	Sossalla S	Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.	Journal of molecular and cellular cardiology	2008	59
18464934	Sodium	Watanabe H	Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.	The Journal of clinical investigation	2008	100
18662191	Sodium	Moss AJ	Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.	Journal of cardiovascular electrophysiology	2008	57
19013462	Sodium	Scaldaferri F	VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.	Gastroenterology	2009	71
19412328	Sodium	Hershberger RE	Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy.	Clinical and translational science	2008	57
19427495	Sodium	Harrison DG	Oxidative stress and hypertension.	The Medical clinics of North America	2009	79
19808477	Sodium	Watanabe H	Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.	Circulation. Arrhythmia and electrophysiology	2009	57
20062060	Sodium	Pfeufer A	Genome-wide association study of PR interval.	Nature genetics	2010	147
20062061	Sodium	Chambers JC	Genetic variation in SCN10A influences cardiac conduction.	Nature genetics	2010	82
20091048	Sodium	Amin AS	Cardiac sodium channelopathies.	Pflugers Archiv 	2010	47
20234356	Sodium	Briet M	Aldosterone: effects on the kidney and cardiovascular system.	Nature reviews. Nephrology	2010	53
20385929	Sodium	Japp AG	Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure.	Circulation	2010	45
21082022	Sodium	Padmanabhan S	Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.	PLoS genetics	2010	98
21150449	Sodium	de Jong S	Fibrosis and cardiac arrhythmias.	Journal of cardiovascular pharmacology	2011	56
21164104	Sodium	Petitprez S	SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes.	Circulation research	2011	85
21347284	Sodium	Smith JG	Genome-wide association studies of the PR interval in African Americans.	PLoS genetics	2011	44
21447824	Sodium	Kattygnarath D	MOG1: a new susceptibility gene for Brugada syndrome.	Circulation. Cardiovascular genetics	2011	41
21637795	Sodium	O'Hara T	Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation.	PLoS computational biology	2011	190
21705062	Sodium	Tahrani AA	Management of type 2 diabetes: new and future developments in treatment.	Lancet	2011	74
21723914	Sodium	McCurley A	Mineralocorticoid receptors in vascular function and disease.	Molecular and cellular endocrinology	2012	39
21862461	Sodium	Lawlor DA	Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children.	European heart journal	2012	32
21937582	Sodium	Rook MB	Biology of cardiac sodium channel Nav1.5 expression.	Cardiovascular research	2012	40
21944663	Sodium	Hecking M	Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).	American journal of kidney diseases 	2012	34
21976025	Sodium	Hu NJ	Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT.	Nature	2011	53
22240500	Sodium	Gomes J	Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study.	European heart journal	2012	33
22310849	Sodium	Ferrannini E	SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.	Nature reviews. Endocrinology	2012	49
22647976	Sodium	Davis RP	Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.	Circulation	2012	76
22706305	Sodium	van den Boogaard M	Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer.	The Journal of clinical investigation	2012	51
22771675	Sodium	Eirin A	Inflammatory and injury signals released from the post-stenotic human kidney.	European heart journal	2013	40
23123192	Sodium	Shy D	Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model.	Biochimica et biophysica acta	2013	32
23178689	Sodium	Noorman M	Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.	Heart rhythm	2013	33
23440193	Sodium	Deo M	KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia.	Proceedings of the National Academy of Sciences of the United States of America	2013	35
23463857	Sodium	Ritchie MD	Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk.	Circulation	2013	64
23509259	Sodium	Geier EG	Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
23558162	Sodium	He FJ	Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.	BMJ	2013	133
23584425	Sodium	Wu CC	20-HETE and blood pressure regulation: clinical implications.	Cardiology in review	2014	37
23633321	Sodium	He FJ	Effect of longer-term modest salt reduction on blood pressure.	The Cochrane database of systematic reviews	2013	39
24026259	Sodium	Vasilakou D	Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.	Annals of internal medicine	2013	98
24158986	Sodium	Scialla JJ	Fibroblast growth factor-23 and cardiovascular events in CKD.	Journal of the American Society of Nephrology 	2014	76
24185693	Sodium	Trudu M	Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.	Nature medicine	2013	64
24204003	Sodium	McMahon EJ	A randomized trial of dietary sodium restriction in CKD.	Journal of the American Society of Nephrology 	2013	41
24352520	Sodium	Cerrone M	Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.	Circulation	2014	68
24375052	Sodium	Muskiet MH	The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?	Nature reviews. Nephrology	2014	27
24642470	Sodium	van den Boogaard M	A common genetic variant within SCN10A modulates cardiac SCN5A expression.	The Journal of clinical investigation	2014	33
24732974	Sodium	DeMarco VG	The pathophysiology of hypertension in patients with obesity.	Nature reviews. Endocrinology	2014	51
24737235	Sodium	Antzelevitch C	The role of late I Na in development of cardiac arrhythmias.	Handbook of experimental pharmacology	2014	24
24766495	Sodium	Liakos A	Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis.	Diabetes, obesity & metabolism	2014	36
24850863	Sodium	Bagnéris C	Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
24890683	Sodium	Leiter LA	Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension.	Journal of the American Geriatrics Society	2014	21
24895455	Sodium	Shy D	PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.	Circulation	2014	26
24903467	Sodium	Chin MP	Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.	American journal of nephrology	2014	26
25100048	Sodium	Dahlmann A	Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients.	Kidney international	2015	21
25427230	Sodium	Fan F	Cytochrome P450 eicosanoids in hypertension and renal disease.	Current opinion in nephrology and hypertension	2015	21
25460862	Sodium	Belardinelli L	Cardiac late Na⁺ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress.	Heart rhythm	2015	22
25468945	Sodium	Neal B	Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes.	Diabetes care	2015	46
25488697	Sodium	Scheen AJ	Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.	Drugs	2015	31
25767285	Sodium	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	66
25927480	Sodium	de Lera Ruiz M	Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.	Journal of medicinal chemistry	2015	16
26005865	Sodium	Alakbarzade V	A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome.	Nature genetics	2015	15
26009231	Sodium	Gilbert RE	Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.	Lancet	2015	37
26475588	Sodium	Chappell MC	Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?	American journal of physiology. Heart and circulatory physiology	2016	22
26497848	Sodium	Chan MM	Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.	European journal of heart failure	2016	10
26668301	Sodium	Jaisser F	Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology.	Pharmacological reviews	2016	17
26680203	Sodium	Ahuja S	Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.	Science	2015	36
26803770	Sodium	Malan D	Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.	Basic research in cardiology	2016	15
26880444	Sodium	Rajasekeran H	Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis.	Kidney international	2016	13
26895767	Sodium	Sonesson C	Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.	Cardiovascular diabetology	2016	26
27009625	Sodium	Wu JH	Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.	The lancet. Diabetes & endocrinology	2016	45
27088241	Sodium	Maruthur NM	Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.	Annals of internal medicine	2016	27
27112340	Sodium	Sattar N	SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?	Diabetologia	2016	16
27208375	Sodium	Abdul-Ghani M	SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study.	Diabetes care	2016	30
27289124	Sodium	Mudaliar S	Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis.	Diabetes care	2016	43
27299675	Sodium	Wanner C	Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.	The New England journal of medicine	2016	143
27358439	Sodium	Shah SJ	Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.	Circulation	2016	50
27470431	Sodium	Gnudi L	Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.	Trends in endocrinology and metabolism	2016	16
27488726	Sodium	Monami M	Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.	Acta diabetologica	2017	11
27651331	Sodium	Frías JP	Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.	The lancet. Diabetes & endocrinology	2016	13
27941935	Sodium	DeFronzo RA	Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.	Nature reviews. Nephrology	2017	8
28055075	Sodium	Qaseem A	Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.	Annals of internal medicine	2017	8
28244644	Sodium	Neal B	Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.	Diabetes, obesity & metabolism	2017	12
28522450	Sodium	Kosiborod M	Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).	Circulation	2017	27
10921872	L-Lactic acid	Kirk P	CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.	The EMBO journal	2000	134
11299236	L-Lactic acid	Chen Z	Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice.	American journal of physiology. Heart and circulatory physiology	2001	90
11559017	L-Lactic acid	Brown DM	Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines.	Toxicology and applied pharmacology	2001	104
18957536	L-Lactic acid	Yeo TW	Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.	Proceedings of the National Academy of Sciences of the United States of America	2008	105
20086073	L-Lactic acid	Tappy L	Metabolic effects of fructose and the worldwide increase in obesity.	Physiological reviews	2010	200
20634355	L-Lactic acid	Amann M	Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans.	Journal of applied physiology	2010	71
21550068	L-Lactic acid	Jarius S	Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.	Journal of the neurological sciences	2011	49
21569296	L-Lactic acid	Cucullo L	The role of shear stress in Blood-Brain Barrier endothelial physiology.	BMC neuroscience	2011	57
24158164	L-Lactic acid	Terpstra ML	Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*.	Critical care medicine	2014	24
24789919	L-Lactic acid	Carrière A	Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure.	Diabetes	2014	37
25128877	L-Lactic acid	Skriver K	Acute exercise improves motor memory: exploring potential biomarkers.	Neurobiology of learning and memory	2014	27
25748677	L-Lactic acid	McCommis KS	Mitochondrial pyruvate transport: a historical perspective and future research directions.	The Biochemical journal	2015	18
25833956	L-Lactic acid	Cofiell R	Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.	Blood	2015	18
25930027	L-Lactic acid	Stenmark KR	Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.	Journal of applied physiology	2015	19
26018532	L-Lactic acid	Hanson J	Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: an observational study.	BMC medicine	2015	19
26780750	L-Lactic acid	McCreight LJ	Metformin and the gastrointestinal tract.	Diabetologia	2016	28
1671422	D-Glucose	McKeigue PM	Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.	Lancet	1991	270
2044434	D-Glucose	DeFronzo RA	Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.	Diabetes care	1991	390
2645527	D-Glucose	James DE	Molecular cloning and characterization of an insulin-regulatable glucose transporter.	Nature	1989	161
3282647	D-Glucose	Jain RK	Determinants of tumor blood flow: a review.	Cancer research	1988	237
8353913	D-Glucose	Newman AB	Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.	Circulation	1993	159
8622248	D-Glucose	Kannel WB	Blood pressure as a cardiovascular risk factor: prevention and treatment.	JAMA	1996	140
9303923	D-Glucose	Ferrannini E	Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).	The Journal of clinical investigation	1997	122
9408743	D-Glucose	Dunaif A	Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.	Endocrine reviews	1997	289
9742976	D-Glucose	-	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.	Lancet	1998	2807
9920074	D-Glucose	Banerji MA	Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.	The Journal of clinical endocrinology and metabolism	1999	105
10189543	D-Glucose	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	189
10209084	D-Glucose	Andrews RC	Glucocorticoids and insulin resistance: old hormones, new targets.	Clinical science	1999	104
10591709	D-Glucose	Rimm EB	Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.	BMJ	1999	175
10600804	D-Glucose	Kelley DE	Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.	The American journal of physiology	1999	182
10880413	D-Glucose	Festa A	Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).	Circulation	2000	331
10902785	D-Glucose	Katz A	Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.	The Journal of clinical endocrinology and metabolism	2000	508
11157411	D-Glucose	Geffken DF	Association between physical activity and markers of inflammation in a healthy elderly population.	American journal of epidemiology	2001	103
11315831	D-Glucose	Isomaa B	Cardiovascular morbidity and mortality associated with the metabolic syndrome.	Diabetes care	2001	599
11574423	D-Glucose	Barzilay JI	The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.	Diabetes	2001	92
11673759	D-Glucose	Festa A	The relation of body fat mass and distribution to markers of chronic inflammation.	International journal of obesity and related metabolic disorders 	2001	115
11681807	D-Glucose	Trayhurn P	Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.	The Proceedings of the Nutrition Society	2001	152
11895820	D-Glucose	Whincup PH	Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children.	BMJ	2002	83
11916936	D-Glucose	Festa A	Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.	Diabetes	2002	194
11923038	D-Glucose	Nappo F	Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.	Journal of the American College of Cardiology	2002	93
12057982	D-Glucose	Rudd JH	Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography.	Circulation	2002	175
12081851	D-Glucose	Willett W	Glycemic index, glycemic load, and risk of type 2 diabetes.	The American journal of clinical nutrition	2002	83
12086956	D-Glucose	Romeo G	Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.	Diabetes	2002	89
12087016	D-Glucose	Hanley AJ	Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.	Diabetes care	2002	101
12089061	D-Glucose	Shiojima I	Role of Akt signaling in vascular homeostasis and angiogenesis.	Circulation research	2002	208
12162730	D-Glucose	Abbott NJ	Astrocyte-endothelial interactions and blood-brain barrier permeability.	Journal of anatomy	2002	180
12213876	D-Glucose	Ramsay JE	Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways.	The Journal of clinical endocrinology and metabolism	2002	112
12540621	D-Glucose	Garvey WT	Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.	Diabetes	2003	100
12551861	D-Glucose	Ridker PM	C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.	Circulation	2003	322
12558712	D-Glucose	Haan MN	Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors.	Journal of the American Geriatrics Society	2003	107
12679416	D-Glucose	Goran MI	Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.	The Journal of clinical endocrinology and metabolism	2003	107
12684358	D-Glucose	Esposito K	Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.	JAMA	2003	235
12788800	D-Glucose	Fernández-Real JM	Insulin resistance and chronic cardiovascular inflammatory syndrome.	Endocrine reviews	2003	116
14623617	D-Glucose	McLaughlin T	Use of metabolic markers to identify overweight individuals who are insulin resistant.	Annals of internal medicine	2003	162
14670831	D-Glucose	Yan SF	Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.	Circulation research	2003	82
14715836	D-Glucose	Cruz ML	The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.	The Journal of clinical endocrinology and metabolism	2004	100
14747278	D-Glucose	Holten MK	Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes.	Diabetes	2004	103
15007034	D-Glucose	Benson SC	Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.	Hypertension	2004	162
15111517	D-Glucose	Laaksonen DE	Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.	Diabetes care	2004	126
15159263	D-Glucose	Hu G	Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.	Archives of internal medicine	2004	129
15175438	D-Glucose	Weiss R	Obesity and the metabolic syndrome in children and adolescents.	The New England journal of medicine	2004	507
15181024	D-Glucose	Goldstein BJ	Adiponectin: A novel adipokine linking adipocytes and vascular function.	The Journal of clinical endocrinology and metabolism	2004	107
15197140	D-Glucose	Esposito K	Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.	Circulation	2004	75
15265818	D-Glucose	Meier U	Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.	Clinical chemistry	2004	118
15383514	D-Glucose	Esposito K	Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.	JAMA	2004	298
15629253	D-Glucose	Kota BP	An overview on biological mechanisms of PPARs.	Pharmacological research	2005	120
15660291	D-Glucose	Reiner AP	Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study.	American journal of human genetics	2005	66
15660501	D-Glucose	Moller DE	Metabolic syndrome: a clinical and molecular perspective.	Annual review of medicine	2005	116
15669880	D-Glucose	Krentz AJ	Oral antidiabetic agents: current role in type 2 diabetes mellitus.	Drugs	2005	137
15925013	D-Glucose	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	88
16046315	D-Glucose	Staels B	Therapeutic roles of peroxisome proliferator-activated receptor agonists.	Diabetes	2005	101
16159812	D-Glucose	Bartunek J	Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.	Circulation	2005	110
16186392	D-Glucose	Berndt J	Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.	Diabetes	2005	93
16227461	D-Glucose	Punjabi NM	Disorders of glucose metabolism in sleep apnea.	Journal of applied physiology	2005	88
16239637	D-Glucose	Nissen SE	Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.	JAMA	2005	71
16311215	D-Glucose	Koerner A	Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.	Best practice & research. Clinical endocrinology & metabolism	2005	79
16385087	D-Glucose	Isoda K	Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.	Arteriosclerosis, thrombosis, and vascular biology	2006	88
16388523	D-Glucose	Basaria S	Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.	Cancer	2006	66
16434464	D-Glucose	Smith MR	Insulin sensitivity during combined androgen blockade for prostate cancer.	The Journal of clinical endocrinology and metabolism	2006	99
16460270	D-Glucose	Kalaany NY	LXRS and FXR: the yin and yang of cholesterol and fat metabolism.	Annual review of physiology	2006	147
16470636	D-Glucose	Wolfram S	Anti-obesity effects of green tea: from bedside to bench.	Molecular nutrition & food research	2006	62
16492903	D-Glucose	Nigro J	Insulin resistance and atherosclerosis.	Endocrine reviews	2006	63
16511589	D-Glucose	Lefebvre P	Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.	The Journal of clinical investigation	2006	191
16511591	D-Glucose	Barish GD	PPAR delta: a dagger in the heart of the metabolic syndrome.	The Journal of clinical investigation	2006	158
16531507	D-Glucose	Yang RZ	Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.	American journal of physiology. Endocrinology and metabolism	2006	108
16550171	D-Glucose	Coucke PJ	Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.	Nature genetics	2006	77
16567536	D-Glucose	Festa A	The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.	Diabetes	2006	78
16600341	D-Glucose	Zittermann A	Vitamin D and disease prevention with special reference to cardiovascular disease.	Progress in biophysics and molecular biology	2006	83
16613757	D-Glucose	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	413
16618833	D-Glucose	Kim JA	Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.	Circulation	2006	288
16644701	D-Glucose	Abdul-Ghani MA	Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.	Diabetes	2006	110
16644702	D-Glucose	Clerk LH	Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.	Diabetes	2006	85
16766796	D-Glucose	Patwari P	The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.	The Journal of biological chemistry	2006	85
16786033	D-Glucose	Martins IJ	Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.	Molecular psychiatry	2006	80
16818923	D-Glucose	Estruch R	Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.	Annals of internal medicine	2006	216
16894525	D-Glucose	Gurney JG	Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.	Cancer	2006	64
16926254	D-Glucose	Vega GL	Influence of body fat content and distribution on variation in metabolic risk.	The Journal of clinical endocrinology and metabolism	2006	82
16970929	D-Glucose	Fülöp N	Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.	Cardiovascular research	2007	56
17015487	D-Glucose	Lang F	(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.	Physiological reviews	2006	167
17043079	D-Glucose	Fitzpatrick AL	Leukocyte telomere length and cardiovascular disease in the cardiovascular health study.	American journal of epidemiology	2007	219
17068132	D-Glucose	Kharitonenkov A	The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.	Endocrinology	2007	166
17071576	D-Glucose	Cowey S	The metabolic syndrome: A high-risk state for cancer?	The American journal of pathology	2006	104
17095717	D-Glucose	Lee DS	Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.	Arteriosclerosis, thrombosis, and vascular biology	2007	86
17101706	D-Glucose	Laughlin GA	Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study.	American journal of epidemiology	2007	56
17116015	D-Glucose	Oby E	The blood-brain barrier and epilepsy.	Epilepsia	2006	82
17130488	D-Glucose	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	103
17145742	D-Glucose	Kahn SE	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.	The New England journal of medicine	2006	549
17148564	D-Glucose	Sharma AM	Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.	The Journal of clinical endocrinology and metabolism	2007	107
17151862	D-Glucose	Krabbe KS	Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.	Diabetologia	2007	97
17179929	D-Glucose	Rask-Madsen C	Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.	Nature clinical practice. Endocrinology & metabolism	2007	108
17202130	D-Glucose	Popa C	The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.	Journal of lipid research	2007	95
17225955	D-Glucose	Virgintino D	An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.	Angiogenesis	2007	60
17242275	D-Glucose	Silver AE	Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress.	Circulation	2007	57
17286524	D-Glucose	Newcomer JW	Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.	The Journal of clinical psychiatry	2007	56
17327345	D-Glucose	Kilpatrick ES	Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.	Diabetes care	2007	56
17374708	D-Glucose	Anderson PD	Innate immunity modulates adipokines in humans.	The Journal of clinical endocrinology and metabolism	2007	57
17389326	D-Glucose	Chen YH	High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.	Diabetes	2007	78
17391153	D-Glucose	Oh DK	Adiponectin in health and disease.	Diabetes, obesity & metabolism	2007	56
17443605	D-Glucose	Horvath K	Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.	The Cochrane database of systematic reviews	2007	70
17515892	D-Glucose	Seckl JR	Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.	Nature clinical practice. Endocrinology & metabolism	2007	119
17525361	D-Glucose	Muniyappa R	Cardiovascular actions of insulin.	Endocrine reviews	2007	186
17533210	D-Glucose	Wilson PW	Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.	Archives of internal medicine	2007	236
17574431	D-Glucose	Das Evcimen N	The role of protein kinase C activation and the vascular complications of diabetes.	Pharmacological research	2007	86
17609686	D-Glucose	Cucullo L	Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.	Journal of cerebral blood flow and metabolism 	2008	51
17618108	D-Glucose	Galisteo M	Effects of dietary fibers on disturbances clustered in the metabolic syndrome.	The Journal of nutritional biochemistry	2008	58
17618858	D-Glucose	Klöting N	Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.	Cell metabolism	2007	92
17620449	D-Glucose	Tso AW	Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.	Diabetes care	2007	57
17690317	D-Glucose	Kotronen A	Fatty liver: a novel component of the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	167
17823655	D-Glucose	Son NH	Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.	The Journal of clinical investigation	2007	101
17924864	D-Glucose	Russell-Jones D	Insulin-associated weight gain in diabetes--causes, effects and coping strategies.	Diabetes, obesity & metabolism	2007	71
17957034	D-Glucose	Muniyappa R	Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.	American journal of physiology. Endocrinology and metabolism	2008	275
17959861	D-Glucose	Fleischman A	Salsalate improves glycemia and inflammatory parameters in obese young adults.	Diabetes care	2008	97
17997608	D-Glucose	Li S	The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.	PLoS genetics	2007	91
18039092	D-Glucose	Waki H	Endocrine functions of adipose tissue.	Annual review of pathology	2007	83
18179892	D-Glucose	Wallace C	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.	American journal of human genetics	2008	178
18220619	D-Glucose	Simó R	Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.	Current diabetes reviews	2006	79
18220694	D-Glucose	Ziyadeh FN	Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.	Current diabetes reviews	2008	91
18250214	D-Glucose	Tasali E	Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation.	Proceedings of the American Thoracic Society	2008	78
18256393	D-Glucose	Gaede P	Effect of a multifactorial intervention on mortality in type 2 diabetes.	The New England journal of medicine	2008	548
18281663	D-Glucose	Ligibel JA	Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.	Journal of clinical oncology 	2008	53
18371555	D-Glucose	Sluimer JC	Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.	Journal of the American College of Cardiology	2008	75
18378618	D-Glucose	Schramm TK	Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.	Circulation	2008	79
18434349	D-Glucose	Macfarlane DP	Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.	The Journal of endocrinology	2008	71
18458145	D-Glucose	Fonseca VA	Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.	Diabetes care	2008	51
18463376	D-Glucose	Rowan JA	Metformin versus insulin for the treatment of gestational diabetes.	The New England journal of medicine	2008	121
18515784	D-Glucose	Park TS	Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.	Journal of lipid research	2008	101
18544448	D-Glucose	Shaw JE	Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.	Diabetes research and clinical practice	2008	65
18584872	D-Glucose	Wong TY	Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study.	Ophthalmology	2008	71
18612041	D-Glucose	Clark MG	Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.	American journal of physiology. Endocrinology and metabolism	2008	52
18689793	D-Glucose	Zhang QJ	Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice.	Cardiovascular research	2008	95
18707012	D-Glucose	Komulainen P	BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.	Neurobiology of learning and memory	2008	63
18775919	D-Glucose	Hajer GR	Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.	European heart journal	2008	242
18929315	D-Glucose	Van Cauter E	Metabolic consequences of sleep and sleep loss.	Sleep medicine	2008	99
19026395	D-Glucose	Matsuo H	Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.	American journal of human genetics	2008	73
19028792	D-Glucose	Laczy B	Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.	American journal of physiology. Heart and circulatory physiology	2009	55
19082851	D-Glucose	Volek JS	Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.	Lipids	2009	60
19141606	D-Glucose	Maratou E	Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.	European journal of endocrinology	2009	56
19183311	D-Glucose	Katulanda P	Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS).	Diabetic medicine 	2008	56
19199892	D-Glucose	Crawford TN	Diabetic retinopathy and angiogenesis.	Current diabetes reviews	2009	73
19286634	D-Glucose	Orimo M	Protective role of SIRT1 in diabetic vascular dysfunction.	Arteriosclerosis, thrombosis, and vascular biology	2009	52
19342601	D-Glucose	Barcelos LS	Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.	Circulation research	2009	68
19478200	D-Glucose	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	47
19487712	D-Glucose	Sowers JR	Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.	Annals of internal medicine	2009	65
19515415	D-Glucose	Henry RR	Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.	Lancet	2009	49
19584181	D-Glucose	Tarcin O	Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects.	The Journal of clinical endocrinology and metabolism	2009	81
19625659	D-Glucose	Elmasri H	Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.	FASEB journal 	2009	61
19789205	D-Glucose	Kalyani RR	The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.	The Journal of clinical endocrinology and metabolism	2009	55
19802338	D-Glucose	Chasman DI	Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.	Circulation. Cardiovascular genetics	2008	51
19826624	D-Glucose	Cottrell EC	Prenatal stress, glucocorticoids and the programming of adult disease.	Frontiers in behavioral neuroscience	2009	109
19884662	D-Glucose	Melmed S	Acromegaly pathogenesis and treatment.	The Journal of clinical investigation	2009	78
19896496	D-Glucose	Castañeda TR	Ghrelin in the regulation of body weight and metabolism.	Frontiers in neuroendocrinology	2010	78
19906806	D-Glucose	Ziemke F	Adiponectin in insulin resistance: lessons from translational research.	The American journal of clinical nutrition	2010	87
19931306	D-Glucose	Reynolds GP	Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.	Pharmacology & therapeutics	2010	66
20061378	D-Glucose	Pacholec M	SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.	The Journal of biological chemistry	2010	286
20065965	D-Glucose	Manolopoulos KN	Gluteofemoral body fat as a determinant of metabolic health.	International journal of obesity	2010	123
20067962	D-Glucose	Dasu MR	Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.	Diabetes care	2010	116
20075143	D-Glucose	Read PA	DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.	Circulation. Cardiovascular imaging	2010	46
20082925	D-Glucose	Matthews KA	Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?	Journal of the American College of Cardiology	2009	91
20092409	D-Glucose	Jain SK	Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?	Antioxidants & redox signaling	2010	56
20097779	D-Glucose	Bertoni AG	Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).	Diabetes care	2010	51
20151996	D-Glucose	Elhayany A	A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study.	Diabetes, obesity & metabolism	2010	43
20190196	D-Glucose	Tao YX	The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.	Endocrine reviews	2010	93
20212276	D-Glucose	Ix JH	Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study.	Circulation	2010	41
20228402	D-Glucose	NAVIGATOR Study Group.	Effect of nateglinide on the incidence of diabetes and cardiovascular events.	The New England journal of medicine	2010	83
20336705	D-Glucose	Speliotes EK	Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.	Hepatology	2010	86
20370677	D-Glucose	Bugianesi E	Insulin resistance in nonalcoholic fatty liver disease.	Current pharmaceutical design	2010	55
20392876	D-Glucose	Pearen MA	Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.	Molecular endocrinology	2010	90
20484490	D-Glucose	Preis SR	Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study.	The Journal of clinical endocrinology and metabolism	2010	70
20497976	D-Glucose	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	85
20505494	D-Glucose	Ford ES	Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.	AIDS	2010	80
20526369	D-Glucose	Gall WE	alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.	PloS one	2010	137
20587723	D-Glucose	Gogitidze Joy N	Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals.	Diabetes care	2010	44
20588114	D-Glucose	Dinarello CA	Role of IL-1beta in type 2 diabetes.	Current opinion in endocrinology, diabetes, and obesity	2010	83
20592272	D-Glucose	Manco M	Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk.	Endocrine reviews	2010	90
20628408	D-Glucose	Velho S	Metabolically healthy obesity: different prevalences using different criteria.	European journal of clinical nutrition	2010	49
20631354	D-Glucose	Zhao Y	NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.	Arteriosclerosis, thrombosis, and vascular biology	2010	63
20646185	D-Glucose	Aversa A	Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.	The journal of sexual medicine	2010	45
20651284	D-Glucose	Zampetaki A	Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.	Circulation research	2010	289
20660625	D-Glucose	Bindom SM	Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.	Diabetes	2010	43
20817486	D-Glucose	Ernst MC	Chemerin: at the crossroads of inflammation and obesity.	Trends in endocrinology and metabolism	2010	60
20829514	D-Glucose	Lima FO	The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion.	Stroke	2010	48
20833756	D-Glucose	Chuang KJ	Long-term air pollution exposure and risk factors for cardiovascular diseases among the elderly in Taiwan.	Occupational and environmental medicine	2011	47
20884846	D-Glucose	Yang Q	Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.	Circulation. Cardiovascular genetics	2010	100
20929995	D-Glucose	Best JH	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.	Diabetes care	2011	57
20937689	D-Glucose	Calori G	Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.	Diabetes care	2011	65
20943795	D-Glucose	Mozaffarian D	Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.	The American journal of clinical nutrition	2010	48
20944545	D-Glucose	Yvan-Charvet L	Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.	Kidney international	2011	40
20978091	D-Glucose	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	56
21080476	D-Glucose	Lee M	Inverse association between adiposity and telomere length: The Fels Longitudinal Study.	American journal of human biology 	2011	36
21109577	D-Glucose	Lawlor DA	Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study.	BMJ	2010	78
21194578	D-Glucose	Nauck MA	Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.	The American journal of medicine	2011	67
21208359	D-Glucose	Madsbad S	An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.	Diabetes, obesity & metabolism	2011	42
21270272	D-Glucose	Tan Y	Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.	Diabetes	2011	90
21291474	D-Glucose	Uchida Y	Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors.	Journal of neurochemistry	2011	93
21321189	D-Glucose	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	83
21386085	D-Glucose	Kraja AT	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Diabetes	2011	83
21531886	D-Glucose	Bakris GL	Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.	Mayo Clinic proceedings	2011	35
21551420	D-Glucose	Schnabel RB	Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods.	Circulation. Cardiovascular imaging	2011	46
21551454	D-Glucose	Cui X	Seipin ablation in mice results in severe generalized lipodystrophy.	Human molecular genetics	2011	41
21670502	D-Glucose	Liao X	Krüppel-like factor 4 regulates macrophage polarization.	The Journal of clinical investigation	2011	147
21685543	D-Glucose	Ross AC	Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.	Antiviral therapy	2011	37
21724622	D-Glucose	Chaanine AH	AKT signalling in the failing heart.	European journal of heart failure	2011	42
21737012	D-Glucose	Farb MG	Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.	Journal of the American College of Cardiology	2011	39
21778425	D-Glucose	Zhou S	Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.	Circulation research	2011	49
21811634	D-Glucose	Caillou B	Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.	PloS one	2011	36
21812507	D-Glucose	Baetta R	Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences.	Drugs	2011	42
21829446	D-Glucose	Anand SS	Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE).	PloS one	2011	36
21855697	D-Glucose	Reaven GM	Insulin resistance: the link between obesity and cardiovascular disease.	The Medical clinics of North America	2011	93
21861177	D-Glucose	Wannamethee SG	Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study.	Diabetologia	2012	34
21890681	D-Glucose	Pirola L	Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.	Genome research	2011	43
21933988	D-Glucose	Kowluru RA	Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.	Diabetes	2011	43
21978918	D-Glucose	Qin Z	The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.	Atherosclerosis	2012	62
22021391	D-Glucose	Bailey-Downs LC	Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	54
22173866	D-Glucose	Borst O	Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX.	American journal of physiology. Cell physiology	2012	30
22215383	D-Glucose	Monami M	DPP-4 inhibitors and lipids: systematic review and meta-analysis.	Advances in therapy	2012	39
22226221	D-Glucose	Wronska A	Structural and biochemical characteristics of various white adipose tissue depots.	Acta physiologica	2012	64
22240132	D-Glucose	Matsubara J	A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.	Journal of the American College of Cardiology	2012	68
22307032	D-Glucose	Liu J	Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.	Gastroenterology	2012	45
22315324	D-Glucose	Santulli G	Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor.	Diabetes	2012	35
22322078	D-Glucose	Grundy SM	Pre-diabetes, metabolic syndrome, and cardiovascular risk.	Journal of the American College of Cardiology	2012	101
22323472	D-Glucose	Ussher JR	Cardiovascular biology of the incretin system.	Endocrine reviews	2012	109
22330739	D-Glucose	Tiano JP	Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.	Nature reviews. Endocrinology	2012	41
22344039	D-Glucose	Fraser A	Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.	Circulation	2012	59
22374636	D-Glucose	Dunstan DW	Breaking up prolonged sitting reduces postprandial glucose and insulin responses.	Diabetes care	2012	191
22427379	D-Glucose	Greco S	MicroRNA dysregulation in diabetic ischemic heart failure patients.	Diabetes	2012	58
22461740	D-Glucose	Go GW	Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis.	The Yale journal of biology and medicine	2012	33
22496159	D-Glucose	Cheng S	Metabolite profiling identifies pathways associated with metabolic risk in humans.	Circulation	2012	116
22498478	D-Glucose	Kobayashi S	Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury.	Autophagy	2012	31
22520962	D-Glucose	Patwari P	An expanded family of arrestins regulate metabolism.	Trends in endocrinology and metabolism	2012	31
22550135	D-Glucose	Porez G	Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.	Journal of lipid research	2012	47
22572877	D-Glucose	Cani PD	Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.	Gut microbes	2012	81
22614056	D-Glucose	Enhörning S	Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.	International journal of obesity	2013	26
22703861	D-Glucose	Patil HR	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.	The American journal of cardiology	2012	40
22738663	D-Glucose	Yan S	The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey.	Obesity reviews 	2012	47
22743373	D-Glucose	Ostrowski SR	Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.	The journal of trauma and acute care surgery	2012	44
22749178	D-Glucose	Bogdanski P	Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.	Nutrition research	2012	39
22776039	D-Glucose	Meloni AR	GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence.	Diabetes, obesity & metabolism	2013	28
22809513	D-Glucose	Zhang R	Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels.	Biochemical and biophysical research communications	2012	71
22820012	D-Glucose	Banks WA	Insulin in the brain: there and back again.	Pharmacology & therapeutics	2012	71
22858285	D-Glucose	Mehta NN	Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.	Atherosclerosis	2012	32
22876189	D-Glucose	Voight BF	The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits.	PLoS genetics	2012	208
22895668	D-Glucose	Abel ED	Insulin resistance: metabolic mechanisms and consequences in the heart.	Arteriosclerosis, thrombosis, and vascular biology	2012	39
22905670	D-Glucose	Santos FL	Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors.	Obesity reviews 	2012	34
22972646	D-Glucose	Lo RY	Vascular burden and Alzheimer disease pathologic progression.	Neurology	2012	50
22997257	D-Glucose	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	39
23023510	D-Glucose	Mineo C	Novel biological functions of high-density lipoprotein cholesterol.	Circulation research	2012	32
23048186	D-Glucose	Kievit P	Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.	Diabetes	2013	36
23062489	D-Glucose	Satoh-Asahara N	A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.	Metabolism	2013	29
23083681	D-Glucose	Zhong J	An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.	Atherosclerosis	2013	45
23129601	D-Glucose	Ridker PM	Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.	Circulation	2012	89
23144172	D-Glucose	Mocharla P	AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.	Blood	2013	37
23164767	D-Glucose	Jacobi J	Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.	Critical care medicine	2012	71
23201900	D-Glucose	Gut P	Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism.	Nature chemical biology	2013	42
23249272	D-Glucose	Passos-Silva DG	Angiotensin-(1-7): beyond the cardio-renal actions.	Clinical science	2013	37
23250986	D-Glucose	Spinetti G	Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway.	Circulation research	2013	25
23296071	D-Glucose	Scheen AJ	Cardiovascular effects of gliptins.	Nature reviews. Cardiology	2013	28
23303873	D-Glucose	Vulevic J	A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.	The Journal of nutrition	2013	39
23337530	D-Glucose	Ervinna N	Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.	Endocrinology	2013	40
23337953	D-Glucose	Stefan N	The role of hepatokines in metabolism.	Nature reviews. Endocrinology	2013	42
23356701	D-Glucose	Weiss R	What is metabolic syndrome, and why are children getting it?	Annals of the New York Academy of Sciences	2013	51
23369227	D-Glucose	Choi YK	Serum irisin levels in new-onset type 2 diabetes.	Diabetes research and clinical practice	2013	63
23370525	D-Glucose	Goldfine AB	A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.	Diabetologia	2013	34
23375680	D-Glucose	Barbieri M	Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.	Atherosclerosis	2013	29
23386232	D-Glucose	Matsubara J	Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.	Circulation journal 	2013	34
23431266	D-Glucose	Girousse A	Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.	PLoS biology	2013	41
23433305	D-Glucose	Wang B	Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.	Diabetes, obesity & metabolism	2013	31
23436032	D-Glucose	Xu YJ	Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.	Heart failure reviews	2014	20
23449634	D-Glucose	Rosenstock J	Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial.	Diabetes & vascular disease research	2013	30
23475142	D-Glucose	Gennuso KP	Sedentary behavior, physical activity, and markers of health in older adults.	Medicine and science in sports and exercise	2013	57
23509172	D-Glucose	Parkinson JR	Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis.	Pediatrics	2013	40
23516412	D-Glucose	de Bock M	Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial.	PloS one	2013	25
23561637	D-Glucose	Breslavsky A	Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.	Clinical nutrition	2013	28
23568441	D-Glucose	Berryman DE	The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.	Nature reviews. Endocrinology	2013	34
23584084	D-Glucose	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	93
23594109	D-Glucose	Monami M	Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2013	31
23636237	D-Glucose	Tanaka T	Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.	The American journal of clinical nutrition	2013	48
23651522	D-Glucose	Bueno NB	Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials.	The British journal of nutrition	2013	30
23680280	D-Glucose	Zhou JY	Neck circumference as an independent predictive contributor to cardio-metabolic syndrome.	Cardiovascular diabetology	2013	31
23733199	D-Glucose	Lazo M	NH2-terminal pro-brain natriuretic peptide and risk of diabetes.	Diabetes	2013	27
23746901	D-Glucose	Yang G	Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.	Lancet	2013	276
23781121	D-Glucose	Monsalve FA	Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.	Mediators of inflammation	2013	47
23781214	D-Glucose	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23823329	D-Glucose	Bouchonville M	Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.	International journal of obesity	2014	30
23852538	D-Glucose	Yao Y	A role for the endothelium in vascular calcification.	Circulation research	2013	44
23887638	D-Glucose	Chow WS	Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	32
23895803	D-Glucose	Neal B	Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial.	American heart journal	2013	72
23943882	D-Glucose	O'Carroll AM	The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.	The Journal of endocrinology	2013	37
24014835	D-Glucose	Jansen F	Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.	Circulation	2013	77
24041680	D-Glucose	Stahn A	Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias.	Diabetes care	2014	23
24057291	D-Glucose	Park KH	Circulating irisin in relation to insulin resistance and the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2013	61
24077098	D-Glucose	Erickson JR	Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.	Nature	2013	117
24167194	D-Glucose	Ekblom-Bak E	The importance of non-exercise physical activity for cardiovascular health and longevity.	British journal of sports medicine	2014	24
24169007	D-Glucose	Shechter M	Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease.	The American journal of cardiology	2014	22
24204837	D-Glucose	Alvarez ML	Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.	PloS one	2013	25
24284436	D-Glucose	Ley SH	Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women.	The American journal of clinical nutrition	2014	25
24296717	D-Glucose	Dimas AS	Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.	Diabetes	2014	80
24353182	D-Glucose	Cassuto J	Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.	Diabetes	2014	23
24356592	D-Glucose	Nathan DM	The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.	Diabetes care	2014	80
24411942	D-Glucose	Roberts LD	β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.	Cell metabolism	2014	75
24429158	D-Glucose	Aurora RN	Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association.	The Lancet. Respiratory medicine	2013	35
24462370	D-Glucose	Holmes MV	Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.	American journal of human genetics	2014	42
24475922	D-Glucose	Cherney DZ	The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.	Cardiovascular diabetology	2014	58
24558077	D-Glucose	Bakris GL	Microalbuminuria as a risk predictor in diabetes: the continuing saga.	Diabetes care	2014	22
24577463	D-Glucose	Ng TP	Long-term metformin usage and cognitive function among older adults with diabetes.	Journal of Alzheimer's disease 	2014	22
24622715	D-Glucose	Preiss D	Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.	The lancet. Diabetes & endocrinology	2014	22
24631482	D-Glucose	Oliva RV	Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors.	Journal of the American Society of Hypertension 	2014	38
24668104	D-Glucose	Emerging Risk Factors Collaboration.	Glycated hemoglobin measurement and prediction of cardiovascular disease.	JAMA	2014	35
24699409	D-Glucose	Prokopenko I	A central role for GRB10 in regulation of islet function in man.	PLoS genetics	2014	28
24723555	D-Glucose	Gaens KH	Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.	Arteriosclerosis, thrombosis, and vascular biology	2014	25
24731669	D-Glucose	Yki-Järvinen H	Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.	The lancet. Diabetes & endocrinology	2014	83
24732719	D-Glucose	Carson V	Patterns of sedentary time and cardiometabolic risk among Canadian adults.	Preventive medicine	2014	33
24750644	D-Glucose	Wu S	Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants.	Cardiovascular therapeutics	2014	29
24757202	D-Glucose	Chow E	Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.	Diabetes	2014	50
24781596	D-Glucose	Paneni F	Insulin resistance, diabetes, and cardiovascular risk.	Current atherosclerosis reports	2014	23
24855202	D-Glucose	Ussher JR	Cardiovascular actions of incretin-based therapies.	Circulation research	2014	44
24898304	D-Glucose	Ahrén B	HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.	Diabetes care	2014	46
24899464	D-Glucose	Halperin F	Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.	JAMA surgery	2014	40
24943000	D-Glucose	Zinman B	Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).	Cardiovascular diabetology	2014	23
25035342	D-Glucose	Lim S	Links between ectopic fat and vascular disease in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	32
25062042	D-Glucose	Arnold N	Regulation of cardiac expression of the diabetic marker microRNA miR-29.	PloS one	2014	21
25074318	D-Glucose	Nakamura K	DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.	Cardiovascular diabetology	2014	27
25102180	D-Glucose	Ng MC	Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.	PLoS genetics	2014	46
25111123	D-Glucose	Jin R	Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.	Nutrients	2014	22
25212743	D-Glucose	Zhang R	A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy.	Cardiovascular diabetology	2014	22
25242225	D-Glucose	Soccio RE	Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.	Cell metabolism	2014	52
25249673	D-Glucose	Avogaro A	The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.	Diabetes care	2014	25
25262344	D-Glucose	Swerdlow DI	HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.	Lancet	2015	82
25287289	D-Glucose	Frier BM	Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.	Nature reviews. Endocrinology	2014	35
25288136	D-Glucose	Coffee and Caffeine Genetics Consortium.	Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.	Molecular psychiatry	2015	24
25304002	D-Glucose	Vrhovac I	Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.	Pflugers Archiv 	2015	23
25324472	D-Glucose	Olivieri F	Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells.	Aging	2014	22
25325735	D-Glucose	Balestrieri ML	Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment.	Diabetes	2015	22
25329075	D-Glucose	Rangasamy S	Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.	PloS one	2014	24
25336635	D-Glucose	Marsh SA	Protein O-GlcNAcylation and cardiovascular (patho)physiology.	The Journal of biological chemistry	2014	22
25341005	D-Glucose	Vallon V	The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.	Annual review of medicine	2015	25
25352637	D-Glucose	Fuster JJ	Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.	Diabetes	2015	24
25387570	D-Glucose	Menegazzo L	NETosis is induced by high glucose and associated with type 2 diabetes.	Acta diabetologica	2015	17
25421524	D-Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25456737	D-Glucose	Foretz M	Metformin: from mechanisms of action to therapies.	Cell metabolism	2014	110
25457209	D-Glucose	Zhou Y	Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.	Journal of hepatology	2015	16
25476696	D-Glucose	Everard A	Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.	Nature communications	2014	42
25497344	D-Glucose	Blüher M	From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.	Metabolism	2015	46
25528528	D-Glucose	Savarese G	Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis.	International journal of cardiology	2015	19
25561694	D-Glucose	Veerbeek JH	Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension.	Hypertension	2015	17
25589482	D-Glucose	Inzucchi SE	SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.	Diabetes & vascular disease research	2015	58
25625282	D-Glucose	Mahajan A	Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.	PLoS genetics	2015	33
25631608	D-Glucose	Wessel J	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Nature communications	2015	44
25713189	D-Glucose	Nolan CJ	Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.	Diabetes	2015	20
25733469	D-Glucose	van Bussel BC	A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease.	The Journal of nutrition	2015	16
25825943	D-Glucose	Schwarz JM	Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.	The Journal of clinical endocrinology and metabolism	2015	25
25892112	D-Glucose	Mlynarski EE	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.	American journal of human genetics	2015	21
25908766	D-Glucose	Akinkuolie AO	Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.	Arteriosclerosis, thrombosis, and vascular biology	2015	16
25934864	D-Glucose	Dower JI	Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial.	The American journal of clinical nutrition	2015	20
26063450	D-Glucose	Ferrannini E	Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.	European heart journal	2015	26
26067718	D-Glucose	Pivonello R	The Treatment of Cushing's Disease.	Endocrine reviews	2015	24
26112890	D-Glucose	Fadini GP	Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database.	European heart journal	2015	21
26207054	D-Glucose	Hirsch IB	Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!	Diabetes care	2015	16
26369473	D-Glucose	Mingrone G	Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.	Lancet	2015	62
26386349	D-Glucose	Munasinghe PE	Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway.	International journal of cardiology	2016	12
26437782	D-Glucose	Hochhaus A	Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.	Leukemia	2016	14
26461112	D-Glucose	Chastin SF	Combined Effects of Time Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity and Cardio-Metabolic Health Markers: A Novel Compositional Data Analysis Approach.	PloS one	2015	42
26489970	D-Glucose	Nauck M	Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.	Diabetes, obesity & metabolism	2016	23
26556368	D-Glucose	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26563978	D-Glucose	Allen DB	GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.	European journal of endocrinology	2016	18
26628415	D-Glucose	Henson J	Breaking Up Prolonged Sitting With Standing or Walking Attenuates the Postprandial Metabolic Response in Postmenopausal Women: A Randomized Acute Study.	Diabetes care	2016	21
26628419	D-Glucose	Mita T	Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).	Diabetes care	2016	21
26643952	D-Glucose	Soriano-Tárraga C	Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.	Human molecular genetics	2016	17
26683796	D-Glucose	Mishra AK	Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota.	Metabolism	2016	15
26689977	D-Glucose	Lawman HG	Associations of Relative Handgrip Strength and Cardiovascular Disease Biomarkers in U.S. Adults, 2011-2012.	American journal of preventive medicine	2016	14
26694027	D-Glucose	Bennett BJ	Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.	PLoS genetics	2015	17
26721390	D-Glucose	Lin AL	Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2017	12
26733412	D-Glucose	Aguirre GA	Insulin-like growth factor-1 deficiency and metabolic syndrome.	Journal of translational medicine	2016	23
26822324	D-Glucose	Mita T	Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.	Diabetes care	2016	24
26912151	D-Glucose	Kim SH	Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders.	Diabetes & metabolism journal	2016	20
26951205	D-Glucose	Lockyer S	Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial.	European journal of nutrition	2017	7
26959184	D-Glucose	Talukdar S	A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.	Cell metabolism	2016	25
26975935	D-Glucose	Ashwell M	Waist-to-height ratio as an indicator of 'early health risk': simpler and more predictive than using a 'matrix' based on BMI and waist circumference.	BMJ open	2016	15
26993047	D-Glucose	Wang ZV	Adiponectin, the past two decades.	Journal of molecular cell biology	2016	18
27002059	D-Glucose	Steven S	Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.	Diabetes care	2016	12
27034277	D-Glucose	Riehle C	Insulin Signaling and Heart Failure.	Circulation research	2016	19
27040154	D-Glucose	de Courten B	Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial.	Obesity	2016	12
27099265	D-Glucose	Willeit P	Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?	European heart journal	2016	11
27144581	D-Glucose	Bonnefont-Rousselot D	Resveratrol and Cardiovascular Diseases.	Nutrients	2016	18
27165273	D-Glucose	Cardinali DP	Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies.	Neuroendocrinology	2017	7
27196572	D-Glucose	Duparc T	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.	Gut	2017	14
27207552	D-Glucose	Xue M	Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.	Diabetes	2016	19
27322064	D-Glucose	Volkov P	A Genome-Wide mQTL Analysis in Human Adipose Tissue Identifies Genetic Variants Associated with DNA Methylation, Gene Expression and Metabolic Traits.	PloS one	2016	11
27345422	D-Glucose	Drucker DJ	The Cardiovascular Biology of Glucagon-like Peptide-1.	Cell metabolism	2016	25
27347932	D-Glucose	Laganà AS	Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.	International journal of molecular sciences	2016	12
27409811	D-Glucose	Pedersen HK	Human gut microbes impact host serum metabolome and insulin sensitivity.	Nature	2016	63
27434443	D-Glucose	Palmer SC	Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.	JAMA	2016	34
27473078	D-Glucose	Polak K	New markers of insulin resistance in polycystic ovary syndrome.	Journal of endocrinological investigation	2017	6
27500523	D-Glucose	Zhou K	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.	Nature genetics	2016	13
27514514	D-Glucose	Avogaro A	Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice.	Cardiovascular diabetology	2016	11
27532830	D-Glucose	Stewart ZA	Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.	The New England journal of medicine	2016	10
27745828	D-Glucose	Rehman MB	Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.	Diabetes & metabolism	2017	5
27796346	D-Glucose	Li X	lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.	Scientific reports	2016	11
27908689	D-Glucose	Schmidt AF	PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2017	23
27935822	D-Glucose	Luo L	Adipose tissue in control of metabolism.	The Journal of endocrinology	2016	16
27959767	D-Glucose	Ference BA	Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.	The New England journal of medicine	2016	41
28039838	D-Glucose	Gómez-Sámano MÁ	Fibroblast growth factor 21 and its novel association with oxidative stress.	Redox biology	2017	7
28053201	D-Glucose	Noakes TD	Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review.	British journal of sports medicine	2017	5
28065883	D-Glucose	Rawal S	Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.	Cardiovascular research	2017	7
28095040	D-Glucose	Garber AJ	CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.	Endocrine practice 	2017	42
28120497	D-Glucose	Neal B	Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.	Diabetes, obesity & metabolism	2017	12
28208791	D-Glucose	Menezes R	Impact of Flavonols on Cardiometabolic Biomarkers:  A Meta-Analysis of Randomized Controlled Human  Trials to Explore the Role of Inter-Individual  Variability.	Nutrients	2017	7
28209220	D-Glucose	Pechlaner R	Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.	Journal of the American College of Cardiology	2017	7
28231835	D-Glucose	Dei Cas A	Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.	Cardiovascular diabetology	2017	6
28270201	D-Glucose	Nagy R	Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants.	Genome medicine	2017	5
28293093	D-Glucose	Rinaldi L	Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.	World journal of gastroenterology	2017	5
28314735	D-Glucose	Adams LA	Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.	Gut	2017	12
28533672	D-Glucose	Gelli C	Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.	World journal of gastroenterology	2017	5
2889967	Aspirin	Radomski MW	Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.	Lancet	1987	179
9077376	Aspirin	Ridker PM	Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.	The New England journal of medicine	1997	556
9630216	Aspirin	Tsujii M	Cyclooxygenase regulates angiogenesis induced by colon cancer cells.	Cell	1998	347
9989963	Aspirin	de Lorgeril M	Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.	Circulation	1999	261
11282915	Aspirin	Ridker PM	High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.	Circulation	2001	149
11434828	Aspirin	Albert MA	Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.	JAMA	2001	189
11679405	Aspirin	Blake GJ	Novel clinical markers of vascular wall inflammation.	Circulation research	2001	96
12192226	Aspirin	Ford ES	Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.	Epidemiology	2002	88
12588269	Aspirin	Lincoff AM	Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.	JAMA	2003	95
12853707	Aspirin	Hemker HC	Calibrated automated thrombin generation measurement in clotting plasma.	Pathophysiology of haemostasis and thrombosis	2003	152
15677512	Aspirin	Schulze MB	Adiponectin and future coronary heart disease events among men with type 2 diabetes.	Diabetes	2005	69
15947398	Aspirin	Hippisley-Cox J	Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.	BMJ	2005	87
16118353	Aspirin	Wang D	Prostaglandins and cancer.	Gut	2006	181
16491072	Aspirin	Ulrich CM	Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.	Nature reviews. Cancer	2006	161
16612330	Aspirin	Parving HH	Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.	Kidney international	2006	71
16943400	Aspirin	Bertagnolli MM	Celecoxib for the prevention of sporadic colorectal adenomas.	The New England journal of medicine	2006	278
16943401	Aspirin	Arber N	Celecoxib for the prevention of colorectal adenomatous polyps.	The New England journal of medicine	2006	231
17087947	Aspirin	Baron JA	A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.	Gastroenterology	2006	106
17124018	Aspirin	Stone GW	Bivalirudin for patients with acute coronary syndromes.	The New England journal of medicine	2006	118
17546309	Aspirin	Mendis S	The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.	Bulletin of the World Health Organization	2007	85
18574280	Aspirin	Bates SM	Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).	Chest	2008	67
18832751	Aspirin	Shaw JA	Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.	Circulation research	2008	68
19108880	Aspirin	Collet JP	Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.	Lancet	2009	135
19203472	Aspirin	Rao P	Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.	Journal of pharmacy & pharmaceutical sciences 	2008	70
19470889	Aspirin	APPRAISE Steering Committee and Investigators.	Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.	Circulation	2009	51
20079528	Aspirin	Cannon CP	Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.	Lancet	2010	60
20227026	Aspirin	Sostres C	Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.	Best practice & research. Clinical gastroenterology	2010	50
20828644	Aspirin	Bonello L	Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.	Journal of the American College of Cardiology	2010	100
22932716	Aspirin	Scirica BM	Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.	Lancet	2012	32
23121439	Aspirin	Collet JP	Bedside monitoring to adjust antiplatelet therapy for coronary stenting.	The New England journal of medicine	2012	75
23283721	Aspirin	Willeit P	Circulating microRNAs as novel biomarkers for platelet activation.	Circulation research	2013	57
23470494	Aspirin	Oldgren J	New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis.	European heart journal	2013	32
23792451	Aspirin	Ogino S	Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.	Oncogene	2014	43
23890998	Aspirin	Stone GW	Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.	Lancet	2013	46
24315894	Aspirin	Goodman SG	Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).	Journal of the American College of Cardiology	2014	22
25263946	Aspirin	Patrignani P	Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.	Biochimica et biophysica acta	2015	20
25467565	Aspirin	Elmariah S	Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.	Lancet	2015	26
25773268	Aspirin	Bonaca MP	Long-term use of ticagrelor in patients with prior myocardial infarction.	The New England journal of medicine	2015	79
25776112	Aspirin	Solomon DH	Disease activity in rheumatoid arthritis and the risk of cardiovascular events.	Arthritis & rheumatology	2015	26
26324537	Aspirin	Udell JA	Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.	European heart journal	2016	25
26719230	Aspirin	Zalcman G	Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.	Lancet	2016	63
27892890	Aspirin	Windecker S	Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.	American heart journal	2017	7
27959713	Aspirin	Gibson CM	Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.	The New England journal of medicine	2016	25
28079976	Aspirin	Lannan KL	Maresin 1 induces a novel pro-resolving phenotype in human platelets.	Journal of thrombosis and haemostasis 	2017	7
1654338	L-Cysteine	Bradham DM	Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.	The Journal of cell biology	1991	141
9600969	L-Cysteine	Babic AM	CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	1998	113
9691094	L-Cysteine	Sukhova GK	Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.	The Journal of clinical investigation	1998	130
10027396	L-Cysteine	Nör JE	Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.	The American journal of pathology	1999	129
10728374	L-Cysteine	Saraste A	Morphologic and biochemical hallmarks of apoptosis.	Cardiovascular research	2000	147
11714645	L-Cysteine	Rabkin E	Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.	Circulation	2001	148
11728344	L-Cysteine	Wiley SR	A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.	Immunity	2001	91
12235282	L-Cysteine	Baker AH	Metalloproteinase inhibitors: biological actions and therapeutic opportunities.	Journal of cell science	2002	213
12639996	L-Cysteine	Sukhova GK	Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.	The Journal of clinical investigation	2003	94
14567912	L-Cysteine	Matsushita K	Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor.	Cell	2003	165
14581476	L-Cysteine	Cirman T	Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.	The Journal of biological chemistry	2004	97
15178558	L-Cysteine	Liu J	Lysosomal cysteine proteases in atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2004	83
16469948	L-Cysteine	van Hinsbergh VW	Pericellular proteases in angiogenesis and vasculogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2006	84
17185628	L-Cysteine	Pan S	Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway.	Circulation research	2007	59
17420353	L-Cysteine	Jaffer FA	Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.	Circulation	2007	76
18508595	L-Cysteine	Turk V	Cystatins: biochemical and structural properties, and medical relevance.	Frontiers in bioscience 	2008	61
19065049	L-Cysteine	Park YM	CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.	The Journal of clinical investigation	2009	118
19539236	L-Cysteine	Chabriat H	Cadasil.	The Lancet. Neurology	2009	135
20191298	L-Cysteine	Kimura H	Hydrogen sulfide: its production, release and functions.	Amino acids	2011	105
20213804	L-Cysteine	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	57
20694660	L-Cysteine	Giudice A	Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.	Methods in molecular biology	2010	51
22158710	L-Cysteine	Zhang DX	H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation.	Circulation research	2012	51
22535894	L-Cysteine	Frangogiannis NG	Matricellular proteins in cardiac adaptation and disease.	Physiological reviews	2012	114
22581845	L-Cysteine	Smith MA	Calpains, mitochondria, and apoptosis.	Cardiovascular research	2012	46
23174564	L-Cysteine	Goldsmith EC	Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression.	American journal of physiology. Cell physiology	2013	35
23219527	L-Cysteine	Bryan HK	The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation.	Biochemical pharmacology	2013	159
23581969	L-Cysteine	Kimura H	Production and physiological effects of hydrogen sulfide.	Antioxidants & redox signaling	2014	41
24577967	L-Cysteine	Rienks M	Myocardial extracellular matrix: an ever-changing and diverse entity.	Circulation research	2014	26
24630725	L-Cysteine	Alegre-Cebollada J	S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding.	Cell	2014	36
25288605	L-Cysteine	Fresquet M	Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.	Journal of the American Society of Nephrology 	2015	34
26668317	L-Cysteine	Noy PJ	TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.	The Journal of biological chemistry	2016	13
27650695	L-Cysteine	Pla D	Proteomics and antivenomics of Papuan black snake (Pseudechis papuanus) venom with analysis of its toxicological profile and the preclinical efficacy of Australian antivenoms.	Journal of proteomics	2017	5
15315818	24,25-Dihydroxyvitamin D	Uitterlinden AG	Genetics and biology of vitamin D receptor polymorphisms.	Gene	2004	229
16197570	24,25-Dihydroxyvitamin D	Zittermann A	Putting cardiovascular disease and vitamin D insufficiency into perspective.	The British journal of nutrition	2005	75
16316359	24,25-Dihydroxyvitamin D	Agarwal R	Antiproteinuric effect of oral paricalcitol in chronic kidney disease.	Kidney international	2005	91
17082756	24,25-Dihydroxyvitamin D	Chonchol M	25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey.	Kidney international	2007	64
18180395	24,25-Dihydroxyvitamin D	Wang TJ	Vitamin D deficiency and risk of cardiovascular disease.	Circulation	2008	521
19559169	24,25-Dihydroxyvitamin D	Wilhelm-Leen ER	Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey.	The American journal of medicine	2009	71
20515678	24,25-Dihydroxyvitamin D	Tomaschitz A	Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.	Clinica chimica acta; international journal of clinical chemistry	2010	49
21115878	24,25-Dihydroxyvitamin D	Jablonski KL	25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults.	Hypertension	2011	87
21325459	24,25-Dihydroxyvitamin D	Yiu YF	Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	35
21939825	24,25-Dihydroxyvitamin D	Kestenbaum B	Vitamin D, parathyroid hormone, and cardiovascular events among older adults.	Journal of the American College of Cardiology	2011	59
21947295	24,25-Dihydroxyvitamin D	Chen S	Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.	Circulation	2011	63
21996139	24,25-Dihydroxyvitamin D	Amer M	Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006).	The American journal of cardiology	2012	44
22261577	24,25-Dihydroxyvitamin D	Michos ED	25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files.	Nutrition	2012	35
22283597	24,25-Dihydroxyvitamin D	Wang L	Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials.	American journal of cardiovascular drugs 	2012	30
22337679	24,25-Dihydroxyvitamin D	Thadhani R	Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.	JAMA	2012	97
22492635	24,25-Dihydroxyvitamin D	Lim K	Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.	Circulation	2012	102
22596255	24,25-Dihydroxyvitamin D	Rosen CJ	The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.	Endocrine reviews	2012	115
22703926	24,25-Dihydroxyvitamin D	Ix JH	Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).	Journal of the American College of Cardiology	2012	86
23150009	24,25-Dihydroxyvitamin D	Levin GP	Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.	JAMA	2012	48
24974252	24,25-Dihydroxyvitamin D	Vimaleswaran KS	Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2014	48
25406188	24,25-Dihydroxyvitamin D	Afzal S	Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts.	BMJ	2014	40
25813139	24,25-Dihydroxyvitamin D	Prasad P	Interplay of vitamin D and metabolic syndrome: A review.	Diabetes & metabolic syndrome	2016	16
26000280	24,25-Dihydroxyvitamin D	Mozos I	Links between Vitamin D Deficiency and Cardiovascular Diseases.	BioMed research international	2015	22
26322175	24,25-Dihydroxyvitamin D	Husain K	Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.	World journal of biological chemistry	2015	22
10675071	Alpha-Tocopherol	-	Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.	Lancet	2000	337
11997274	Alpha-Tocopherol	Marchioli R	Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.	Circulation	2002	171
12668514	Alpha-Tocopherol	Takahashi T	Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes.	Circulation	2003	97
12788804	Alpha-Tocopherol	Rigotti A	The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.	Endocrine reviews	2003	109
18032779	Alpha-Tocopherol	Milman U	Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.	Arteriosclerosis, thrombosis, and vascular biology	2008	78
19158321	Alpha-Tocopherol	Iqbal J	Intestinal lipid absorption.	American journal of physiology. Endocrinology and metabolism	2009	109
20181810	Alpha-Tocopherol	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	45
22326434	Alpha-Tocopherol	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
23363012	Alpha-Tocopherol	Masuoka HC	Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.	Annals of the New York Academy of Sciences	2013	50
7929268	Heparin	Park JE	Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.	The Journal of biological chemistry	1994	155
8167412	Heparin	Park JE	The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.	Molecular biology of the cell	1993	188
9354625	Heparin	Hoogewerf AJ	Glycosaminoglycans mediate cell surface oligomerization of chemokines.	Biochemistry	1997	124
12241831	Heparin	Fox KA	Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.	Lancet	2002	82
12697737	Heparin	Manuelian T	Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.	The Journal of clinical investigation	2003	91
16816121	Heparin	Kärpänen T	Functional interaction of VEGF-C and VEGF-D with neuropilin receptors.	FASEB journal 	2006	80
25002178	Heparin	Shahzad A	Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.	Lancet	2014	45
25775052	Heparin	Han Y	Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.	JAMA	2015	22
27573206	Heparin	Connolly SJ	Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.	The New England journal of medicine	2016	44
8626565	Sulfate	Whitelock JM	The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.	The Journal of biological chemistry	1996	124
12435733	Sulfate	Mongiat M	Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan.	The Journal of biological chemistry	2003	84
14623248	Sulfate	Darland DC	Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival.	Developmental biology	2003	104
15687490	Sulfate	Richard JP	Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.	The Journal of biological chemistry	2005	110
17923576	Sulfate	Rehm M	Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.	Circulation	2007	107
19008778	Sulfate	Arumugam TV	Toll-like receptors in ischemia-reperfusion injury.	Shock	2009	79
20097882	Sulfate	Purushothaman A	Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.	Blood	2010	80
22410250	Sulfate	Miner JH	The glomerular basement membrane.	Experimental cell research	2012	45
22456598	Sulfate	Lepeule J	Chronic exposure to fine particles and mortality: an extended follow-up of the Harvard Six Cities study from 1974 to 2009.	Environmental health perspectives	2012	90
23665161	Sulfate	Hendriksz CJ	Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.	Molecular genetics and metabolism	2013	28
25282103	Sulfate	Wood AR	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nature genetics	2014	348
25889764	Sulfate	Rahbar E	Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients.	Journal of translational medicine	2015	22
25979432	Sulfate	Marki A	Role of the endothelial surface layer in neutrophil recruitment.	Journal of leukocyte biology	2015	20
15194177	Uric acid	Barst RJ	Diagnosis and differential assessment of pulmonary arterial hypertension.	Journal of the American College of Cardiology	2004	120
16041161	Uric acid	Yoo TW	Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.	Circulation journal 	2005	67
17701281	Uric acid	Kanbay M	Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.	International urology and nephrology	2007	73
19503597	Uric acid	Kolz M	Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.	PLoS genetics	2009	180
19565556	Uric acid	Kim SY	Hyperuricemia and risk of stroke: a systematic review and meta-analysis.	Arthritis and rheumatism	2009	78
20191515	Uric acid	Kim SY	Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.	Arthritis care & research	2010	110
20538833	Uric acid	Goicoechea M	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.	Clinical journal of the American Society of Nephrology 	2010	136
23062212	Uric acid	Gurka MJ	A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences.	Cardiovascular diabetology	2012	35
25595565	Uric acid	Goicoechea M	Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.	American journal of kidney diseases 	2015	38
25928556	Uric acid	Kanji T	Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.	BMC nephrology	2015	18
26316329	Uric acid	Maiuolo J	Regulation of uric acid metabolism and excretion.	International journal of cardiology	2016	19
26816492	Uric acid	Srikanthan K	Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.	International journal of medical sciences	2016	20
12764219	Cortisol	Schommer NC	Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress.	Psychosomatic medicine	2003	81
12845411	Cortisol	Sinha R	Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.	Psychopharmacology	2003	103
15041083	Cortisol	Steptoe A	Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middle-aged men and women.	Psychoneuroendocrinology	2004	91
15554887	Cortisol	Seckl JR	Prenatal glucocorticoids and long-term programming.	European journal of endocrinology	2004	113
15677396	Cortisol	Seckl JR	Glucocorticoid programming.	Annals of the New York Academy of Sciences	2004	113
15705924	Cortisol	Alesci S	Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.	The Journal of clinical endocrinology and metabolism	2005	75
15718497	Cortisol	Jaffe IZ	Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.	Circulation research	2005	81
15840727	Cortisol	Steptoe A	Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes.	Proceedings of the National Academy of Sciences of the United States of America	2005	115
16002223	Cortisol	Nater UM	Stress-induced changes in human salivary alpha-amylase activity -- associations with adrenergic activity.	Psychoneuroendocrinology	2006	76
16781084	Cortisol	Black PH	The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.	Medical hypotheses	2006	62
17536998	Cortisol	Jansson T	Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.	Clinical science	2007	93
17716366	Cortisol	Jeschke MG	Burn size determines the inflammatory and hypermetabolic response.	Critical care	2007	61
18222063	Cortisol	Choi J	Reduced telomerase activity in human T lymphocytes exposed to cortisol.	Brain, behavior, and immunity	2008	74
18258663	Cortisol	Förster C	Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.	The Journal of physiology	2008	66
18467630	Cortisol	Caprio M	Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion.	Circulation research	2008	61
19144222	Cortisol	Stroud LR	Stress response and the adolescent transition: performance versus peer rejection stressors.	Development and psychopathology	2009	129
19703817	Cortisol	Dünser MW	Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress.	Journal of intensive care medicine	2009	60
19796062	Cortisol	Steptoe A	Positive affect and psychobiological processes relevant to health.	Journal of personality	2009	75
22146091	Cortisol	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	49
22275527	Cortisol	Boulkroun S	Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.	Hypertension	2012	36
22998948	Cortisol	Reynolds RM	Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.	Psychoneuroendocrinology	2013	59
23735216	Cortisol	Lee MJ	Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.	Biochimica et biophysica acta	2014	44
24616496	Cortisol	Zalli A	Shorter telomeres with high telomerase activity are associated with raised allostatic load and impoverished psychosocial resources.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
27468060	Cortisol	Kühnen P	Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist.	The New England journal of medicine	2016	18
28364485	Cortisol	Li Y	Objective, but Not Subjective, Sleepiness is Associated With Inflammation in Sleep Apnea.	Sleep	2017	8
2472431	Histamine	McEver RP	GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.	The Journal of clinical investigation	1989	165
7673356	Histamine	Roberts WG	Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.	Journal of cell science	1995	174
9580552	Histamine	García-Cardeña G	Dynamic activation of endothelial nitric oxide synthase by Hsp90.	Nature	1998	200
10051240	Histamine	Salvi S	Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers.	American journal of respiratory and critical care medicine	1999	174
11257000	Histamine	Wójciak-Stothard B	Rho and Rac but not Cdc42 regulate endothelial cell permeability.	Journal of cell science	2001	133
23169049	Histamine	Orsenigo F	Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo.	Nature communications	2012	91
23490289	Histamine	Kounis NG	Coronary hypersensitivity disorder: the Kounis syndrome.	Clinical therapeutics	2013	29
25958181	Histamine	Caughey GH	Mast cell proteases as pharmacological targets.	European journal of pharmacology	2016	10
10484602	Ethanol	Ntambi JM	Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.	Journal of lipid research	1999	101
11466099	Ethanol	Pradhan AD	C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.	JAMA	2001	749
11864854	Ethanol	Liu S	Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.	The American journal of clinical nutrition	2002	96
15082700	Ethanol	Pischon T	Plasma adiponectin levels and risk of myocardial infarction in men.	JAMA	2004	314
15113816	Ethanol	Meigs JB	Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.	JAMA	2004	142
15364185	Ethanol	Yusuf S	Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.	Lancet	2004	1464
15447916	Ethanol	Lopez-Garcia E	Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2004	151
15699277	Ethanol	Oei HH	Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.	Circulation	2005	84
15735094	Ethanol	Lopez-Garcia E	Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.	The Journal of nutrition	2005	70
15767524	Ethanol	Margolis KL	Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.	Archives of internal medicine	2005	69
15827312	Ethanol	Shlipak MG	Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.	JAMA	2005	162
16002815	Ethanol	Fung TT	Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2005	135
16489089	Ethanol	Desai N	Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.	Clinical cancer research 	2006	196
16738067	Ethanol	McDade TW	Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study.	Psychosomatic medicine	2006	101
17021763	Ethanol	Sommer DM	Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.	Archives of dermatological research	2006	92
17255528	Ethanol	Bogdarina I	Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension.	Circulation research	2007	101
17846344	Ethanol	Kloner RA	To drink or not to drink? That is the question.	Circulation	2007	59
18203129	Ethanol	Jofre-Monseny L	Impact of apoE genotype on oxidative stress, inflammation and disease risk.	Molecular nutrition & food research	2008	73
18414631	Ethanol	Auchincloss AH	Associations between recent exposure to ambient fine particulate matter and blood pressure in the Multi-ethnic Study of Atherosclerosis (MESA).	Environmental health perspectives	2008	90
18427559	Ethanol	Grant BF	Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.	Molecular psychiatry	2009	221
18510434	Ethanol	Swarbrick MM	Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.	Metabolic syndrome and related disorders	2008	67
19029462	Ethanol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19168210	Ethanol	Schuckit MA	Alcohol-use disorders.	Lancet	2009	89
19802349	Ethanol	Finkelstein J	Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.	International journal of chronic obstructive pulmonary disease	2009	48
19853041	Ethanol	Flöel A	Physical activity and memory functions: are neurotrophins and cerebral gray matter volume the missing link?	NeuroImage	2010	53
20339361	Ethanol	Preis SR	Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.	Obesity	2010	85
20561675	Ethanol	O'Donnell MJ	Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.	Lancet	2010	439
20569726	Ethanol	Soliman EZ	Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).	American heart journal	2010	51
20576628	Ethanol	Wijndaele K	Television viewing time independently predicts all-cause and cardiovascular mortality: the EPIC Norfolk study.	International journal of epidemiology	2011	78
21091952	Ethanol	Kalaria RN	Vascular basis for brain degeneration: faltering controls and risk factors for dementia.	Nutrition reviews	2010	60
21093416	Ethanol	Costa LG	Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.	Biochemical pharmacology	2011	35
21343206	Ethanol	Brien SE	Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.	BMJ	2011	108
21533241	Ethanol	Gamble KL	Shift work in nurses: contribution of phenotypes and genotypes to adaptation.	PloS one	2011	35
21570529	Ethanol	Taylor EN	Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.	American heart journal	2011	37
23143785	Ethanol	Gupta SC	Therapeutic roles of curcumin: lessons learned from clinical trials.	The AAPS journal	2013	154
23666091	Ethanol	Gaggini M	Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.	Nutrients	2013	86
23670794	Ethanol	Martínez-Lapiscina EH	Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial.	Journal of neurology, neurosurgery, and psychiatry	2013	48
24382882	Ethanol	Chen CH	Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.	Physiological reviews	2014	62
24505082	Ethanol	Lloyd-Sherlock P	Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control.	International journal of epidemiology	2014	80
25011450	Ethanol	Holmes MV	Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.	BMJ	2014	89
25447616	Ethanol	Parthasarathy S	Persistent insomnia is associated with mortality risk.	The American journal of medicine	2015	23
25733647	Ethanol	Ekelund U	Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC).	The American journal of clinical nutrition	2015	54
25880521	Ethanol	Alexander BT	Fetal programming and cardiovascular pathology.	Comprehensive Physiology	2015	17
26025389	Ethanol	Saleheen D	Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.	The lancet. Diabetes & endocrinology	2015	65
26850495	Ethanol	Mancina RM	The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.	Gastroenterology	2016	26
27431356	Ethanol	O'Donnell MJ	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.	Lancet	2016	48
27843151	Ethanol	Liu C	A DNA methylation biomarker of alcohol consumption.	Molecular psychiatry	2018	14
28107775	Ethanol	Varga ZV	β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.	British journal of pharmacology	2018	6
28118842	Ethanol	Coleman LG Jr	Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7.	Journal of neuroinflammation	2017	10
9176490	Cisplatin	Heise C	ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.	Nature medicine	1997	133
20215556	Cisplatin	Sikora AG	Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.	Clinical cancer research 	2010	43
23816960	Cisplatin	Sequist LV	Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.	Journal of clinical oncology 	2013	472
24473399	Cisplatin	Kurokawa Y	Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1).	British journal of cancer	2014	26
25316259	Cisplatin	Yamada Y	Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.	Annals of oncology 	2015	37
25589191	Cisplatin	Yang JC	Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.	The Lancet. Oncology	2015	226
11778052	Sirolimus	Maeshima Y	Tumstatin, an endothelial cell-specific inhibitor of protein synthesis.	Science	2002	87
12039858	Sirolimus	Humar R	Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.	FASEB journal 	2002	89
14744976	Sirolimus	Virmani R	Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?	Circulation	2004	131
16075055	Sirolimus	Shiojima I	Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.	The Journal of clinical investigation	2005	271
16469695	Sirolimus	Wullschleger S	TOR signaling in growth and metabolism.	Cell	2006	1712
16904613	Sirolimus	Phung TL	Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.	Cancer cell	2006	152
17275731	Sirolimus	Tsang CK	Targeting mammalian target of rapamycin (mTOR) for health and diseases.	Drug discovery today	2007	109
18596087	Sirolimus	Wong J	Autophagosome supports coxsackievirus B3 replication in host cells.	Journal of virology	2008	118
18652940	Sirolimus	Joner M	Endothelial cell recovery between comparator polymer-based drug-eluting stents.	Journal of the American College of Cardiology	2008	82
19223493	Sirolimus	Yu G	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.	Clinical cancer research 	2009	51
19771169	Sirolimus	Balgi AD	Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.	PloS one	2009	113
21339483	Sirolimus	Grundmann S	MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells.	Circulation	2011	48
22545721	Sirolimus	Chong ZZ	Mammalian target of rapamycin signaling in diabetic cardiovascular disease.	Cardiovascular diabetology	2012	39
22622204	Sirolimus	Han J	Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage.	Autophagy	2012	38
23601105	Sirolimus	Chang HH	A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.	Cell host & microbe	2013	32
23686371	Sirolimus	Sen S	Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.	Journal of the American Heart Association	2013	33
23929677	Sirolimus	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	48
24077167	Sirolimus	Liu R	Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity.	Circulation	2013	29
24481845	Sirolimus	Sciarretta S	Mammalian target of rapamycin signaling in cardiac physiology and disease.	Circulation research	2014	87
24603327	Sirolimus	Ma J	Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor.	Cell death & disease	2014	21
24980430	Sirolimus	Peng N	An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E⁻/⁻ mice.	Scientific reports	2014	43
25110610	Sirolimus	Xu S	mTOR Signaling from Cellular Senescence to Organismal Aging.	Aging and disease	2014	23
25253086	Sirolimus	Jia G	Overnutrition, mTOR signaling, and cardiovascular diseases.	American journal of physiology. Regulatory, integrative and comparative physiology	2014	31
25394488	Sirolimus	Su M	MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis.	Cell death and differentiation	2015	21
25593290	Sirolimus	Ranchoux B	Endothelial-to-mesenchymal transition in pulmonary hypertension.	Circulation	2015	57
25787015	Sirolimus	Wang ZG	bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway.	Scientific reports	2015	20
26607973	Sirolimus	López-Lluch G	Calorie restriction as an intervention in ageing.	The Journal of physiology	2016	15
27098600	Sirolimus	Zou M	Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.	Scientific reports	2016	13
27723557	Sirolimus	Jackman CP	Dynamic culture yields engineered myocardium with near-adult functional output.	Biomaterials	2016	15
28007903	Sirolimus	Zhu P	Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.	Human molecular genetics	2017	6
28165011	Sirolimus	Palmieri M	mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases.	Nature communications	2017	11
28336668	Sirolimus	Castellano BM	Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.	Science	2017	17
12771008	Adenosine	Hachamovitch R	Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.	Circulation	2003	130
12838422	Adenosine	Baldwin SA	The equilibrative nucleoside transporter family, SLC29.	Pflugers Archiv 	2004	152
16631001	Adenosine	Klem I	Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.	Journal of the American College of Cardiology	2006	79
17077301	Adenosine	Kong T	HIF-dependent induction of adenosine A2B receptor in hypoxia.	FASEB journal 	2006	112
17541822	Adenosine	Hausenloy DJ	Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.	Heart failure reviews	2007	88
20505987	Adenosine	Yang X	Mechanism of cardioprotection by early ischemic preconditioning.	Cardiovascular drugs and therapy	2010	55
21371928	Adenosine	Markello TC	Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum.	Molecular genetics and metabolism	2011	40
24552284	Adenosine	Zhou Q	Early-onset stroke and vasculopathy associated with mutations in ADA2.	The New England journal of medicine	2014	47
25262373	Adenosine	Kim DG	A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability.	Molecular neurobiology	2015	15
25593060	Adenosine	Heusch G	Remote ischemic conditioning.	Journal of the American College of Cardiology	2015	69
25622143	Adenosine	Orr AG	Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory.	Nature neuroscience	2015	33
28235198	Adenosine	Glukhova A	Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity.	Cell	2017	7
11937178	Atenolol	Dahlöf B	Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.	Lancet	2002	460
15734615	Atenolol	Wachtell K	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.	Journal of the American College of Cardiology	2005	80
9030556	NADPH	Garvey EP	1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.	The Journal of biological chemistry	1997	155
18431508	NADPH	Sharma K	Adiponectin regulates albuminuria and podocyte function in mice.	The Journal of clinical investigation	2008	158
19237660	NADPH	Pierce GL	Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans.	Circulation	2009	66
19245678	NADPH	Rodríguez-Mañas L	Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation.	Aging cell	2009	46
20877715	NADPH	Kleinschnitz C	Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.	PLoS biology	2010	124
21294650	NADPH	Carrano A	Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.	Antioxidants & redox signaling	2011	51
21785215	NADPH	Swaminathan PD	Oxidized CaMKII causes cardiac sinus node dysfunction in mice.	The Journal of clinical investigation	2011	76
22124756	NADPH	Agarwal D	Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR.	Basic research in cardiology	2011	40
22284365	NADPH	Shiraki A	The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells.	Atherosclerosis	2012	34
23244617	NADPH	Mahmood DF	The thioredoxin system as a therapeutic target in human health and disease.	Antioxidants & redox signaling	2013	46
23466554	NADPH	Abdul-Muneer PM	Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast.	Free radical biology & medicine	2013	51
24494202	NADPH	Jiang F	NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses.	Redox biology	2014	33
24992685	NADPH	Rochfort KD	Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.	PloS one	2014	30
25326534	NADPH	Gano LB	The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice.	American journal of physiology. Heart and circulatory physiology	2014	25
25552596	NADPH	Antonopoulos AS	Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue.	Diabetes	2015	25
25655936	NADPH	Donato AJ	Cellular and molecular biology of aging endothelial cells.	Journal of molecular and cellular cardiology	2015	48
26551716	NADPH	Rochfort KD	The blood-brain barrier endothelium: a target for pro-inflammatory cytokines.	Biochemical Society transactions	2015	20
27821539	NADPH	Abbas M	Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways.	Circulation	2017	5
27986445	NADPH	Lozhkin A	NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis.	Journal of molecular and cellular cardiology	2017	5
28063251	NADPH	Nosalski R	Perivascular adipose tissue inflammation in vascular disease.	British journal of pharmacology	2017	9
10580070	Creatine	Fatkin D	Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.	The New England journal of medicine	1999	187
11524400	Creatine	Kamihata H	Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.	Circulation	2001	146
11535563	Creatine	Choi KM	Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.	Circulation	2001	87
12460879	Creatine	Weinberg EO	Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.	Circulation	2002	98
12672737	Creatine	Thompson PD	Statin-associated myopathy.	JAMA	2003	185
14573731	Creatine	Brennan ML	Prognostic value of myeloperoxidase in patients with chest pain.	The New England journal of medicine	2003	146
14662268	Creatine	Vatta M	Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.	Journal of the American College of Cardiology	2003	90
17394957	Creatine	Patti G	Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.	Journal of the American College of Cardiology	2007	64
17408535	Creatine	Ward S	A systematic review and economic evaluation of statins for the prevention of coronary events.	Health technology assessment	2007	68
19833260	Creatine	Voora D	The SLCO1B1*5 genetic variant is associated with statin-induced side effects.	Journal of the American College of Cardiology	2009	95
21642241	Creatine	Kuwabara Y	Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.	Circulation. Cardiovascular genetics	2011	110
22252325	Creatine	Devaux Y	Use of circulating microRNAs to diagnose acute myocardial infarction.	Clinical chemistry	2012	45
23547171	Creatine	Devaux Y	MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction.	Circulation. Cardiovascular genetics	2013	28
23868944	Creatine	Woo JS	Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.	Arteriosclerosis, thrombosis, and vascular biology	2013	31
23995691	Creatine	Mangravite LM	A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.	Nature	2013	50
25915661	Creatine	Navarese EP	Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.	Annals of internal medicine	2015	61
12193651	Sterol	Tangirala RK	Identification of macrophage liver X receptors as inhibitors of atherosclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2002	97
12543086	Sterol	Berridge MJ	The endoplasmic reticulum: a multifunctional signaling organelle.	Cell calcium	2002	196
16449388	Sterol	Cohen JC	Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.	Proceedings of the National Academy of Sciences of the United States of America	2006	141
19098903	Sterol	Bell RD	SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.	Nature cell biology	2009	89
20809793	Sterol	Jia L	Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.	Annual review of physiology	2011	37
21226579	Sterol	Vergeer M	Genetic variant of the scavenger receptor BI in humans.	The New England journal of medicine	2011	73
21548778	Sterol	Moore KJ	The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.	Annual review of nutrition	2011	41
22012398	Sterol	Rayner KJ	Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.	Nature	2011	214
22516720	Sterol	Georgiadi A	Mechanisms of gene regulation by fatty acids.	Advances in nutrition	2012	39
23973703	Sterol	Urban D	Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.	Journal of the American College of Cardiology	2013	37
24468148	Sterol	Gylling H	Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.	Atherosclerosis	2014	37
24657242	Sterol	Sirtori CR	The pharmacology of statins.	Pharmacological research	2014	25
25550450	Sterol	Chen Z	Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a.	Circulation	2015	31
25561459	Sterol	Kootte RS	Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.	Journal of lipid research	2015	16
28095459	Sterol	Mendelson MM	Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach.	PLoS medicine	2017	8
17101640	1,1-Dimethylbiguanide	Mazzone T	Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.	JAMA	2006	113
17638715	1,1-Dimethylbiguanide	Bolen S	Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.	Annals of internal medicine	2007	116
20357375	1,1-Dimethylbiguanide	Fadini GP	The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.	Diabetes care	2010	70
21403054	1,1-Dimethylbiguanide	Bennett WL	Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.	Annals of internal medicine	2011	96
21471135	1,1-Dimethylbiguanide	Schramm TK	Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.	European heart journal	2011	66
22748821	1,1-Dimethylbiguanide	Gallwitz B	2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.	Lancet	2012	78
26377054	1,1-Dimethylbiguanide	Diabetes Prevention Program Research Group.	Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.	The lancet. Diabetes & endocrinology	2015	47
26597596	1,1-Dimethylbiguanide	Deacon CF	Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.	Diabetes, obesity & metabolism	2016	13
26932742	1,1-Dimethylbiguanide	Ou HT	Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.	Cardiovascular diabetology	2016	14
27399082	1,1-Dimethylbiguanide	Ko SH	Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.	Medicine	2016	11
27935183	1,1-Dimethylbiguanide	Petrie JR	Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.	Diabetes, obesity & metabolism	2017	5
19054062	Phytonadione	Li Q	Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.	Experimental dermatology	2009	58
22169620	Phytonadione	Westenfeld R	Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.	American journal of kidney diseases 	2012	32
22433576	Phytonadione	Skanes AC	Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.	The Canadian journal of cardiology	2012	77
26330425	Phytonadione	Camm AJ	XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.	European heart journal	2016	35
1463530	Enalapril	SOLVD Investigators.	Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.	The New England journal of medicine	1992	243
15516696	Enalapril	Barnett AH	Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.	The New England journal of medicine	2004	112
23563576	Enalapril	McMurray JJ	Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).	European journal of heart failure	2013	29
25125488	Enalapril	Garg R	Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.	Diabetes	2015	20
25176015	Enalapril	McMurray JJ	Angiotensin-neprilysin inhibition versus enalapril in heart failure.	The New England journal of medicine	2014	243
25403646	Enalapril	Packer M	Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.	Circulation	2015	54
25771069	Enalapril	Huo Y	Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.	JAMA	2015	81
26754626	Enalapril	Kristensen SL	Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.	Circulation. Heart failure	2016	16
15302780	Losartan	de Zeeuw D	Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.	Circulation	2004	108
15547162	Losartan	Devereux RB	Prognostic significance of left ventricular mass change during treatment of hypertension.	JAMA	2004	111
17495027	Losartan	Ai D	Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2007	60
19153265	Losartan	Solomon SD	Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.	Circulation	2009	54
24206457	Losartan	Fried LF	Combined angiotensin inhibition for the treatment of diabetic nephropathy.	The New England journal of medicine	2013	121
24355923	Losartan	Gallo EM	Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.	The Journal of clinical investigation	2014	48
18378520	Ramipril	ONTARGET Investigators.	Telmisartan, ramipril, or both in patients at high risk for vascular events.	The New England journal of medicine	2008	443
18707986	Ramipril	Mann JF	Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.	Lancet	2008	252
11413075	Simvastatin	Vasa M	Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.	Circulation	2001	137
11430324	Simvastatin	Ridker PM	Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.	The New England journal of medicine	2001	156
12132975	Simvastatin	Benner JS	Long-term persistence in use of statin therapy in elderly patients.	JAMA	2002	229
14996776	Simvastatin	Nissen SE	Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.	JAMA	2004	224
15537681	Simvastatin	Taylor AJ	Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.	Circulation	2004	121
15635109	Simvastatin	Ridker PM	C-reactive protein levels and outcomes after statin therapy.	The New England journal of medicine	2005	262
15635110	Simvastatin	Nissen SE	Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.	The New England journal of medicine	2005	148
15660968	Simvastatin	Schachter M	Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.	Fundamental & clinical pharmacology	2005	116
16043642	Simvastatin	Sen-Banerjee S	Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.	Circulation	2005	86
16339495	Simvastatin	Rikitake Y	Rho GTPases, statins, and nitric oxide.	Circulation research	2005	91
16714062	Simvastatin	Shitara Y	Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.	Pharmacology & therapeutics	2006	71
17276178	Simvastatin	Moura LM	Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.	Journal of the American College of Cardiology	2007	60
17284700	Simvastatin	Nicholls SJ	Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.	JAMA	2007	97
17707755	Simvastatin	Messerli FH	Essential hypertension.	Lancet	2007	81
17928595	Simvastatin	Ford I	Long-term follow-up of the West of Scotland Coronary Prevention Study.	The New England journal of medicine	2007	80
18033751	Simvastatin	Careskey HE	Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.	Journal of lipid research	2008	63
18261682	Simvastatin	van der Steeg WA	High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.	Journal of the American College of Cardiology	2008	61
18519851	Simvastatin	Kastelein JJ	Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.	Circulation	2008	71
18650507	Simvastatin	SEARCH Collaborative Group.	SLCO1B1 variants and statin-induced myopathy--a genomewide study.	The New England journal of medicine	2008	370
19151728	Simvastatin	Whitehead KJ	The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.	Nature medicine	2009	115
19449008	Simvastatin	Packard RR	Innate and adaptive immunity in atherosclerosis.	Seminars in immunopathology	2009	48
19785645	Simvastatin	Kalliokoski A	Impact of OATP transporters on pharmacokinetics.	British journal of pharmacology	2009	119
19968965	Simvastatin	Villarreal G Jr	Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells.	Biochemical and biophysical research communications	2010	53
21243006	Simvastatin	Brunham LR	Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.	The pharmacogenomics journal	2012	38
21986285	Simvastatin	Raal FJ	Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.	Circulation	2011	39
22089718	Simvastatin	Nicholls SJ	Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.	JAMA	2011	77
22453571	Simvastatin	Boekholdt SM	Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.	JAMA	2012	102
22797450	Simvastatin	Emerging Risk Factors Collaboration.	Lipid-related markers and cardiovascular disease prediction.	JAMA	2012	57
23034020	Simvastatin	Emerging Risk Factors Collaboration.	C-reactive protein, fibrinogen, and cardiovascular disease prediction.	The New England journal of medicine	2012	197
23973688	Simvastatin	Albers JJ	Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).	Journal of the American College of Cardiology	2013	35
24474739	Simvastatin	Holmes MV	Mendelian randomization of blood lipids for coronary heart disease.	European heart journal	2015	65
24694531	Simvastatin	Stroes E	Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab.	Journal of the American College of Cardiology	2014	78
24743428	Simvastatin	Byrne CD	Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2014	28
24825642	Simvastatin	Robinson JG	Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.	JAMA	2014	63
24958078	Simvastatin	Dadu RT	Lipid lowering with PCSK9 inhibitors.	Nature reviews. Cardiology	2014	33
25038074	Simvastatin	Keene D	Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.	BMJ	2014	45
25066560	Simvastatin	Blazing MA	Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.	American heart journal	2014	22
25082583	Simvastatin	Boekholdt SM	Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.	Journal of the American College of Cardiology	2014	42
25770315	Simvastatin	Ference BA	Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.	Journal of the American College of Cardiology	2015	33
26424461	Simvastatin	Lo J	Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.	The lancet. HIV	2015	42
26564598	Simvastatin	Nicholls SJ	Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.	Journal of the American College of Cardiology	2015	16
26687696	Simvastatin	Moriarty PM	Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.	Journal of clinical lipidology	2015	33
27545498	Simvastatin	Guixé-Muntet S	Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury.	Journal of hepatology	2017	7
27846344	Simvastatin	Nicholls SJ	Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.	JAMA	2016	43
28002550	Simvastatin	Feinstein MJ	Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.	JAMA cardiology	2017	8
28620111	Simvastatin	Sacks FM	Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.	Circulation	2017	19
11757504	Nicotinic acid	Brown BG	Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.	The New England journal of medicine	2001	244
15929991	Nicotinic acid	Taggart AK	(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.	The Journal of biological chemistry	2005	89
16968945	Nicotinic acid	Kontush A	Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.	Pharmacological reviews	2006	160
19825813	Nicotinic acid	Chapman MJ	Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.	European heart journal	2010	51
20965889	Nicotinic acid	Nordestgaard BG	Lipoprotein(a) as a cardiovascular risk factor: current status.	European heart journal	2010	178
21243009	Nicotinic acid	Degoma EM	Novel HDL-directed pharmacotherapeutic strategies.	Nature reviews. Cardiology	2011	58
21737816	Nicotinic acid	DeWire SM	Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.	Circulation research	2011	45
23479408	Nicotinic acid	Chehade JM	Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.	Drugs	2013	29
27673306	Nicotinic acid	Silverman MG	Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.	JAMA	2016	22
27891663	Nicotinic acid	Batuca JR	Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein-cholesterol: the EXPLORE clinical trial.	British journal of clinical pharmacology	2017	5
7540722	Nitric oxide	Giaid A	Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.	The New England journal of medicine	1995	192
8642338	Nitric oxide	Nicholson S	Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.	The Journal of experimental medicine	1996	141
8816815	Nitric oxide	Topper JN	Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.	Proceedings of the National Academy of Sciences of the United States of America	1996	141
9530222	Nitric oxide	Meldrum DR	Tumor necrosis factor in the heart.	The American journal of physiology	1998	109
9598824	Nitric oxide	Traub O	Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force.	Arteriosclerosis, thrombosis, and vascular biology	1998	172
11108718	Nitric oxide	Kim I	Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.	The Journal of biological chemistry	2001	146
11581493	Nitric oxide	Nilius B	Ion channels and their functional role in vascular endothelium.	Physiological reviews	2001	173
11773611	Nitric oxide	Roman RJ	P-450 metabolites of arachidonic acid in the control of cardiovascular function.	Physiological reviews	2002	329
11940543	Nitric oxide	Guzik TJ	Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.	Circulation	2002	204
12089442	Nitric oxide	Eiserich JP	Myeloperoxidase, a leukocyte-derived vascular NO oxidase.	Science	2002	123
12093770	Nitric oxide	Takemoto M	Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.	Circulation	2002	92
12154060	Nitric oxide	Gupta K	Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.	Cancer research	2002	91
12377579	Nitric oxide	Busse R	EDHF: bringing the concepts together.	Trends in pharmacological sciences	2002	176
12446767	Nitric oxide	Ming XF	Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells.	Molecular and cellular biology	2002	96
12482742	Nitric oxide	Fleming I	Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase.	American journal of physiology. Regulatory, integrative and comparative physiology	2003	169
12506127	Nitric oxide	Brutsaert DL	Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.	Physiological reviews	2003	113
12874180	Nitric oxide	Verma S	Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.	Circulation	2003	97
14605020	Nitric oxide	Gulati R	Diverse origin and function of cells with endothelial phenotype obtained from adult human blood.	Circulation research	2003	97
14699017	Nitric oxide	Hur J	Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2004	212
15078802	Nitric oxide	Verma S	C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.	Circulation	2004	71
15110495	Nitric oxide	Damy T	Increased neuronal nitric oxide synthase-derived NO production in the failing human heart.	Lancet	2004	70
15284284	Nitric oxide	Endemann DH	Endothelial dysfunction.	Journal of the American Society of Nephrology 	2004	161
15319269	Nitric oxide	Wolfrum S	Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.	Arteriosclerosis, thrombosis, and vascular biology	2004	98
15333630	Nitric oxide	Prior BM	What makes vessels grow with exercise training?	Journal of applied physiology	2004	79
15364894	Nitric oxide	Xu W	Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.	FASEB journal 	2004	104
15569838	Nitric oxide	Ming XF	Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.	Circulation	2004	77
15601578	Nitric oxide	Hristov M	Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.	Journal of cellular and molecular medicine	2004	83
15660333	Nitric oxide	Kanellis J	Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.	Seminars in nephrology	2005	69
15723618	Nitric oxide	Pacher P	Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.	Current medicinal chemistry	2005	73
15832402	Nitric oxide	de la Lastra CA	Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.	Molecular nutrition & food research	2005	98
16049344	Nitric oxide	Dekker RJ	Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes.	The American journal of pathology	2005	80
16192427	Nitric oxide	Amabile N	Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.	Journal of the American Society of Nephrology 	2005	96
16198162	Nitric oxide	Kaminska B	MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.	Biochimica et biophysica acta	2005	158
16251237	Nitric oxide	Kang DH	Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.	Journal of the American Society of Nephrology 	2005	154
16288777	Nitric oxide	Jones SP	The ubiquitous role of nitric oxide in cardioprotection.	Journal of molecular and cellular cardiology	2006	123
16357085	Nitric oxide	Andresen J	Endothelial influences on cerebrovascular tone.	Journal of applied physiology	2006	60
16455954	Nitric oxide	Dekker RJ	KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium.	Blood	2006	95
16648850	Nitric oxide	Arking DE	A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.	Nature genetics	2006	195
16763172	Nitric oxide	Mineo C	Endothelial and antithrombotic actions of HDL.	Circulation research	2006	131
16973825	Nitric oxide	Csiszar A	Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.	American journal of physiology. Heart and circulatory physiology	2006	87
17229978	Nitric oxide	Guzik TJ	Adipocytokines - novel link between inflammation and vascular function?	Journal of physiology and pharmacology 	2006	87
17346243	Nitric oxide	Higuchi S	Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.	Clinical science	2007	102
17576865	Nitric oxide	Aarnoudse AJ	Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.	Circulation	2007	57
17592079	Nitric oxide	Sorrentino SA	Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.	Circulation	2007	88
17654441	Nitric oxide	Hartge MM	The endothelium and vascular inflammation in diabetes.	Diabetes & vascular disease research	2007	56
17933075	Nitric oxide	Rudijanto A	The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.	Acta medica Indonesiana	2007	67
18068232	Nitric oxide	Kuehbacher A	Targeting microRNA expression to regulate angiogenesis.	Trends in pharmacological sciences	2008	73
18375481	Nitric oxide	Movva R	Laboratory assessment of HDL heterogeneity and function.	Clinical chemistry	2008	56
18550634	Nitric oxide	Urbich C	Role of microRNAs in vascular diseases, inflammation, and angiogenesis.	Cardiovascular research	2008	223
19089334	Nitric oxide	Stasch JP	NO-independent, haem-dependent soluble guanylate cyclase stimulators.	Handbook of experimental pharmacology	2009	56
19204306	Nitric oxide	Kao WH	Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.	Circulation	2009	76
19289637	Nitric oxide	Greenstein AS	Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients.	Circulation	2009	125
19298861	Nitric oxide	Zhou L	Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications.	Nitric oxide 	2009	98
19342613	Nitric oxide	Balligand JL	eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues.	Physiological reviews	2009	91
19429441	Nitric oxide	Kerachian MA	Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action.	The Journal of steroid biochemistry and molecular biology	2009	52
19465546	Nitric oxide	Donato AJ	Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase.	American journal of physiology. Heart and circulatory physiology	2009	79
19639676	Nitric oxide	Krüger M	Titin-based mechanical signalling in normal and failing myocardium.	Journal of molecular and cellular cardiology	2009	54
19661270	Nitric oxide	Choi YS	Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production.	Blood	2009	74
19883397	Nitric oxide	Bruns AF	Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis.	Traffic	2010	46
20110409	Nitric oxide	Fijalkowska I	Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.	The American journal of pathology	2010	76
20153722	Nitric oxide	Weber M	MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity.	Biochemical and biophysical research communications	2010	91
20159829	Nitric oxide	Jelic S	Vascular inflammation in obesity and sleep apnea.	Circulation	2010	45
20431067	Nitric oxide	Kane NM	Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo.	Arteriosclerosis, thrombosis, and vascular biology	2010	49
20462865	Nitric oxide	Durán WN	The NO cascade, eNOS location, and microvascular permeability.	Cardiovascular research	2010	46
20678595	Nitric oxide	Sitia S	From endothelial dysfunction to atherosclerosis.	Autoimmunity reviews	2010	52
21036891	Nitric oxide	Guazzi M	PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.	Circulation. Heart failure	2011	82
21474820	Nitric oxide	Madhur MS	Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2011	60
21610226	Nitric oxide	Barrett EJ	Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.	American journal of physiology. Endocrinology and metabolism	2011	53
21691084	Nitric oxide	Molinari C	1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells.	Cellular physiology and biochemistry 	2011	42
21768538	Nitric oxide	Wu W	Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.	Circulation	2011	77
21836066	Nitric oxide	Zheng Q	C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.	Arteriosclerosis, thrombosis, and vascular biology	2011	39
21852557	Nitric oxide	Rautou PE	Microparticles, vascular function, and atherothrombosis.	Circulation research	2011	70
21876168	Nitric oxide	Song JW	Fluid forces control endothelial sprouting.	Proceedings of the National Academy of Sciences of the United States of America	2011	104
22167522	Nitric oxide	Kietadisorn R	Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.	American journal of physiology. Endocrinology and metabolism	2012	55
22254000	Nitric oxide	Vauzour D	Polyphenols and human health: prevention of disease and mechanisms of action.	Nutrients	2010	68
22267480	Nitric oxide	Fang Y	Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium.	Arteriosclerosis, thrombosis, and vascular biology	2012	77
22345126	Nitric oxide	Lüscher TF	Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.	European heart journal	2012	37
22382311	Nitric oxide	Nakata R	Recent advances in the study on resveratrol.	Biological & pharmaceutical bulletin	2012	34
22653084	Nitric oxide	Yi W	C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart.	Circulation	2012	32
23108656	Nitric oxide	Sun HX	Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase.	Hypertension	2012	68
23132368	Nitric oxide	Bidani AK	Renal microvascular dysfunction, hypertension and CKD progression.	Current opinion in nephrology and hypertension	2013	32
23204109	Nitric oxide	Tabit CE	Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.	Circulation	2013	43
23297346	Nitric oxide	Zhang Y	Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases.	Molecular and cellular biology	2013	27
23306778	Nitric oxide	Muniyappa R	Role of insulin resistance in endothelial dysfunction.	Reviews in endocrine & metabolic disorders	2013	44
23349247	Nitric oxide	Riwanto M	Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.	Circulation	2013	61
23349535	Nitric oxide	Bender SB	Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?	Diabetes	2013	44
23477738	Nitric oxide	Speer T	Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.	Immunity	2013	51
23536307	Nitric oxide	Vion AC	Shear stress regulates endothelial microparticle release.	Circulation research	2013	25
23583836	Nitric oxide	Bosse K	Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.	Journal of molecular and cellular cardiology	2013	34
23625959	Nitric oxide	Margaritis M	Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels.	Circulation	2013	33
23684677	Nitric oxide	Paulus WJ	A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.	Journal of the American College of Cardiology	2013	257
23825361	Nitric oxide	Ghebremariam YT	Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.	Circulation	2013	27
23986401	Nitric oxide	Tian W	Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.	Science translational medicine	2013	37
24036884	Nitric oxide	Jelinic M	Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment.	FASEB journal 	2014	21
24357508	Nitric oxide	Katusic ZS	Endothelial nitric oxide: protector of a healthy mind.	European heart journal	2014	33
24373826	Nitric oxide	Mancuso C	Ferulic acid: pharmacological and toxicological aspects.	Food and chemical toxicology 	2014	23
24414072	Nitric oxide	Zhao Z	Role of estrogen in diastolic dysfunction.	American journal of physiology. Heart and circulatory physiology	2014	21
24526691	Nitric oxide	Horio E	Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.	Arteriosclerosis, thrombosis, and vascular biology	2014	26
25001649	Nitric oxide	Iantorno M	Obesity, inflammation and endothelial dysfunction.	Journal of biological regulators and homeostatic agents	2014	25
25012134	Nitric oxide	Kumar S	Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs.	Arteriosclerosis, thrombosis, and vascular biology	2014	45
25351818	Nitric oxide	Bach LA	Endothelial cells and the IGF system.	Journal of molecular endocrinology	2015	20
25444755	Nitric oxide	Das A	PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer.	Pharmacology & therapeutics	2015	34
25645978	Nitric oxide	Cocks M	Sprint interval and moderate-intensity continuous training have equal benefits on aerobic capacity, insulin sensitivity, muscle capillarisation and endothelial eNOS/NAD(P)Hoxidase protein ratio in obese men.	The Journal of physiology	2016	15
26137590	Nitric oxide	Premer C	Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.	EBioMedicine	2015	23
26800561	Nitric oxide	Bretón-Romero R	Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.	Arteriosclerosis, thrombosis, and vascular biology	2016	13
27229925	Nitric oxide	Pogoda K	Regulation of gap junction channels and hemichannels by phosphorylation and redox changes: a revision.	BMC cell biology	2016	11
27590257	Nitric oxide	Leo CH	Vascular actions of relaxin: nitric oxide and beyond.	British journal of pharmacology	2017	10
27732846	Nitric oxide	Van den Bossche J	Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages.	Cell reports	2016	20
27859264	Nitric oxide	Ahn SJ	Inwardly rectifying K+ channels are major contributors to flow-induced vasodilatation in resistance arteries.	The Journal of physiology	2017	9
28116308	Nitric oxide	Cai W	Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway.	BioMed research international	2017	6
28193797	Nitric oxide	Hernáez Á	Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial.	Circulation	2017	9
16157788	Norepinephrine	Cornelissen VA	Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors.	Hypertension	2005	97
17414649	Norepinephrine	Mancia G	The sympathetic nervous system and the metabolic syndrome.	Journal of hypertension	2007	66
19332353	Norepinephrine	Krum H	Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.	Lancet	2009	275
20101001	Norepinephrine	Heusser K	Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.	Hypertension	2010	47
20331902	Norepinephrine	Sturgess DJ	Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers.	Critical care	2010	43
21857681	Norepinephrine	Hara MR	A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.	Nature	2011	74
22261894	Norepinephrine	Raake PW	AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.	European heart journal	2013	50
22573363	Norepinephrine	Kandzari DE	Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.	Clinical cardiology	2012	42
26858430	Norepinephrine	Morris CJ	Circadian misalignment increases cardiovascular disease risk factors in humans.	Proceedings of the National Academy of Sciences of the United States of America	2016	29
27144442	Norepinephrine	Johansson PI	Traumatic Endotheliopathy: A Prospective Observational Study of 424 Severely Injured Patients.	Annals of surgery	2017	6
28528561	Norepinephrine	Khanna A	Angiotensin II for the Treatment of Vasodilatory Shock.	The New England journal of medicine	2017	11
17174323	Phenylephrine	Ohba T	Upregulation of TRPC1 in the development of cardiac hypertrophy.	Journal of molecular and cellular cardiology	2007	58
17492053	Phenylephrine	Sanada S	IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.	The Journal of clinical investigation	2007	172
21047517	Phenylephrine	Földes G	Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?	Journal of molecular and cellular cardiology	2011	41
25775528	Phenylephrine	Tripathi A	Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
11489932	3-Hydroxy-3-methylglutaryl-CoA	Dimmeler S	HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.	The Journal of clinical investigation	2001	189
12815379	3-Hydroxy-3-methylglutaryl-CoA	Tobert JA	Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.	Nature reviews. Drug discovery	2003	98
16341084	3-Hydroxy-3-methylglutaryl-CoA	Demierre MF	Statins and cancer prevention.	Nature reviews. Cancer	2005	188
17640385	3-Hydroxy-3-methylglutaryl-CoA	Wolozin B	Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.	BMC medicine	2007	69
23115084	3-Hydroxy-3-methylglutaryl-CoA	Shitara Y	Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.	Biopharmaceutics & drug disposition	2013	32
23696639	3-Hydroxy-3-methylglutaryl-CoA	Sharpe LJ	Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR).	The Journal of biological chemistry	2013	38
28846118	3-Hydroxy-3-methylglutaryl-CoA	Ference BA	Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.	JAMA	2017	9
18378613	Clopidogrel	Sabatine MS	Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.	Circulation	2008	52
19106083	Clopidogrel	Simon T	Genetic determinants of response to clopidogrel and cardiovascular events.	The New England journal of medicine	2009	251
19414633	Clopidogrel	Mega JL	Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.	Circulation	2009	76
20620727	Clopidogrel	Hulot JS	Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.	Journal of the American College of Cardiology	2010	62
20801498	Clopidogrel	Wallentin L	Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.	Lancet	2010	92
20979470	Clopidogrel	Paré G	Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.	The New England journal of medicine	2010	95
21406646	Clopidogrel	Price MJ	Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.	JAMA	2011	117
21816733	Clopidogrel	Bauer T	Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.	BMJ	2011	38
21875913	Clopidogrel	Price MJ	Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.	Circulation	2011	41
22190063	Clopidogrel	Delaney JT	Predicting clopidogrel response using DNA samples linked to an electronic health record.	Clinical pharmacology and therapeutics	2012	44
22203539	Clopidogrel	Holmes MV	CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.	JAMA	2011	90
22464343	Clopidogrel	Roberts JD	Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.	Lancet	2012	57
23698643	Clopidogrel	Scott SA	Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.	Clinical pharmacology and therapeutics	2013	120
25896078	Clopidogrel	Aradi D	Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.	European heart journal	2015	19
26061035	Clopidogrel	Shah NH	Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.	PloS one	2015	35
28053157	Clopidogrel	Wong PC	Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.	Science translational medicine	2017	11
10411845	Pravastatin	Ridker PM	Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.	Circulation	1999	123
11030795	Pravastatin	Wolozin B	Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.	Archives of neurology	2000	241
11100127	Pravastatin	Kwak B	Statins as a newly recognized type of immunomodulator.	Nature medicine	2000	196
15692087	Monocrotaline	Zhao YD	Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.	Circulation research	2005	119
15931388	Monocrotaline	McMurtry MS	Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.	The Journal of clinical investigation	2005	94
22161164	Monocrotaline	Pullamsetti SS	Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension.	American journal of respiratory and critical care medicine	2012	58
26076038	Monocrotaline	Long L	Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.	Nature medicine	2015	49
26912814	Monocrotaline	Antigny F	Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.	Circulation	2016	10
27742621	Monocrotaline	Rogers NM	TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.	Cardiovascular research	2017	9
9804796	L-Threonine	Gerber HP	Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.	The Journal of biological chemistry	1998	377
10376603	L-Threonine	Dimmeler S	Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.	Nature	1999	741
10625301	L-Threonine	Kim I	Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.	Circulation research	2000	133
10734041	L-Threonine	Papapetropoulos A	Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway.	The Journal of biological chemistry	2000	124
11448997	L-Threonine	Worthylake RA	RhoA is required for monocyte tail retraction during transendothelial migration.	The Journal of cell biology	2001	138
11917134	L-Threonine	Tran J	A role for survivin in chemoresistance of endothelial cells mediated by VEGF.	Proceedings of the National Academy of Sciences of the United States of America	2002	80
12093740	L-Threonine	Boehm M	A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.	The EMBO journal	2002	80
15769444	L-Threonine	Layland J	Regulation of cardiac contractile function by troponin I phosphorylation.	Cardiovascular research	2005	124
16007268	L-Threonine	Nagoshi T	PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury.	The Journal of clinical investigation	2005	80
17182864	L-Threonine	Shiojima I	Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.	Genes & development	2006	115
18606491	L-Threonine	Luo J	Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.	Cancer letters	2009	118
19114994	L-Threonine	Goumans MJ	TGF-beta signaling in vascular biology and dysfunction.	Cell research	2009	106
20203304	L-Threonine	Zu Y	SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.	Circulation research	2010	59
20592472	L-Threonine	Zheng X	CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.	The Journal of clinical investigation	2010	47
20656490	L-Threonine	Pardali E	Signaling by members of the TGF-beta family in vascular morphogenesis and disease.	Trends in cell biology	2010	109
21622831	L-Threonine	Satoh K	Rho-kinase: important new therapeutic target in cardiovascular diseases.	American journal of physiology. Heart and circulatory physiology	2011	60
21742790	L-Threonine	Erickson JR	CaMKII in the cardiovascular system: sensing redox states.	Physiological reviews	2011	69
3670400	L-Serine	McLean JW	cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.	Nature	1987	163
9215638	L-Serine	Hayashi H	The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.	Cell	1997	286
10604470	L-Serine	Kojima M	Ghrelin is a growth-hormone-releasing acylated peptide from stomach.	Nature	1999	1062
10973254	L-Serine	International PPH Consortium.	Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.	Nature genetics	2000	308
11356985	L-Serine	Macfarlane SR	Proteinase-activated receptors.	Pharmacological reviews	2001	253
14551207	L-Serine	Skurk C	The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP.	The Journal of biological chemistry	2004	77
14654844	L-Serine	Lorenz K	Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.	Nature	2003	91
15689571	L-Serine	Steinhoff M	Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.	Endocrine reviews	2005	108
15748242	L-Serine	Perzborn E	In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor.	Journal of thrombosis and haemostasis 	2005	68
16554528	L-Serine	Cohen JC	Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.	The New England journal of medicine	2006	510
17332893	L-Serine	Vaisar T	Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.	The Journal of clinical investigation	2007	252
17498057	L-Serine	Caughey GH	Mast cell tryptases and chymases in inflammation and host defense.	Immunological reviews	2007	82
17635716	L-Serine	Rau JC	Serpins in thrombosis, hemostasis and fibrinolysis.	Journal of thrombosis and haemostasis 	2007	68
18621108	L-Serine	Candelario-Jalil E	Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.	Neuroscience	2009	142
19387015	L-Serine	Hara K	Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease.	The New England journal of medicine	2009	67
19712804	L-Serine	Brauch KM	Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.	Journal of the American College of Cardiology	2009	54
20626406	L-Serine	Cesari M	Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.	Cardiovascular therapeutics	2010	45
21046060	L-Serine	Ehrnthaller C	New insights of an old defense system: structure, function, and clinical relevance of the complement system.	Molecular medicine	2011	49
21051663	L-Serine	Chen J	Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation.	Arteriosclerosis, thrombosis, and vascular biology	2011	40
21572424	L-Serine	Adibekian A	Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.	Nature chemical biology	2011	55
21710321	L-Serine	Bidart M	BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.	Cellular and molecular life sciences 	2012	34
22307629	L-Serine	Lefrançais E	IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G.	Proceedings of the National Academy of Sciences of the United States of America	2012	102
22479366	L-Serine	Boivin WA	Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1.	PloS one	2012	33
22946099	L-Serine	Cocks M	Sprint interval and endurance training are equally effective in increasing muscle microvascular density and eNOS content in sedentary males.	The Journal of physiology	2013	36
23086754	L-Serine	Austin KM	Matrix metalloproteases and PAR1 activation.	Blood	2013	33
23153585	L-Serine	Mizuno K	Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation.	Cellular signalling	2013	94
23277200	L-Serine	Barrett A	p130Cas: a key signalling node in health and disease.	Cellular signalling	2013	28
24040362	L-Serine	Zins K	A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.	PloS one	2013	26
24625727	L-Serine	Seidah NG	PCSK9: a key modulator of cardiovascular health.	Circulation research	2014	57
24949972	L-Serine	Eswarappa SM	Programmed translational readthrough generates antiangiogenic VEGF-Ax.	Cell	2014	42
25698643	L-Serine	Prassas I	Unleashing the therapeutic potential of human kallikrein-related serine proteases.	Nature reviews. Drug discovery	2015	28
26578202	L-Serine	Lipinski MJ	The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis.	European heart journal	2016	33
11830509	Celecoxib	Leahy KM	Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.	Cancer research	2002	81
15117884	Celecoxib	Warner TD	Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic.	FASEB journal 	2004	103
15713944	Celecoxib	Solomon SD	Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.	The New England journal of medicine	2005	348
18378608	Celecoxib	Solomon SD	Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis.	Circulation	2008	91
19336730	Celecoxib	Bertagnolli MM	Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.	Cancer prevention research	2009	65
21115882	Celecoxib	Elmets CA	Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.	Journal of the National Cancer Institute	2010	46
21345578	Celecoxib	Jendrossek V	Targeting apoptosis pathways by Celecoxib in cancer.	Cancer letters	2013	43
25322082	Celecoxib	Köhler O	Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.	JAMA psychiatry	2014	69
12065324	Angiotensin II	Touyz RM	Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.	Circulation research	2002	117
12676174	Angiotensin II	Suzuki Y	Inflammation and angiotensin II.	The international journal of biochemistry & cell biology	2003	110
15146194	Angiotensin II	Zou Y	Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.	Nature cell biology	2004	142
16055515	Angiotensin II	Ferrario CM	Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.	American journal of physiology. Heart and circulatory physiology	2005	72
16784934	Angiotensin II	Ferrario CM	Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.	The American journal of cardiology	2006	100
17324119	Angiotensin II	Savoia C	Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.	Clinical science	2007	77
17452499	Angiotensin II	Wang M	Proinflammatory profile within the grossly normal aged human aortic wall.	Hypertension	2007	85
18579813	Angiotensin II	Brooke BS	Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.	The New England journal of medicine	2008	162
18793332	Angiotensin II	Fyhrquist F	Renin-angiotensin system revisited.	Journal of internal medicine	2008	79
19050008	Angiotensin II	Sun Y	Myocardial repair/remodelling following infarction: roles of local factors.	Cardiovascular research	2009	60
19635970	Angiotensin II	Matt P	Circulating transforming growth factor-beta in Marfan syndrome.	Circulation	2009	61
20538689	Angiotensin II	Leask A	Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation.	Circulation research	2010	161
20679547	Angiotensin II	Zhong J	Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.	Circulation	2010	69
21035950	Angiotensin II	Saavedra JM	Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.	Psychoneuroendocrinology	2011	47
21310411	Angiotensin II	Zhu N	Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration.	Atherosclerosis	2011	68
21903938	Angiotensin II	Boon RA	MicroRNA-29 in aortic dilation: implications for aneurysm formation.	Circulation research	2011	90
22760500	Angiotensin II	Adam O	Role of miR-21 in the pathogenesis of atrial fibrosis.	Basic research in cardiology	2012	44
22983395	Angiotensin II	Yoshioka K	Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.	Nature medicine	2012	43
23446738	Angiotensin II	Lautner RQ	Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.	Circulation research	2013	32
23478743	Angiotensin II	Gheorghiade M	Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.	JAMA	2013	38
24014829	Angiotensin II	Xia H	Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.	Circulation research	2013	32
24189039	Angiotensin II	Davis J	Myofibroblasts: trust your heart and let fate decide.	Journal of molecular and cellular cardiology	2014	52
24776703	Angiotensin II	Jiang F	Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.	Nature reviews. Cardiology	2014	29
24778429	Angiotensin II	Mercado J	Local control of TRPV4 channels by AKAP150-targeted PKC in arterial smooth muscle.	The Journal of general physiology	2014	24
25814687	Angiotensin II	Leask A	Getting to the heart of the matter: new insights into cardiac fibrosis.	Circulation research	2015	56
25898844	Angiotensin II	Lorenzen JM	Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.	European heart journal	2015	23
26315714	Angiotensin II	Karnik SS	International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli corrected.	Pharmacological reviews	2015	27
26585673	Angiotensin II	Nagpal V	MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.	Circulation	2016	21
26597926	Angiotensin II	Xie X	Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.	American journal of kidney diseases 	2016	12
26873938	Angiotensin II	Mikolajczyk TP	Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension.	FASEB journal 	2016	20
27118293	Angiotensin II	Harvey A	Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications.	The Canadian journal of cardiology	2016	20
18376000	Ezetimibe	Kastelein JJ	Simvastatin with or without ezetimibe in familial hypercholesterolemia.	The New England journal of medicine	2008	177
19075102	Ezetimibe	Liu PY	Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.	Circulation	2009	54
23141813	Ezetimibe	Giugliano RP	Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study.	Lancet	2012	63
24678979	Ezetimibe	Blom DJ	A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.	The New England journal of medicine	2014	89
25037695	Ezetimibe	Roth EM	Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.	International journal of cardiology	2014	44
25282519	Ezetimibe	Raal FJ	PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.	Lancet	2015	78
25390462	Ezetimibe	Myocardial Infarction Genetics Consortium Investigators.	Inactivating mutations in NPC1L1 and protection from coronary heart disease.	The New England journal of medicine	2014	62
26030325	Ezetimibe	Bays H	Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.	The Journal of clinical endocrinology and metabolism	2015	31
26227186	Ezetimibe	Tsujita K	Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.	Journal of the American College of Cardiology	2015	22
26718096	Ezetimibe	Banach M	Lipids, blood pressure and kidney update 2015.	Lipids in health and disease	2015	17
26868195	Ezetimibe	Sattar N	Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data.	The lancet. Diabetes & endocrinology	2016	17
27533159	Ezetimibe	Kazi DS	Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.	JAMA	2016	29
27701660	Ezetimibe	Lotta LA	Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.	JAMA	2016	31
27793396	Ezetimibe	Gaudet D	Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program).	The American journal of cardiology	2017	6
23894014	Sitagliptin	dos Santos L	Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.	Circulation. Heart failure	2013	29
26052984	Sitagliptin	Green JB	Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.	The New England journal of medicine	2015	242
26888822	Sitagliptin	Li L	Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.	BMJ	2016	22
27351380	Sitagliptin	Oyama J	The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.	PLoS medicine	2016	14
27437883	Sitagliptin	McGuire DK	Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.	JAMA cardiology	2016	14
12807871	Rosiglitazone	Tiraby C	Acquirement of brown fat cell features by human white adipocytes.	The Journal of biological chemistry	2003	108
16737350	Rosiglitazone	Yang RZ	Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.	PLoS medicine	2006	72
17040956	Rosiglitazone	Wang Y	Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.	Clinical chemistry	2007	103
18276926	Rosiglitazone	Duan SZ	Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.	Circulation research	2008	73
22616948	Rosiglitazone	Kung J	Thiazolidinedione safety.	Expert opinion on drug safety	2012	44
28098353	Rosiglitazone	Derosa G	The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice.	Journal of cellular physiology	2018	10
14962476	Atorvastatin	Hausenloy DJ	New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.	Cardiovascular research	2004	192
15207950	Atorvastatin	McCarey DW	Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.	Lancet	2004	122
16801565	Atorvastatin	Knopp RH	Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).	Diabetes care	2006	73
16820635	Atorvastatin	Osman L	Role of human valve interstitial cells in valve calcification and their response to atorvastatin.	Circulation	2006	65
17387129	Atorvastatin	Nissen SE	Effect of torcetrapib on the progression of coronary atherosclerosis.	The New England journal of medicine	2007	158
17630038	Atorvastatin	Bots ML	Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.	Lancet	2007	71
19608026	Atorvastatin	Hiro T	Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome study).	Journal of the American College of Cardiology	2009	46
20031582	Atorvastatin	Thompson JF	Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.	Circulation. Cardiovascular genetics	2009	52
21195052	Atorvastatin	Zhang Q	Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease.	Biochemical and biophysical research communications	2011	39
24247616	Atorvastatin	Nicholls SJ	Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.	JAMA	2014	31
25440796	Atorvastatin	Schwartz GG	Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.	American heart journal	2014	41
26558731	Atorvastatin	Nou E	Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.	AIDS	2016	13
27923814	Atorvastatin	He M	miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.	Circulation research	2017	8
28847206	Atorvastatin	HPS3/TIMI55–REVEAL Collaborative Group.	Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.	The New England journal of medicine	2017	23
9217756	Creatinine	-	Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)	Lancet	1997	162
10437863	Creatinine	Ruggenenti P	Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.	Lancet	1999	98
10692273	Creatinine	Yeun JY	C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.	American journal of kidney diseases 	2000	95
10807470	Creatinine	Gottdiener JS	Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.	Journal of the American College of Cardiology	2000	205
11386930	Creatinine	Schiffmann R	Enzyme replacement therapy in Fabry disease: a randomized controlled trial.	JAMA	2001	158
11916939	Creatinine	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	103
12387653	Creatinine	Davì G	Platelet activation in obese women: role of inflammation and oxidant stress.	JAMA	2002	83
12515748	Creatinine	Shlipak MG	Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.	Circulation	2003	133
14769700	Creatinine	McAlister FA	Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.	Circulation	2004	97
15327406	Creatinine	Herget-Rosenthal S	Early detection of acute renal failure by serum cystatin C.	Kidney international	2004	163
15716560	Creatinine	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	81
15809461	Creatinine	Sarnak MJ	Cystatin C concentration as a risk factor for heart failure in older adults.	Annals of internal medicine	2005	96
15811980	Creatinine	Kistorp C	N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.	JAMA	2005	110
15882252	Creatinine	Levey AS	Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).	Kidney international	2005	390
16908914	Creatinine	Shlipak MG	Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.	Annals of internal medicine	2006	145
17190862	Creatinine	Ix JH	Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.	Circulation	2007	75
17457094	Creatinine	Szczech LA	Microalbuminuria in HIV infection.	AIDS	2007	59
17485598	Creatinine	Roman MJ	Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.	Hypertension	2007	148
18295053	Creatinine	Zhang L	Prevalence and factors associated with CKD: a population study from Beijing.	American journal of kidney diseases 	2008	59
18295055	Creatinine	Stevens LA	Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.	American journal of kidney diseases 	2008	349
18385206	Creatinine	Astor BC	Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.	American journal of epidemiology	2008	79
18511168	Creatinine	Elsayed EF	Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.	American journal of kidney diseases 	2008	54
18649981	Creatinine	Wagener G	Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery.	American journal of kidney diseases 	2008	54
19001197	Creatinine	Rifkin DE	Rapid kidney function decline and mortality risk in older adults.	Archives of internal medicine	2008	106
19145003	Creatinine	Parving HH	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.	Nephrology, dialysis, transplantation 	2009	51
19808325	Creatinine	Kuznetsova T	Prevalence of left ventricular diastolic dysfunction in a general population.	Circulation. Heart failure	2009	65
20138414	Creatinine	White SL	Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.	American journal of kidney diseases 	2010	59
20172445	Creatinine	Stevens LA	Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2010	58
20189275	Creatinine	Matsushita K	Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.	American journal of kidney diseases 	2010	67
20441712	Creatinine	Black C	Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.	Health technology assessment	2010	47
20483451	Creatinine	Chronic Kidney Disease Prognosis Consortium.	Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.	Lancet	2010	651
20525986	Creatinine	Shah RV	Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.	European journal of heart failure	2010	55
20682604	Creatinine	Upadhyay A	Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.	Nephrology, dialysis, transplantation 	2011	39
20709438	Creatinine	Choi A	Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.	American journal of kidney diseases 	2010	45
21098347	Creatinine	Roussel R	Metformin use and mortality among patients with diabetes and atherothrombosis.	Archives of internal medicine	2010	54
21164029	Creatinine	Peralta CA	Cystatin C identifies chronic kidney disease patients at higher risk for complications.	Journal of the American Society of Nephrology 	2011	63
21232094	Creatinine	Englberger L	Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery.	Critical care	2011	46
21242477	Creatinine	James MT	Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography.	Circulation	2011	49
21646496	Creatinine	Alonso A	Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.	Circulation	2011	78
21953279	Creatinine	Walsh M	Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis.	Arthritis and rheumatism	2012	33
22305758	Creatinine	Astor BC	Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.	American journal of kidney diseases 	2012	50
22770927	Creatinine	Roshanravan B	A prospective study of frailty in nephrology-referred patients with CKD.	American journal of kidney diseases 	2012	54
22951890	Creatinine	Ärnlöv J	Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.	Kidney international	2013	39
23111824	Creatinine	Hallan SI	Age and association of kidney measures with mortality and end-stage renal disease.	JAMA	2012	103
24004120	Creatinine	Shlipak MG	Cystatin C versus creatinine in determining risk based on kidney function.	The New England journal of medicine	2013	139
24206459	Creatinine	de Zeeuw D	Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.	The New England journal of medicine	2013	134
24716680	Creatinine	Pitt B	Spironolactone for heart failure with preserved ejection fraction.	The New England journal of medicine	2014	150
24819981	Creatinine	Semba RD	Resveratrol levels and all-cause mortality in older community-dwelling adults.	JAMA internal medicine	2014	23
25029429	Creatinine	Langefeld CD	Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.	Kidney international	2015	33
25075773	Creatinine	Gallagher SM	Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery.	Kidney international	2015	17
25311702	Creatinine	Liu KD	Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2015	18
25393378	Creatinine	Naik RP	Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.	JAMA	2014	30
25651366	Creatinine	Floege J	Development and validation of a predictive mortality risk score from a European hemodialysis cohort.	Kidney international	2015	20
26342047	Creatinine	Dewitte A	Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery.	Clinical journal of the American Society of Nephrology 	2015	16
26635076	Creatinine	Unger ED	Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.	European journal of heart failure	2016	11
27190381	Creatinine	Ebert N	Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study.	Nephrology, dialysis, transplantation 	2017	6
28089986	Creatinine	Pottel H	Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.	Nephrology, dialysis, transplantation 	2017	7
28286957	Creatinine	Chen H	Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.	Journal of proteome research	2017	8
17272778	Superoxide	Kamada H	Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.	Stroke	2007	76
17916769	Superoxide	Sukhanov S	IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	64
18334666	Superoxide	Kim DH	Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells.	The Journal of pharmacology and experimental therapeutics	2008	52
19951898	Superoxide	Ilieva H	Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.	The Journal of cell biology	2009	327
20089851	Superoxide	Tanno M	Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.	The Journal of biological chemistry	2010	88
20458006	Superoxide	Giannotti G	Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction.	Hypertension	2010	41
22140047	Superoxide	Bubolz AH	Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling.	American journal of physiology. Heart and circulatory physiology	2012	41
25578927	Superoxide	Johnson SA	Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial.	Journal of the Academy of Nutrition and Dietetics	2015	18
27916526	Superoxide	Pomatto LCD	The Mitochondrial Lon Protease Is Required for Age-Specific and Sex-Specific Adaptation to Oxidative Stress.	Current biology 	2017	8
9588554	Bradykinin	Kroll RA	Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.	Neurosurgery	1998	117
16177542	Bradykinin	Moreau ME	The kallikrein-kinin system: current and future pharmacological targets.	Journal of pharmacological sciences	2005	69
1828192	Aldosterone	Weber KT	Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.	Circulation	1991	199
15583075	Aldosterone	Rahmouni K	Obesity-associated hypertension: new insights into mechanisms.	Hypertension	2005	127
15837256	Aldosterone	Milliez P	Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.	Journal of the American College of Cardiology	2005	158
17492946	Aldosterone	Young WF	Primary aldosteronism: renaissance of a syndrome.	Clinical endocrinology	2007	63
17903302	Aldosterone	Levy D	Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness.	BMC medical genetics	2007	90
17970613	Aldosterone	Atlas SA	The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.	Journal of managed care pharmacy 	2007	73
18536749	Aldosterone	Forrest MJ	Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.	British journal of pharmacology	2008	59
19574461	Aldosterone	Lin Z	miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.	Proceedings of the National Academy of Sciences of the United States of America	2009	104
19643310	Aldosterone	Edwards NC	Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.	Journal of the American College of Cardiology	2009	50
19874988	Aldosterone	Triposkiadis F	The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.	Journal of the American College of Cardiology	2009	134
20177053	Aldosterone	Wang K	miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.	The Journal of biological chemistry	2010	43
20440277	Aldosterone	Ruggenenti P	The RAAS in the pathogenesis and treatment of diabetic nephropathy.	Nature reviews. Nephrology	2010	47
21242487	Aldosterone	Birks EJ	Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.	Circulation	2011	46
21699940	Aldosterone	Zhuo JL	New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.	Peptides	2011	44
21718915	Aldosterone	Al Mheid I	Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.	Journal of the American College of Cardiology	2011	71
22511654	Aldosterone	van Vark LC	Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.	European heart journal	2012	56
23375582	Aldosterone	Lan TH	Vascular fibrosis in atherosclerosis.	Cardiovascular pathology 	2013	27
23821090	Aldosterone	Ledwidge M	Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.	JAMA	2013	46
23932846	Aldosterone	Aroor AR	Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.	Metabolism	2013	47
24130346	Aldosterone	Dart AB	Earlier onset of complications in youth with type 2 diabetes.	Diabetes care	2014	22
24490814	Aldosterone	Zucker IH	The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure.	Clinical science	2014	33
24569031	Aldosterone	Assmus B	Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.	European heart journal	2014	26
24880146	Aldosterone	Cavalera M	Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.	Translational research 	2014	25
25400162	Aldosterone	Kandzari DE	Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.	European heart journal	2015	48
25418979	Aldosterone	Edelmann F	Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.	European journal of heart failure	2015	20
26936907	Aldosterone	Lindhardt M	Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.	BMJ open	2016	14
27340270	Aldosterone	Prabhu SD	The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.	Circulation research	2016	61
3277611	Cholesterol	Davignon J	Apolipoprotein E polymorphism and atherosclerosis.	Arteriosclerosis	1988	206
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	637
7732003	Cholesterol	Stemme S	T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.	Proceedings of the National Academy of Sciences of the United States of America	1995	147
8035924	Cholesterol	Breteler MM	Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.	Neurology	1994	143
8432214	Cholesterol	Stamler J	Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.	Diabetes care	1993	483
9163428	Cholesterol	Kozarsky KF	Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.	Nature	1997	129
9610529	Cholesterol	Ridker PM	C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.	Circulation	1998	106
9613910	Cholesterol	Downs JR	Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.	JAMA	1998	462
9671306	Cholesterol	Mach F	Reduction of atherosclerosis in mice by inhibition of CD40 signalling.	Nature	1998	124
9673301	Cholesterol	Haffner SM	Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.	The New England journal of medicine	1998	895
9761744	Cholesterol	Ilangumaran S	Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane.	The Biochemical journal	1998	122
9987089	Cholesterol	Zimmermann J	Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.	Kidney international	1999	136
10079097	Cholesterol	Gosling J	MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.	The Journal of clinical investigation	1999	117
10192396	Cholesterol	Jaye M	A novel endothelial-derived lipase that modulates HDL metabolism.	Nature genetics	1999	96
10225972	Cholesterol	Raabe M	Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.	The Journal of clinical investigation	1999	100
10333910	Cholesterol	-	Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.	Diabetes care	1999	172
10430941	Cholesterol	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	114
10657556	Cholesterol	Yudkin JS	Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?	Atherosclerosis	2000	233
10872459	Cholesterol	Krieger M	Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.	Annual review of biochemistry	1999	105
11063384	Cholesterol	Loos BG	Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients.	Journal of periodontology	2000	110
11126342	Cholesterol	Savva SC	Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index.	International journal of obesity and related metabolic disorders 	2000	132
11238037	Cholesterol	Sugiyama S	Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.	The American journal of pathology	2001	102
11440984	Cholesterol	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	431
11577954	Cholesterol	Noack B	Periodontal infections contribute to elevated systemic C-reactive protein level.	Journal of periodontology	2001	97
11683410	Cholesterol	Bell SE	Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.	Journal of cell science	2001	111
11692019	Cholesterol	Rost NS	Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.	Stroke	2001	111
11705484	Cholesterol	Tounian P	Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study.	Lancet	2001	107
11752030	Cholesterol	Zoccali C	Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.	Journal of the American Society of Nephrology 	2002	92
11882522	Cholesterol	Eichner JE	Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.	American journal of epidemiology	2002	159
12020339	Cholesterol	Beckman JA	Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.	JAMA	2002	364
12093894	Cholesterol	Pullinger CR	Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.	The Journal of clinical investigation	2002	82
12432042	Cholesterol	Ridker PM	Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.	The New England journal of medicine	2002	516
12479764	Cholesterol	ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.	Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).	JAMA	2002	184
12690094	Cholesterol	Tontonoz P	Liver X receptor signaling pathways in cardiovascular disease.	Molecular endocrinology	2003	143
14600188	Cholesterol	Nissen SE	Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.	JAMA	2003	295
14747502	Cholesterol	Liu Y	Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.	JAMA	2004	120
14769624	Cholesterol	Wassertheil-Smoller S	Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).	Archives of internal medicine	2004	104
15023877	Cholesterol	Hsue PY	Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.	Circulation	2004	155
15142859	Cholesterol	Burke AP	Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study.	Arteriosclerosis, thrombosis, and vascular biology	2004	94
15148148	Cholesterol	Reitz C	Relation of plasma lipids to Alzheimer disease and vascular dementia.	Archives of neurology	2004	78
15173056	Cholesterol	Willerson JT	Inflammation as a cardiovascular risk factor.	Circulation	2004	170
15197153	Cholesterol	Ridker PM	Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?	Circulation	2004	84
15240608	Cholesterol	Malkin CJ	The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.	The Journal of clinical endocrinology and metabolism	2004	104
15262834	Cholesterol	Rutter MK	C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.	Circulation	2004	109
15297675	Cholesterol	Cohen JC	Multiple rare alleles contribute to low plasma levels of HDL cholesterol.	Science	2004	381
15314690	Cholesterol	Zheng L	Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.	The Journal of clinical investigation	2004	172
15466496	Cholesterol	Nicklas BJ	Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study.	American journal of epidemiology	2004	73
15486323	Cholesterol	Barter PJ	Antiinflammatory properties of HDL.	Circulation research	2004	271
15536110	Cholesterol	Yaffe K	The metabolic syndrome, inflammation, and risk of cognitive decline.	JAMA	2004	210
15677572	Cholesterol	Arking DE	Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.	Circulation research	2005	71
15699278	Cholesterol	Desvarieux M	Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).	Circulation	2005	116
16030277	Cholesterol	Ridker PM	Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.	JAMA	2005	141
16061755	Cholesterol	Dekker JM	Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.	Circulation	2005	94
16216938	Cholesterol	Kivipelto M	Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.	Archives of neurology	2005	242
16314544	Cholesterol	Ballantyne CM	Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.	Archives of internal medicine	2005	66
16316964	Cholesterol	Pischon T	Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.	Circulation	2005	77
16344423	Cholesterol	Wannamethee SG	Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.	Archives of internal medicine	2005	129
16403839	Cholesterol	Vaziri ND	Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.	American journal of physiology. Renal physiology	2006	90
16452169	Cholesterol	Ajees AA	Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.	Proceedings of the National Academy of Sciences of the United States of America	2006	65
16476102	Cholesterol	Barter PJ	Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.	Journal of internal medicine	2006	71
16629855	Cholesterol	Walldius G	The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.	Journal of internal medicine	2006	79
16860699	Cholesterol	Andersen LB	Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study).	Lancet	2006	238
17030687	Cholesterol	Kastelein JJ	Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.	Circulation	2006	64
17158434	Cholesterol	Esmaillzadeh A	Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome.	The American journal of clinical nutrition	2006	91
17182639	Cholesterol	O'Neill MS	Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.	Occupational and environmental medicine	2007	77
17192343	Cholesterol	Samaras K	Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and corrected hypoadiponectinemia.	Diabetes care	2007	62
17215532	Cholesterol	Cuchel M	Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.	The New England journal of medicine	2007	84
17225957	Cholesterol	Pollitt RA	Early-life and adult socioeconomic status and inflammatory risk markers in adulthood.	European journal of epidemiology	2007	65
17237796	Cholesterol	Qiu X	Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules.	Nature structural & molecular biology	2007	66
17242417	Cholesterol	Graham MJ	Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice.	Journal of lipid research	2007	58
17258085	Cholesterol	Gami AS	Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.	Journal of the American College of Cardiology	2007	326
17259501	Cholesterol	Bonora E	Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.	Diabetes care	2007	57
17322482	Cholesterol	Williams CJ	Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes.	Diabetes care	2007	59
17322881	Cholesterol	Romeo S	Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.	Nature genetics	2007	204
17339582	Cholesterol	Solomon A	Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.	Neurology	2007	55
17387133	Cholesterol	Tardif JC	Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.	JAMA	2007	143
17389279	Cholesterol	Xu A	Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.	Circulation	2007	80
17493938	Cholesterol	Fisher TS	Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.	The Journal of biological chemistry	2007	55
17495599	Cholesterol	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	63
17522380	Cholesterol	Lutgens SP	Cathepsin cysteine proteases in cardiovascular disease.	FASEB journal 	2007	71
17531663	Cholesterol	Ridker PM	C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.	Journal of the American College of Cardiology	2007	125
17699012	Cholesterol	Singh IM	High-density lipoprotein as a therapeutic target: a systematic review.	JAMA	2007	90
17702268	Cholesterol	Taheri S	Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing.	Sleep	2007	60
17827399	Cholesterol	Hamilton MT	Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease.	Diabetes	2007	317
17873875	Cholesterol	Göring HH	Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes.	Nature genetics	2007	278
17903299	Cholesterol	Kathiresan S	A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.	BMC medical genetics	2007	122
17906084	Cholesterol	Young RP	Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes.	The European respiratory journal	2007	60
17920177	Cholesterol	Seeman T	Education, income and ethnic differences in cumulative biological risk profiles in a national sample of US adults: NHANES III (1988-1994).	Social science & medicine	2008	73
17984166	Cholesterol	Kjekshus J	Rosuvastatin in older patients with systolic heart failure.	The New England journal of medicine	2007	157
18039658	Cholesterol	Poirier S	The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.	The Journal of biological chemistry	2008	82
18160725	Cholesterol	Packard RR	Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.	Clinical chemistry	2008	191
18193044	Cholesterol	Kathiresan S	Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.	Nature genetics	2008	496
18223541	Cholesterol	Williams KJ	Rapid regression of atherosclerosis: insights from the clinical and experimental literature.	Nature clinical practice. Cardiovascular medicine	2008	70
18240558	Cholesterol	Ridker PM	Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.	Nutrition reviews	2007	60
18317847	Cholesterol	Schmittdiel JA	Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.	Journal of general internal medicine	2008	78
18321997	Cholesterol	Waldo SW	Heterogeneity of human macrophages in culture and in atherosclerotic plaques.	The American journal of pathology	2008	71
18325082	Cholesterol	Leigh SE	Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database.	Annals of human genetics	2008	58
18399797	Cholesterol	Ooi EM	Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.	Clinical science	2008	62
18427135	Cholesterol	Moran A	Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females.	Circulation	2008	54
18440684	Cholesterol	Foster MC	Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.	American journal of kidney diseases 	2008	62
18452784	Cholesterol	Bahrami H	Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.	Journal of the American College of Cardiology	2008	91
18480203	Cholesterol	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	186
18505169	Cholesterol	Phillips AN	Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.	Antiviral therapy	2008	63
18523221	Cholesterol	Frikke-Schmidt R	Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.	JAMA	2008	84
18565848	Cholesterol	Adiels M	Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	135
18602635	Cholesterol	Lefevre M	Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals.	Atherosclerosis	2009	53
18711012	Cholesterol	Mora S	Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.	Circulation	2008	68
18719109	Cholesterol	Shao B	Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.	Proceedings of the National Academy of Sciences of the United States of America	2008	61
18797930	Cholesterol	Sima AV	Vascular endothelium in atherosclerosis.	Cell and tissue research	2009	49
18955664	Cholesterol	Langsted A	Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.	Circulation	2008	81
18997194	Cholesterol	Ridker PM	C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.	Circulation	2008	150
18997196	Cholesterol	Ridker PM	Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.	The New England journal of medicine	2008	998
19060906	Cholesterol	Kathiresan S	Common variants at 30 loci contribute to polygenic dyslipidemia.	Nature genetics	2009	487
19121469	Cholesterol	Kovesdy CP	Why is protein-energy wasting associated with mortality in chronic kidney disease?	Seminars in nephrology	2009	50
19148283	Cholesterol	Deo RC	Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.	PLoS genetics	2009	49
19153411	Cholesterol	El Harchaoui K	High-density lipoprotein particle size and concentration and coronary risk.	Annals of internal medicine	2009	65
19158205	Cholesterol	Hakanen M	FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity.	The Journal of clinical endocrinology and metabolism	2009	47
19203419	Cholesterol	Elahi MM	Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice.	The British journal of nutrition	2009	47
19204302	Cholesterol	Mora S	Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.	Circulation	2009	107
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19281927	Cholesterol	Patel S	Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.	Journal of the American College of Cardiology	2009	57
19287092	Cholesterol	Edmondson AC	Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.	The Journal of clinical investigation	2009	53
19329177	Cholesterol	Ridker PM	Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.	Lancet	2009	173
19351512	Cholesterol	Balijepalli RC	Caveolae, ion channels and cardiac arrhythmias.	Progress in biophysics and molecular biology	2008	55
19360495	Cholesterol	Esquirol Y	Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.	Chronobiology international	2009	58
19402938	Cholesterol	Egert S	Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.	The British journal of nutrition	2009	54
19424218	Cholesterol	Mozaffarian D	Health effects of trans-fatty acids: experimental and observational evidence.	European journal of clinical nutrition	2009	70
19497986	Cholesterol	Lehrke M	Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.	European journal of endocrinology	2009	53
19667238	Cholesterol	Oh J	1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.	Circulation	2009	82
19695853	Cholesterol	Balducci S	Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.	Nutrition, metabolism, and cardiovascular diseases 	2010	85
19698799	Cholesterol	Curcio CA	Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.	Progress in retinal and eye research	2009	89
19837721	Cholesterol	Zhao C	Liver X receptor in cholesterol metabolism.	The Journal of endocrinology	2010	71
19850715	Cholesterol	Chen TS	Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs.	Nucleic acids research	2010	148
19913121	Cholesterol	Talmud PJ	Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.	American journal of human genetics	2009	75
19936222	Cholesterol	Chasman DI	Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.	PLoS genetics	2009	120
20031564	Cholesterol	Ridker PM	Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.	Circulation. Cardiovascular genetics	2009	64
20176986	Cholesterol	Mora S	Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.	Circulation	2010	45
20202975	Cholesterol	Brasier AR	The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.	Cardiovascular research	2010	79
20400780	Cholesterol	Musunuru K	Candidate gene association resource (CARe): design, methods, and proof of concept.	Circulation. Cardiovascular genetics	2010	94
20424337	Cholesterol	Zhou Q	Pleiotropic effects of statins. - Basic research and clinical perspectives -.	Circulation journal 	2010	96
20452521	Cholesterol	Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration.	Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.	Lancet	2010	104
20516377	Cholesterol	Fraser A	Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood.	Circulation	2010	121
20581677	Cholesterol	Kontush A	Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.	Current opinion in lipidology	2010	49
20597691	Cholesterol	Lichtenstein KA	Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.	Clinical infectious diseases 	2010	77
20631351	Cholesterol	Calkin AC	Liver x receptor signaling pathways and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2010	75
20686566	Cholesterol	Musunuru K	From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.	Nature	2010	357
20816088	Cholesterol	Kjolby M	Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.	Cell metabolism	2010	63
20847045	Cholesterol	Lewis TL	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2010	46
20921964	Cholesterol	Harvie MN	The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.	International journal of obesity	2011	91
20942659	Cholesterol	Musunuru K	Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.	The New England journal of medicine	2010	139
21216812	Cholesterol	Myasoedova E	Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.	Annals of the rheumatic diseases	2011	72
21224291	Cholesterol	Healy GN	Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06.	European heart journal	2011	288
21232666	Cholesterol	Stamatakis E	Screen-based entertainment time, all-cause mortality, and cardiovascular events: population-based study with ongoing mortality and hospital events follow-up.	Journal of the American College of Cardiology	2011	82
21242007	Cholesterol	Zhou Q	Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.	Trends in pharmacological sciences	2011	41
21258337	Cholesterol	Bartelt A	Brown adipose tissue activity controls triglyceride clearance.	Nature medicine	2011	321
21298090	Cholesterol	Lee DH	Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes.	PloS one	2011	85
21347282	Cholesterol	Lettre G	Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.	PLoS genetics	2011	134
21386088	Cholesterol	Jones TH	Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).	Diabetes care	2011	76
21392724	Cholesterol	Otvos JD	Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.	Journal of clinical lipidology	2011	51
21399642	Cholesterol	Huang R	Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.	Nature structural & molecular biology	2011	62
21414625	Cholesterol	Recio-Mayoral A	Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.	Atherosclerosis	2011	39
21474825	Cholesterol	Murphy AJ	Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2011	37
21482781	Cholesterol	Feig JE	HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	94
21487090	Cholesterol	Sniderman AD	A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.	Circulation. Cardiovascular quality and outcomes	2011	70
21534675	Cholesterol	Shankar A	Loneliness, social isolation, and behavioral and biological health indicators in older adults.	Health psychology 	2011	62
21542910	Cholesterol	Carson V	Volume, patterns, and types of sedentary behavior and cardio-metabolic health in children and adolescents: a cross-sectional study.	BMC public health	2011	46
21601592	Cholesterol	McLaren JE	Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.	Progress in lipid research	2011	53
21804091	Cholesterol	Holzer M	Uremia alters HDL composition and function.	Journal of the American Society of Nephrology 	2011	59
21818333	Cholesterol	Shiels PG	Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort.	PloS one	2011	39
21947818	Cholesterol	Mitra S	Oxidized LDL, LOX-1 and atherosclerosis.	Cardiovascular drugs and therapy	2011	41
22026577	Cholesterol	de Boer RA	The fibrosis marker galectin-3 and outcome in the general population.	Journal of internal medicine	2012	49
22090275	Cholesterol	Haase CL	LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.	The Journal of clinical endocrinology and metabolism	2012	35
22113483	Cholesterol	Langan SM	Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.	The Journal of investigative dermatology	2012	56
22331829	Cholesterol	Chasman DI	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Circulation. Cardiovascular genetics	2012	46
22347441	Cholesterol	Pinto Pereira SM	Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work.	PloS one	2012	42
22356914	Cholesterol	Oh J	Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation.	The Journal of biological chemistry	2012	63
22398274	Cholesterol	Raal FJ	Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.	Atherosclerosis	2012	33
22450430	Cholesterol	Brock M	AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.	European heart journal	2014	40
22467316	Cholesterol	Lacolley P	The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles.	Cardiovascular research	2012	104
22508708	Cholesterol	Hamer M	Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.	The Journal of clinical endocrinology and metabolism	2012	90
22550134	Cholesterol	Barter PJ	Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.	Journal of lipid research	2012	31
22587332	Cholesterol	Gao W	Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.	Lipids in health and disease	2012	47
22741595	Cholesterol	Liu CJ	Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.	Journal of gastroenterology and hepatology	2012	39
22751103	Cholesterol	Strong A	Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.	The Journal of clinical investigation	2012	59
22811413	Cholesterol	Lambert G	The PCSK9 decade.	Journal of lipid research	2012	50
22981231	Cholesterol	Smith B	Anticancer activity of the cholesterol exporter ABCA1 gene.	Cell reports	2012	34
22998429	Cholesterol	Kronenberg F	Lipoprotein(a): resurrected by genetics.	Journal of internal medicine	2013	59
23015032	Cholesterol	Friedemann C	Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis.	BMJ	2012	70
23126252	Cholesterol	Schwartz GG	Effects of dalcetrapib in patients with a recent acute coronary syndrome.	The New England journal of medicine	2012	322
23141484	Cholesterol	Yamamoto S	Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.	Journal of the American College of Cardiology	2012	43
23152494	Cholesterol	Fisher EA	High-density lipoprotein function, dysfunction, and reverse cholesterol transport.	Arteriosclerosis, thrombosis, and vascular biology	2012	66
23234628	Cholesterol	Saylor PJ	Metabolic complications of androgen deprivation therapy for prostate cancer.	The Journal of urology	2013	25
23312047	Cholesterol	Superko HR	High-density lipoprotein subclasses and their relationship to cardiovascular disease.	Journal of clinical lipidology	2012	30
23332012	Cholesterol	Longenecker CT	Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.	HIV medicine	2013	56
23351925	Cholesterol	Anderson TJ	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.	The Canadian journal of cardiology	2013	162
23415864	Cholesterol	Zhang R	Emerging roles of Lipasin as a critical lipid regulator.	Biochemical and biophysical research communications	2013	30
23690465	Cholesterol	Tavori H	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	Circulation	2013	42
23726366	Cholesterol	Coram MA	Genome-wide characterization of shared and distinct genetic components that influence blood lipid levels in ethnically diverse human populations.	American journal of human genetics	2013	46
23727030	Cholesterol	Yamada H	Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.	Clinica chimica acta; international journal of clinical chemistry	2013	41
23775089	Cholesterol	Seidah NG	The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions.	The Journal of biological chemistry	2013	37
23817481	Cholesterol	Egan BM	Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.	Circulation	2013	27
23829656	Cholesterol	Monami M	Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	26
23884353	Cholesterol	Desai NR	AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.	Circulation	2013	37
23918283	Cholesterol	Appelqvist H	The lysosome: from waste bag to potential therapeutic target.	Journal of molecular cell biology	2013	115
23926208	Cholesterol	Varbo A	Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.	Circulation	2013	29
23965489	Cholesterol	Boekholdt SM	Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.	Circulation	2013	32
23981342	Cholesterol	Shen Y	Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.	Cardiovascular diabetology	2013	26
23995233	Cholesterol	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	56
24002795	Cholesterol	Mora S	High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.	Circulation	2013	48
24013058	Cholesterol	Thomas GS	Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.	Journal of the American College of Cardiology	2013	32
24013639	Cholesterol	Westra HJ	Systematic identification of trans eQTLs as putative drivers of known disease associations.	Nature genetics	2013	432
24014831	Cholesterol	Stein EA	Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia.	Circulation	2013	44
24056686	Cholesterol	Leebmann J	Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.	Circulation	2013	29
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24243886	Cholesterol	Khera AV	Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).	Circulation	2014	28
24253250	Cholesterol	Funderburg NT	Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.	Clinical infectious diseases 	2014	45
24255061	Cholesterol	Koren MJ	Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.	Circulation	2014	39
24259050	Cholesterol	Rottiers V	Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.	Science translational medicine	2013	40
24317040	Cholesterol	De Nardo D	High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.	Nature immunology	2014	51
24345402	Cholesterol	Mora S	Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.	Circulation	2014	26
24366527	Cholesterol	McKee AC	The neuropathology of sport.	Acta neuropathologica	2014	56
24368514	Cholesterol	McInnes IB	Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.	Annals of the rheumatic diseases	2015	39
24379180	Cholesterol	Gaillard R	Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study.	Hypertension	2014	28
24415784	Cholesterol	Eckard AR	Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.	The Journal of infectious diseases	2014	37
24507774	Cholesterol	Peloso GM	Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.	American journal of human genetics	2014	80
24507775	Cholesterol	Lange LA	Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.	American journal of human genetics	2014	67
24509273	Cholesterol	Raal FJ	Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.	Journal of the American College of Cardiology	2014	49
24558110	Cholesterol	Hoogeveen RC	Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.	Arteriosclerosis, thrombosis, and vascular biology	2014	36
24585268	Cholesterol	Sjouke B	Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.	European heart journal	2015	40
24603306	Cholesterol	Miranda MX	The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.	European heart journal	2015	19
24608080	Cholesterol	Zhang M	MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages.	Atherosclerosis	2014	29
24633158	Cholesterol	Holmen OL	Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.	Nature genetics	2014	57
24639424	Cholesterol	Ray KK	The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.	European heart journal	2014	43
24663222	Cholesterol	Laakso M	Insulin resistance and hyperglycaemia in cardiovascular disease development.	Nature reviews. Endocrinology	2014	41
24811298	Cholesterol	Diffenderfer MR	The composition and metabolism of large and small LDL.	Current opinion in lipidology	2014	21
24864123	Cholesterol	Sandler NG	Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.	The Journal of infectious diseases	2014	25
24918167	Cholesterol	Ramsey LB	The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.	Clinical pharmacology and therapeutics	2014	41
24925270	Cholesterol	Casas R	The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.	PloS one	2014	29
24980493	Cholesterol	Martin SS	HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.	European heart journal	2015	27
25060413	Cholesterol	Gaudet D	Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).	The American journal of cardiology	2014	24
25062744	Cholesterol	Joshi PH	Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies.	European journal of preventive cardiology	2016	16
25070550	Cholesterol	Rashid S	Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.	Circulation	2014	27
25101658	Cholesterol	Strong A	Sortilin and lipoprotein metabolism: making sense out of complexity.	Current opinion in lipidology	2014	20
25282520	Cholesterol	Raal FJ	Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.	Lancet	2015	77
25341796	Cholesterol	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	22
25350695	Cholesterol	Postmus I	Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.	Nature communications	2014	38
25414253	Cholesterol	Foks AC	Treating atherosclerosis with regulatory T cells.	Arteriosclerosis, thrombosis, and vascular biology	2015	28
25449833	Cholesterol	Ronsein GE	Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.	Journal of proteomics	2015	20
25467842	Cholesterol	Chen L	Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.	Metabolism	2015	24
25487149	Cholesterol	Do R	Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.	Nature	2015	114
25583993	Cholesterol	Pfeiffer L	DNA methylation of lipid-related genes affects blood lipid levels.	Circulation. Cardiovascular genetics	2015	35
25691689	Cholesterol	Soininen P	Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics.	Circulation. Cardiovascular genetics	2015	58
25725623	Cholesterol	Vergès B	Pathophysiology of diabetic dyslipidaemia: where are we?	Diabetologia	2015	20
25773378	Cholesterol	Robinson JG	Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.	The New England journal of medicine	2015	201
25773607	Cholesterol	Sabatine MS	Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.	The New England journal of medicine	2015	176
25784512	Cholesterol	Ballantyne CM	Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia.	The American journal of cardiology	2015	29
25791433	Cholesterol	Huan T	Genome-wide identification of microRNA expression quantitative trait loci.	Nature communications	2015	25
25961943	Cholesterol	Surakka I	The impact of low-frequency and rare variants on lipid levels.	Nature genetics	2015	47
25979724	Cholesterol	Nüesch E	Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.	International journal of epidemiology	2016	12
26027630	Cholesterol	Kereiakes DJ	Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study.	American heart journal	2015	39
26049157	Cholesterol	Hoefer IE	Novel methodologies for biomarker discovery in atherosclerosis.	European heart journal	2015	18
26068959	Cholesterol	Hooper L	Reduction in saturated fat intake for cardiovascular disease.	The Cochrane database of systematic reviews	2015	36
26085104	Cholesterol	Butkinaree C	Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other.	The Journal of biological chemistry	2015	16
26088304	Cholesterol	Giugliano RP	Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?	Journal of the American College of Cardiology	2015	16
26116691	Cholesterol	Lin X	Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Journal of the American Heart Association	2015	32
26131930	Cholesterol	Joshi PK	Directional dominance on stature and cognition in diverse human populations.	Nature	2015	29
26333678	Cholesterol	Giunzioni I	Local effects of human PCSK9 on the atherosclerotic lesion.	The Journal of pathology	2016	14
26416579	Cholesterol	Ferretti G	Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.	Progress in lipid research	2015	15
26444323	Cholesterol	Everett BM	Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.	The New England journal of medicine	2015	31
26503748	Cholesterol	Bergeron N	Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.	Circulation	2015	15
26580236	Cholesterol	Wong PM	Social Jetlag, Chronotype, and Cardiometabolic Risk.	The Journal of clinical endocrinology and metabolism	2015	20
26719191	Cholesterol	Hammad S	Current Evidence Supporting the Link Between Dietary Fatty Acids and Cardiovascular Disease.	Lipids	2016	11
26744084	Cholesterol	Guo T	Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels.	Scientific reports	2016	11
26817832	Cholesterol	Ortega Moreno L	Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes.	Cardiovascular diabetology	2016	10
26848159	Cholesterol	Barter PJ	Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead--Pro.	Arteriosclerosis, thrombosis, and vascular biology	2016	12
26892965	Cholesterol	Ketelhuth DF	Adaptive Response of T and B Cells in Atherosclerosis.	Circulation research	2016	15
26896437	Cholesterol	Leander K	Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.	Circulation	2016	14
26908947	Cholesterol	Benn M	Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.	European heart journal	2016	19
26916794	Cholesterol	Ridker PM	Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents.	European heart journal	2016	11
26920601	Cholesterol	Sabatine MS	Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial.	American heart journal	2016	25
26933753	Cholesterol	Dewey FE	Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.	The New England journal of medicine	2016	49
26976914	Cholesterol	de Ferranti SD	Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).	Circulation	2016	20
27040132	Cholesterol	Yusuf S	Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.	The New England journal of medicine	2016	45
27050191	Cholesterol	Khera AV	Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.	Journal of the American College of Cardiology	2016	27
27100393	Cholesterol	Medina-Remón A	Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial.	British journal of clinical pharmacology	2017	13
27102113	Cholesterol	Raal FJ	PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.	Journal of lipid research	2016	12
27122601	Cholesterol	Nordestgaard BG	Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.	European heart journal	2016	20
27135400	Cholesterol	Helgadottir A	Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.	Nature genetics	2016	32
27192541	Cholesterol	Nioi P	Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.	The New England journal of medicine	2016	12
27277824	Cholesterol	Mahley RW	Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.	Journal of molecular medicine	2016	24
27350042	Cholesterol	Dekkers KF	Blood lipids influence DNA methylation in circulating cells.	Genome biology	2016	25
27515591	Cholesterol	Bowe B	High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.	Clinical journal of the American Society of Nephrology 	2016	13
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	25
27668658	Cholesterol	Iotchkova V	Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.	Nature genetics	2016	14
27841877	Cholesterol	Lotta LA	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.	Nature genetics	2017	27
27881394	Cholesterol	O'Connor LE	Total red meat intake of ≥0.5 servings/d does not negatively influence cardiovascular disease risk factors: a systemically searched meta-analysis of randomized controlled trials.	The American journal of clinical nutrition	2017	6
27986651	Cholesterol	Reyes-Soffer G	Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.	Circulation	2017	12
28062489	Cholesterol	Moriarty PM	Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.	Arteriosclerosis, thrombosis, and vascular biology	2017	9
28153991	Cholesterol	Lew J	Sex-Based Differences in Cardiometabolic Biomarkers.	Circulation	2017	7
28183512	Cholesterol	Tsimikas S	A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.	Journal of the American College of Cardiology	2017	9
28207502	Cholesterol	Mazidi M	Impact of the dietary fatty acid intake on C-reactive protein levels in US adults.	Medicine	2017	7
28212521	Cholesterol	Camaré C	Angiogenesis in the atherosclerotic plaque.	Redox biology	2017	5
28288972	Cholesterol	Bacchiega BC	Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study.	Journal of the American Heart Association	2017	6
28304224	Cholesterol	Sabatine MS	Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.	The New England journal of medicine	2017	105
28304227	Cholesterol	Ridker PM	Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.	The New England journal of medicine	2017	11
28304242	Cholesterol	Ridker PM	Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.	The New England journal of medicine	2017	30
28306389	Cholesterol	Ray KK	Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.	The New England journal of medicine	2017	14
28329114	Cholesterol	Bernelot Moens SJ	PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia.	European heart journal	2017	6
28334899	Cholesterol	Spracklen CN	Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.	Human molecular genetics	2017	7
28385496	Cholesterol	Stitziel NO	ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.	Journal of the American College of Cardiology	2017	16
28450350	Cholesterol	Khera AV	Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).	Circulation	2017	8
28514624	Cholesterol	Lincoff AM	Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.	The New England journal of medicine	2017	21
28538136	Cholesterol	Dewey FE	Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.	The New England journal of medicine	2017	18
9314845	Isoproterenol	Kubota T	Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.	Circulation research	1997	109
10212248	Isoproterenol	Mason DA	A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.	The Journal of biological chemistry	1999	96
11489934	Isoproterenol	Kehat I	Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.	The Journal of clinical investigation	2001	313
12552097	Isoproterenol	Baillie GS	beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.	Proceedings of the National Academy of Sciences of the United States of America	2003	112
12791707	Isoproterenol	He JQ	Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization.	Circulation research	2003	171
20576935	Isoproterenol	Casey LM	Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.	Circulation research	2010	60
22050625	Isoproterenol	Novak A	Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.	Journal of cellular and molecular medicine	2012	64
23642535	Isoproterenol	Zhang D	Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.	Biomaterials	2013	115
24852842	Isoproterenol	Hirt MN	Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.	Journal of molecular and cellular cardiology	2014	49
25480693	Isoproterenol	Rau CD	Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice.	Circulation. Cardiovascular genetics	2015	24
12454259	TG(16:0/16:0/18:0)	Merkel M	Lipoprotein lipase: genetics, lipid uptake, and regulation.	Journal of lipid research	2002	116
14683737	TG(16:0/16:0/18:0)	Hanefeld M	Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.	European heart journal	2004	80
15033247	TG(16:0/16:0/18:0)	Sajadieh A	Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease.	European heart journal	2004	71
17540190	TG(16:0/16:0/18:0)	Sacks HS	Human epicardial adipose tissue: a review.	American heart journal	2007	158
19075393	TG(16:0/16:0/18:0)	Romeo S	Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.	The Journal of clinical investigation	2009	125
19776010	TG(16:0/16:0/18:0)	McGillicuddy FC	Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.	The Journal of biological chemistry	2009	65
19800867	TG(16:0/16:0/18:0)	Karbiener M	microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma.	Biochemical and biophysical research communications	2009	90
21843325	TG(16:0/16:0/18:0)	Innala L	Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.	Arthritis research & therapy	2011	44
22041134	TG(16:0/16:0/18:0)	Shearer GC	Fish oil -- how does it reduce plasma triglycerides?	Biochimica et biophysica acta	2012	38
22878467	TG(16:0/16:0/18:0)	Pirazzi C	Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.	Journal of hepatology	2012	46
23542898	TG(16:0/16:0/18:0)	Graham MJ	Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.	Circulation research	2013	54
24369119	TG(16:0/16:0/18:0)	Pingitore P	Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function.	Biochimica et biophysica acta	2014	23
24716628	TG(16:0/16:0/18:0)	Abu-Farha M	Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.	Cardiovascular diabetology	2014	20
24721265	TG(16:0/16:0/18:0)	Kersten S	Physiological regulation of lipoprotein lipase.	Biochimica et biophysica acta	2014	54
24886709	TG(16:0/16:0/18:0)	Ko A	Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.	Nature communications	2014	23
24927523	TG(16:0/16:0/18:0)	Mahdessian H	TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
24941082	TG(16:0/16:0/18:0)	Jørgensen AB	Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.	The New England journal of medicine	2014	132
25225788	TG(16:0/16:0/18:0)	Timpson NJ	A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.	Nature communications	2014	23
25555214	TG(16:0/16:0/18:0)	Fabbrini E	Metabolically normal obese people are protected from adverse effects following weight gain.	The Journal of clinical investigation	2015	39
25862742	TG(16:0/16:0/18:0)	Desikan RS	Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.	Circulation	2015	22
26222559	TG(16:0/16:0/18:0)	Gaudet D	Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.	The New England journal of medicine	2015	41
26892959	TG(16:0/16:0/18:0)	Musunuru K	Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.	Circulation research	2016	11
14636671	Arachidonic acid	Spector AA	Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.	Progress in lipid research	2004	156
15930289	Arachidonic acid	Jiang JG	Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.	Cancer research	2005	65
18320251	Arachidonic acid	Malerba G	SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease.	Lipids	2008	70
19601928	Arachidonic acid	Félétou M	EDHF: an update.	Clinical science	2009	77
19891972	Arachidonic acid	Deng Y	Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.	Journal of molecular and cellular cardiology	2010	52
22298653	Arachidonic acid	Imig JD	Epoxides and soluble epoxide hydrolase in cardiovascular physiology.	Physiological reviews	2012	99
24567509	Arachidonic acid	Zhang X	Complex role of STIM1 in the activation of store-independent Orai1/3 channels.	The Journal of general physiology	2014	22
12551955	1-Phosphatidyl-D-myo-inositol	Srinivasan S	Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis.	The Journal of cell biology	2003	163
12682293	1-Phosphatidyl-D-myo-inositol	Sudhakar A	Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.	Proceedings of the National Academy of Sciences of the United States of America	2003	111
16738242	1-Phosphatidyl-D-myo-inositol	Wang L	Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration.	The Journal of neuroscience 	2006	98
20519507	1-Phosphatidyl-D-myo-inositol	He W	Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.	The Journal of biological chemistry	2010	45
